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Abstract
Protein kinases play important roles in regulating cellular functions in many 
organisms. This work deals specifically with the protein kinase CK2 (casein kinase
II) and its role in regulating the activity of proteins involved in oocyte development 
mXenopus laevis. Protein kinase CK2 is a tetrameric enzyme containing two 
catalytic subunits (a and a') and two identical regulatory subunits ((3) which forms 
the holoenzyme. CK2 phosphorylates many different proteins involved in many 
aspects of cellular functions. It phosphorylates serine and threonine sites and is 
considered to be a ubiquitous enzyme, expressed at different levels in different cell 
types.
In this study CK2 activity was characterized in material from, two sources: 
from isolated nuclei and messenger ribonucleoprotein (mRNP) particles from 
Xenopus oocytes. cDNAs expressing both the a and the p subunits were cloned and 
antibodies were raised against the fusion protein containing the a-subunit. The main 
objective of this study was to determine the effects that CK2 had on proteins 
involved in oocyte development.
The interaction of CK2 with a protein known as histone deacetylase was 
studied in depth to determine how phosphorylation might influence its function and 
cellular compartmentalisation. Specifically, phosphorylation by CK2 is shown to 
improve the kinetics of nuclear import, and the interaction of histone deacetylase 
with a-importin, a well-established nuclear transport protein, is revealed to be 
dependent on the phosphorylation state of histone deacetylase.
Another aspect of this work is related to the association of CK2 with mRNP 
particles in the cytoplasm. mRNP particles function as long term storage units for 
mRNA to be used during oocyte maturation and early embryogenesis. It has been 
postulated that a protein kinase associated with these particles plays a role in 
controlling the binding of mRNA to proteins involved in translation repression 
(mRNA masking proteins). This study lends support to that theory, and the possible 
effects of CK2 phosphorylation on the masking “Y-box“ proteins are discussed.
iv
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Chapter 1: Introduction
1.0 Protein Kinases
The activity of protein phosphorylation by kinases is an important control 
mechanism for the activation and repression of transcription, translation and cellular 
transport. Many types of protein kinases exist, which have many different substrates and
regulatory cofactors. The importance of protein kinases as regulators is well known and 
widely studied, especially in signal transduction and cascade events. In general, protein 
kinases are regulating enzymes that function as reversible covalent modifiers; they add 
phosphate groups at specific threonine, serine, or tyrosine residues (Edelman et al,
1987). They generally use ATP as the source of these phosphates, but some can also use 
GTP. This phosphoiylation can cause steric changes to the substrate which may either 
expose or hide the active site, thus increasing or inhibiting its activity. Modulation of 
activity by phosphorylation may occur through the binding of other stimulating or 
inhibiting proteins (Edelman et al., 1987).
This study is specifically concerned with the protein kinase CK2 (Casein-Kinase- 
II) and its regulatory controls in the early development of Xenopus laevis. Its expression 
and activity, as well as its specific function has to some extent been studied in the 
developing oocytes, but more work is required. The activity of the enzyme in 
phosphorylating important substrates, such as histone deacetylase and mRNP complexes, 
has been the major focus of this work. The function of CK2 is not as well defined as 
that of the other kinases and it has been implicated in many different mechanisms. Its 
functions are so diverse and ubiquitous that many roles have been postulated, some of 
which are very different, but none of these roles have been completely explained. The 
importance of CK2 as a regulatory enzyme is becoming more apparent and will merit
more attention.
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1.1 Protein Kinaae CJK-
1. L1 Structure of CK2: In many protein kinases a catalytic domain which binds 
ATP and the substrate to be phosphorylated has been identified. The ATP binding 
domain in the enzyme CK2 (a subunit) is located near the amino terminus and consists 
of the amino acid residues 46GRGKYSEV53 (Hanks and Quinn, 1991). Centrally 
located, usually at Asp 184, is where the transfer of the phosphate group to the substrate 
takes place. At the carboxy-terminus of the catalytic domain is thought to be located the 
substrate binding site consisting of the residues 155D V K PHN 161, but this is still 
under investigation (see figure 1). The clustering of the basic residues around this acidic 
region is supposedly very important for interaction with the acidic regions of potential 
substrates (Kemp and Pearson,1990). The sequence required for CK2 phosphorylation 
is a serine or threonine site followed by any two non-basic residues and ending with a 
aspartic acid or glutamic acid residue (S/T X X D/E). These sites are usually surrounded 
by numerous acidic residues (Pinna, 1990),
MSGPVPSRAR
VEWGNQDDYQ
NNEKVVVKIL
GPNIITLADI
FKQLYQTLTD
GIMHR '
FYHPGQEYNV
YSLDMWSLGC
QLVRIAKVLG
DILGRHSRKR
LDKLLRYDHQ
QSRMAALICP
VYTDVNTHRP
LVRKLGRGKY
KPVKKKKIKR
VKDPVSRTPA
YDIRFYMYEI
VMIDHEHRK
RVASRYFKGP
MLASMIFRKE
TEDLYDYIDK
WERFVHSENQ
TRLTAREAMD
VAAHPSVAPV
RDYWDYESHV 30 
SEVFEAINIT 60 
EIKILENLRG 90 
LVFEHVNNTD 120 
LKALDYCHSM 150 
LRLIDWGLAE 180 
ELLVDYQMYD 210 
PFFHGHDNYD 240 
YNIELDPRFN 270 
HLVSPEALDF 300 
HPYFYPIVKD 330
350
Figure 1: CK2a Functional Domains: Blue = Region of ATP Binding 
Green = NLS
Red = Autophosphorylation Site
= Substrate Recognition sequence
Protein kinase CK2 is a serine/threonine phosphorylating tetrameric enzyme,
consisting of two a,-subunits and two h-subunits, which is found in abundance in both
3
the cytoplasm and the nucleus. However, it is thought that CK2 has roles primarily in 
the nucleus, having a less active role in the cytoplasm (Krek and Nigg 1992). It can use 
both ATP and GTP as cosubstrates, with almost equal efficiency (ATP: Km~lOmM,
GTP: Knr30mM) (Edelman et ah, 1987). CK2 is found in many types of tissues 
throughout the animal kingdom. The highest levels of the enzyme are generally seen in 
dividing cells, both normal and transformed. The human form of the a subunit gene has 
recently been completely characterized. The gene spans 70 kb and consist of 13 exons, 
all of which follow the gt/ag rule in defining the boundaries between intron and exons. 
The size range of the exons are from 51 to 2960 bp in length, and introns range from 527 
to 34000 bp in length. The translation start site has been located in Exon 2, and the stop 
codon in Exon 13. Promoter activity was detected in the region ranging from -256 to 
144, and it seems to show features of a house keeping promoter due to the lack of a 
TATA box, and the presence of a CpG island, and GC boxes (Winkner et ah, 1998). The 
genes that encode the enzymatic subunits in yeast are CKAl, CKA2, CKBl and CKB2. 
This is different from Xenopus, which contains only one P subunit gene (CKB), instead 
of the two seen in yeast. Gene deletion experiments have shown that deletion of the 
CKAl and CKA2 are lethal, but deletion of CKBl and CKB2 are not (Glover, 1998). 
These genes produce the subunits that make up the functional enzyme, and the control of 
their expression is still unclear. The two a-subunits (a-42kDa and a'-38kDa) are 
catalytically active, while the two B subunits (25kDa) act as regulatory subunits by 
increasing the catalytic activity when bound (Allende and Allende, 1995). The a and a' 
subunits have extensive sequence identity with one another, about 90% identity within 
the first 330 amino acids. The C-terminal regions are mostly unrelated; the a subunit
contains 60 amino acids of unrelated sequence and the a' contain approximately 20
amino acids of unrelated sequence (Penner et al., 1997). The a subunits can function in
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the absence of the B subunits in vivo, but with reduced activity. Although it is widely 
accepted to be a tetrameric enzyme, it has been reported that the a subunits of the 
enzyme in the nucleus of Chironomus tentans remain largely separate from the p
subunits, and in fact the a subunits seem to be bound to other nuclear components
(Stigare et al, 1993). The B subunits cause the monomeric a subunits to enter into a 
tetrameric conformation which might enable the two a subunits to phosphorylate each 
other, thus self-stimulate their activity (Tuazon and Traugh, 1991). The B subunits 
usually act as protectors against proteolysis and heat denaturation; in addition, when 
bound to the a subunit pair they can change the enzyme’s specificity to substrates and 
inhibitors (reviewed by Allende and Allende, 1995). The a subunits come together via
the bridge forming homodimeric p subunits, to form the heterotetramer (~130kDa). The 
P subunit has been studied quite extensively by many groups in order to determine how
its controlling effect is produced. Both its interaction with the a subunit and other
substrates, as well as its association with itself have been studied. The p-p homodimer 
comes together via a homodimerization domain which is thought to be located between 
residues 20 and 145 (Kusk et al, 1995). It seems that the C-terminal domain of the p
subunit (last 45 amino acids) is essential for its interaction with the a subunit and may 
also be important for its positive effects on stability and activity (Chen and Copper, 
1997). The N-terminal domain, which contains an acidic group of amino acids, seems to 
be important for its inhibitory effects. (Kusk et ah, 1995). An example of the p 
subunit’s control of activity is the interaction of CK2 with the ribosomal protein L5 
mediated via the p subunits (Kim et al, 1996). The p subunit can also prevent 
phosphorylation of certain substrates, an example being calmodulin (Marin et al., 1995).
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The structure of the CK2 protein tells us much about its possible origins 
and of course its possible function. The amino acid sequence is highly conserved in 
different species, from Drosophila to human, especially in the catalytic domains of both 
the a subunits; the fi subunits are also highly conserved (see figure 2 and 4 for
alignments). The motif 46 G R G K Y S E V 54 in the a subunit is important because it 
encompasses part of the binding site for ATP, and the presence of the tyrosine next to 
serine also appears in the cyclin-dependent kinases (cdk) family which suggests a 
possible common ancestor (Rihis et al, 1991). The motif 74KKKKIKR80 
represents a very basic stretch which could be involved in the binding to acidic regions 
of both substrates and inhibitors, such as those present in heparin, but also it has been 
postulated to be part of the nuclear localization signal for transport into the nucleus 
(Rihis et al, 1991). The amino acid sequence of the CK2B subunit shows similarities to 
the cyclin family, which have similar functions in that they both up- regulate the activity 
of their catalytic subunit and affect its substrate specificity (Ludeman et al, 1993). They 
also seem to share an a-destruction box sequence which could mean that the B subunit, 
like cyclin, might be targeted for ubiquitin-mediated proteolysis which gives some 
insight to its possible regulation during the cell cycle.
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Figure 2: CK2a Amino Acid Alignment: Sequence alignment from different species. Red 
indicates acidic residues, blue indicates basic and yellow indicates neutral residues. Conserved 
regions are boxed. All sequences were obtained from EMBL data bank, aligned using GCG and 
presented in SeqVu.
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Figure 3: CK2p Amino Acid Sequence Alignment: Sequence alignment from different 
species. Red indicates acidic residues, blue indicates basic and yellow indicates neutral residues. 
Conserved regions are boxed. All sequences were obtained from EMBL data bank, aligned 
using GCG and presented in SeqVu.
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The crystal structure of the a-subunit in Zea mays was recently obtained by 
Niefind et ah in 1998. The protein was shown to have a similar active site to cAMP- 
dependent protein kinase (cAPK) and cyclin-dependent kinase 2 (CDK2) bound to 
cyclin A; thus specific structural functionality was extrapolated from these known 
structures. The basic structure of the a-subunit consist of a P-sfrand rich N-terminal
domain and an a-helical rich C-terminal domain between which lies the active site, as
shown in figure 4. Helix aC, which lies in the P-strand rich N-terminal domain, is 
critical for substrate recognition (Pinna and Ruzzene, 1996) and is aligned towards the 
active site. This interaction may contribute to the highly active nature of CK2. This aC 
region contains a highly basic cluster of residues (74-KKKKIKREIK-83) which may 
interact with the P-subunit of CK2 (Samo et ah, 1996). The P8 and P9 loop, which 
composes part of the activation site, could play an important role in catalysis due to the 
fact that they contain the magnesium chelating residue at Asp 175. It helps orientate the 
y-phosphoryl group of ATP properly and also the hydrophobic pocket for binding of 
nucleotide bases in which lie 174 plays a major role (Niefind et ah, 1998). The C- 
terminal lobe contains the aD helix which seems to be important for substrate binding 
and for the anchoring of ATP, but it does not have the well known hydrogen-bonding 
anchor site for the ribose moiety of ATP (Niefind et ah, 1998). The fact that ATP and 
GTP could both be used as co-substrates was explained due to the fact that the binding 
pocket is not highly conserved for ribose and triphosphate fixation. Thus it does not 
provide the specific hydrogen binding pattern that exists in other kinases (cAPK) that 
use only ATP or GTP. When ATP was bound to the purine binding site it bound in an 
disordered fashion, with the adenine base attached to a novel binding site (isoleucine 
instead of alanine) and with a low specificity (Niefind et ah, 1998).
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IFigure 4: Structure of CK2a: Pictorial representation of CK^a subunit showing the 
N-terminal region in blue, activation region in yellow, the active site marked by a bound 
ATP molecule, and the a-helices (red) and (-sheets (green) are number and lettered. 
Taken from Niefind et al., 1998.
1.1.2 Functionof CK2\ Spet^ific functionffor CK2 havebeensoubht inmany 
systems, but the general finding is that it is a multifunctional enzyme having many 
substrates. In Saccharsmyces cerevisiae there have been at least four possible biological 
functions postulated: flocculation, cell cycle regulation, cell polarity, and ion 
homeostasis (reviewed by Glover, 1998). CK2 has also a plethora of substrates that it is 
known to phosphorate. The diversity of these substrates makes it increasingly difficult
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to define a definitive pathway to illustrate CK2’s functions. For example, it can modify 
enzymes involved in nucleic acid synthesis (RNA polymerase I and II, DNA 
topoisomerase I-II, DNA ligase); transcription factors: nuclear oncogene products and 
tumor suppressor proteins (c-myc, large T antigen of SV-40, c-myb, N-myc, C-jun, 
retinoblastoma (RB)); signal transduction proteins (p34cdc’2, protein kinase C, protein 
kinase A, insulin receptor, calmodulin, LD-lipoprotein receptor); protein synthesis 
factors (eIF3, eIF4B, eIF5, EFIB, EF2B, eIF2B); cytoskeleton and structural proteins (B- 
tubulin, myosin heavy and light chain, spectrin, tropin-T, Map-1B); other nuclear and 
nucleolar proteins (HMG 1, HMG 14, nucleolin, Np-B23, pi20, pp35, p210, FK506) 
(reviewed by Allende and Allende, 1995). The (potential) importance of CK2 in 
regulating many cellular processes is illustrated by the wide range of substrates listed 
above. It will be important to explain how these different mechanisms may be linked 
together via this regulating enzyme.
Protein kinase CK2 is an important regulator of transcription and translation in 
both germ cells and somatic cell cycles. It has been deemed necessary for Go/Gi 
transition, early G% and Gi/S transition phases of the cell cycle (Pepperkok et al, 1994). 
The effects of CK2 on transcription and translation events have been widely studied in 
many diverse mechanisms and cellular models. The phosphorylation of the Y-box 
proteins is thought to enhance their binding to mRNA (Murray et al., 1991); it has also 
been postulated that Y-box phosphorylation could block the translation of mRNA 
(Braddock et al, 1994). The association of CK2 with nuclear regulation factors, such as 
FGF-2 (Basic Fibroblast Growth Factor-2) has also been studied. FGF-2 was postulated 
to stimulate the activity of CK2 thus in turn activating potential transcription factors such 
as nucleolin (Bouche et al, 1994). Nucleolin is a nucleolar phosphoprotein which is 
essential in the modulation of rRNA synthesis and pre-ribosome assembly. It is thought 
that nucleolin can bind to the non-transcribed spacer region of rDNA and it may be a
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possible transcription site for RNA polymerase I (Bouche et al, 1994). Nucleolin has 
been described to be an inhibitor of transcription in vitro when unphosphorylated, and 
when phosphorylated it supposedly does not interfere with transcription; therefore 
phosphorylation of nucleolin seems to be required for cell growth.
CK2 is found in greater amounts and with increased activity in cells that are 
actively proliferating, such as embryonic and tumor cells (Issinger et al, 1993). It has 
been proposed that cdc-2 kinase (MPF) phosphorylates CK2 in order to up-regulate its 
activity. Progesterone-induced oocyte maturation seems to have only modest effects on 
stimulating CK2 activity; a 1.7 fold increase has been observed imXenopus laevis 
oocytes (Cicirelli et al, 1988). Although larger levels of increased cdc-2 kinases activity 
are seen after progesterone-induced maturation, it is possible that this kinase could 
activate CK2 activity at a later stage in embryonic development. It has also been shown 
that the activity of CK2 is enhanced by mitogenic factors, such as serum, insulin, IGF-I 
and EGF (Allende and Allende, 1995). This up-regulation could be due to post­
transcriptional modification, and not to increased protein production. However, these 
findings have been the subject of some controversy and the exact effect of mitogenic 
factors in regulating CK2 is still unclear. Insulin is seen to induce phosphorylation of 
nucleolin in 3T3-442A cells. It is proposed that CK2 may play a role in the efflux of 
RNA that is observed in cell nuclei after the addition of insulin. The dose dependence of 
insulin-induced phosphorylation of nucleolin and the insulin-induced efflux of RNA are 
almost identical (Csermely et al, 1992). This suggests that insulin-induced 
phosphorylation and dephosphorylation of nucleolin may regulate RNA transport 
through the nuclear membrane.
Whether CK2 directly participates in a signal transduction pathway, when 
regulated by either FGF-2 or insulin to phosphorylate nucleolin or if its activation is a 
general response to general growth factors, is unclear (Bouche et al, 1994). It is still not
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fully understood whether CK2 is unequivocally involved in intermediate steps of a signal 
transduction pathways, as is for example cAMP-dependent protein kinase, or in cascade 
events, as is protein kinase R2C2 (Sommercom et aL, 1978).
Examinations of CK2 activators and suppressors make it even more difficult to 
assign a specific role, since these seem to be diverse and do not point to any single 
physiological mechanism. Known activators of the CK2 enzyme are the polyamines 
such as spermine and spermidine which increase the activity by 2-3 fold (Meggio et al, 
1992). Polyanionic compounds, such as heparin, are well known potent inhibitors 
(Hathaway et al, 1980; Taylor et al, 1987). This could be due to the fact that heparin is 
a high acidic compound and binds veiy tightly to CK2's catalytic domain which binds to 
acidic residues in its substrates (aspartic and glutamic acids), thus acting as a competitive
inhibitor.
Other compounds such as quercetin (Cochet et al, 1981) and 5,6-dichloro-lp-D- 
ribofuranosylbenzimidazole (DRB) are also well know inhibitors of CK2, but their exact 
mechanisms of inhibition is unknown (Zadomeni and Weinmann, 1984). Kinetic studies 
have shown that quercetin behaves as a competitive inhibitor towards the substrate and 
exhibits a high affinity for the ATP and GTP binding sites of other similar kinases 
(cAMP-independent casein kinase G type (CKG)) (Cochet et al, 1981). DRB is a 
known inhibitor of RNA polymerase II transcription and it is thought that this is due to 
its inhibitory action on protein kinase CK2 (Zadomeni and Weinmann, 1984). Also it has
been shown that DRB some how actually alters the chromosomal distribution of CK2-a
through a time-dependent clearance after the addition of DRB, but again it is unclear 
what the mechanism of this clearance could be (Egyhazi et al, 1998).
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Nucleic acids such as, single stranded DNA, poly U and tRNA have also been 
shown to have an inhibitory effect on CK2, which may suggest a nuclear regulatory 
mechanism yet unknown (Gatica et al, 1989).
CK2 is an example of a protein kinase that can use GTP as well as ATP as a 
phosphate source. It is also known for its inability to use Mn2+ instead of .Mg2+ to 
support activity (Mulner et al, 1988). These criteria are widely used in the 
identification of the CK2 enzyme activity since its cofactors, activators and inhibitors are 
for the most part unique for this enzyme.
1.1.3 Role in nuclear impoet: Protein kinaseCK2 isa multi-fanctionflenzyme 
and although most of this chapter has been focused on its nuclear activity there are other 
important roles which should be mentioned. There are many proteins that are 
transported to the nucleus via a nuclear localization signal (NLS). These proteins 
include the transcription factors, structural proteins and enzymes; they are needed faster, 
and in more concentrated amounts than simple diffusion can supply. They are also 
needed at different stages of the cell cycle, so a system of regulation is needed that can 
responded to external stimuli, cell-cycle progression and developmental cues. These 
specific proteins are selectively transported through the nuclear pore complex (NPC) via 
recognition of internal signals. Uptake of many of these proteins may be regulated by 
phosphorylation and dephosphorylation, particularly during embryogenesis. Protein 
kinases, such as protein kinase CK2 and p34(=n2 kinase, have been shown to play 
important roles in phaspharylati2g sites in transported proteins, which is linked to 
accumulation of these proteins in the nucleus (Vancurova et al, 1995).
There exists a barrier known as the nuclear envelope that separates the nuclear 
matrix from the cytoplasm. This barrier is a selectively permeable membrane, which 
contains many NPC, and allows only certain cellular components entrance into the
14
nucleus. Many proteins and nucleic acids shuttle constantly to and from the nucleus via 
these gates. Nucleic acids such as mRNAs, tRNAs, and rRNAs are the main exports 
while proteins seem to be the main imports(reviewed by Nigg, 1997). The NPC 
provides the channel for transport through the nuclear membrane and this complex 
measures about 9 nm in diameter (Davis, 1995). This allows diffusion of smaller 
molecules such as metabolites, ions and small proteins (40-60K) but provides an energy- 
dependent selective channel for larger proteins. The NPC is made up of over 100 
proteins collectively known as nucleoporins, which form a complex of about 
125,000kDa (reviewed by Nigg, 1997). Of the many hundreds of proteins that make up 
the NPC only a minority have been widely studied. Some of the more important ones 
which have been studied extensively have roles in nuclear docking and translocation. 
Proteins that have been identified for translocation are Ran-GTP/GDP cycle and nuclear 
transport factor-2 (NTF2) (Moore et al, 1993). This is an energy dependent step in 
which docked proteins are shuttled through the pore complex via binding to Ran; this 
process is regulated by Ran GAPl and RCCl. There are other proteins such as 
importin-a and p that are important in recognition and docking to the NPC (fig 5).
Importin-a binds to proteins via a nuclear localization signal (NLS) and importin-P 
mediates docking to the NPC (Gorlich, et al, 1995). There are two possible systems for 
the regulation of nuclear transport. The first is cytoplasmic anchoring and release. 
Proteins are bound or anchored in the cytoplasm and in response to a signal, such as 
hormones, are released by phosphorylation or by selective proteolysis and migrate to the 
nucleus. The second known regulatory pathway is by masking and unmasking of the 
NLS (Nigg, 1990). The nuclear localization signal contains a specific motif within the 
amino acid sequence. The NLS usually consists of basic residues in either one or two 
clusters and therefore are called either mono or bipartite NLS (Dingwall and Laskey,
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1991). It has been well established that phosphorylation of the NLS in proteins effects 
the efficiency of transport of those proteins into the nucleus. It is thought that 
phosphorylation can activate the NLS by the addition of phosphates to residues near or 
within the NLS, which either change the protein conformation thus exposing the NLS, or 
by enhancing the binding of transport proteins (Karin and Hunter, 1995). This means 
that kinases and phosphatases must work as opposing forces controlling which proteins 
and when nuclear transport will occur. It is thought that some protein phosphatases and 
kinases are compartmentalized to restrict subcellular location and improve specificity.
It seems that the targeting of proteins are controlled by a reversible phosphorylation. A 
balance between kinases and phosphatases controls phosphorylation and these enzymes 
appear to be placed in specific cellular areas to augment this control (reviewed by Faux 
and Scott, 1996). Accessibility to the substrates seems to play a major part in regulating 
the selectivity of these enzymes. Many kinases (PKA, PKC, and CK2) and phosphatases 
(PP-1, PP-2A and PP-2B) are know to participate in this nuclear transport regulation 
(reviewed by Faux and Scott, 1996).
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Figure 5: NLS Function Regulated by Phosphorylation: A possible role for CK2 in 
nuclear import. Phosphorylation of certain proteins affect the rate of nuclear import.
The SV40 T-antigen was one of the first proteins to be described having a 
nuclear localization single motif (PKKKRKV)(Kalderon et al., 1984) and whose 
transport was enhanced by phosphorylation of a serine or threonine, between 10-30 
amino acids away from the NLS, by the kinase CK2 (Rihs and Peters, 1989). It was 
shown that residues at 111 or 112 (both serine sites) enhance the transport of this protein 
after phosphorylation with CK2 (Rihs et al, 1991).
The nuclear form of CK2 demonstrates an ability to modulate the activity of 
nucleolin; however cytoplasmic CK2 has also been shown to have a high binding and 
phosphorylation activity towards nucleolin (Dongxia et al, 1996). Nucleolin has been 
shown to shuttle between the cytoplasm and nucleus, which raises the possibilities that 
CK2 might have some direct effect on this movement and movement of other related 
proteins into the nucleus (Borer et al, 1989). Recently it has been shown that the 
bipartite NLS of nucleolin is phosphorylated by both CK2 and cdc2 kinase. Cytoplasmic
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injection experiments, into Xenopus oocytes, demonstrated that the presence of both 
these sites leads to increased nuclear import and that the phosphorylation of the CK2 site 
further increased the rate (Schwab and Dreyer, 1997). The cdc2 sites had a dual role in 
controlling import. The presence of the cdc2 sites, within the nucleolin sequence, 
increased nuclear import, whereas the phosphorylation of these sites promoted 
cytoplasmic localization (Schwab and Dreyer, 1997). This combination of CK2 
enhanced import and cdc2 induced cytoplasmic anchoring provides nucleolin with a 
powerful cell-cycle dependent regulatory mechanism.
Nucleoplasmin, a large pentameric nuclear protein with distinct head and tail 
domains, has been extensively studied, and it has been found that the rate of its nuclear 
transport is proportional to the degree of phosphorylation by CK2. For example, 
nucleoplasmin was treated with alkaline phosphatase, which removes 70% of the 
phosphates from the protein, and was labeled with 35S. It was then microinjected into 
the cytoplasm of Xenopus oocytes (Vancurova et aL, 1995). The observations were that 
treated protein accumulated in the nucleus much slower then the untreated protein. It 
was also observed that CK2 co-purified with nucleoplasmin, which suggests that not 
only does CK2 facilitate transport, but it is also transported with nucleoplasmm for 
possible use in the nucleus (Vancurova et al., 1995). In summary, several studies have 
emphasized the importance of protein kinases and phosphatases as regulators of protein
transport.
1,2 OocyteDevelopment
1.2.1 The use ofXenopus oncytes: ivity hcs veen pseviously mvestlyated
in relation to oocyte development in the South African clawed toad (Xenopus laevis). 
Oogenesis in Xenopus is a suitable model for experimentation due to the fact that there is 
an enormous wealth of developmental information already collected, and due to the large
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size and relative ease of collecting its oocytes. Work was first done on Xenopus oocytes 
in the late 50s and early 60s when they were used to study nuclear transplantation 
(Fischberg et al, 1958; Gurdon, 1960). Work continued, using these oocytes, because 
biochemical experiments, especially dealing with extraction of nucleic acids, was found 
to be much simpler and more reliable than those using oocytes from other species such 
as Rana pipiens. Xenopus oocytes have also proven to be an invaluable model for 
studying transcription and translation, nuclear import, protein secretion, protein 
compartmentalization, protein modification and many other aspects of cell biology.
1.2.2 Classification of aooytos'. Xenopus oovpun growasynchrononsly, which 
makes collection of any and every stage of oocyte very convenient. They are classified 
into six major stages according to size and pigmentation (Dumont, 1972). The smallest 
oocyte is classified as stage I (up to 100pm) and the largest stage VI (1200pm; see fig. 
6). The time taken to develop from the smallest stage to the largest is several months. 
Oocyte development can also be stimulated using hormonal induction, usually follicle- 
stimulating hormone (Wallace, 1985). When stage VI is reached development is 
arrested at late prophase I of meiosis (diplotene), but such oocytes can be induced to 
mature in vitro by adding progesterone (Taylor and Smith, 1986).
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Stages: I II III IV VI
Figure 6: Xenopus oocyte stages: Stage I oocytes are 50-100pm in diameter and are 
translucent. Stage II oocytes are ~ 450pm and are opaque white, vitellogenesis (the 
deposition of yolk) starts at this stage. Stage III oocytes are 450-600pm and show the 
beginning of pigmentation deposit. Stage IV oocytes are 600-1000pm and have 
differentiated animal and vegetal hemispheres. Stage V oocytes are 1000-1200pm and 
show clear delineation of hemispheres: the animal hemisphere appears light brown. 
The final stage VI oocytes are 1200-1300pm have a white band separating the two 
hemispheres and are post-vitellogenic and are ready for maturation. Bar represents 500 
pm. Taken from Kay and Peng 1991.
1.2.3 Developing oocyte: During oogenesis the changes in gene expression and 
rate of protein synthesis increase dramatically, especially with the onset of maturation 
and after fertilization. The accumulation of yolk proteins starts at stage II 
(vitellogenesis) and continues until early stage VI. Large stores of ribosomes (10 ) and 
mRNA molecules (2xlOn) accumulate per oocytes over this period of oogenesis 
(Davidson, 1986). The amount of RNA of all types, increases from about 0.04 pg in
stage I to over 4 pg per oocyte in stage VI. Of this RNA only 1% is messenger RNA, 
which encodes for over 20,000 distinct protein sequences. The rest is mostly ribosomal 
(90%) and transfer RNA (4%) (Davidson, 1986). At stage VI of oogenesis, growth is
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blocked at the diplotene stage of development around the first meiotic division in 
prophase I. Progesterone then activates the maturation process and produces a cascade 
of events. Oocytes complete the first meiotic division and continue through meiosis II to 
metaphase, in which they arrest again as unfertilized eggs. During maturation the 
nuclear envelope breaks down (germinal vesicle breakdown, GVB), exposing the 
chromosomes, which have condensed from their active state (lampbrush chromosomes), 
to cytoplasmic factors. These events enable the first meiotic division to take place 
enabling the G2 to M transition of the cell cycle. The cytoplasmic factors that make up 
this machineiy are stimulated by hormones and are known as the maturation-promoting 
factor (MPF). They are thought to consist of the enzymes cdc2 kinase and cyclin B 
(Sunkara et al, 1979; Colas and Guerrier, 1995). During MPF activation 'mXenopus, a 
burst of phosphorylation is observed which is independent of cyclic-AMP-dependent 
protein kinase, a known stimulator of MPF (Mulner-Lgrillgn et al, 1988). As 
mentioned before, CK2 has been implicated in cell division elsewhere and there is a 
phosphorylation increase during meiotic cell division m Xenopus oocytes. Earlier work 
has also shown that CK2 is a target for cdc2 activation during MPF induced 
phosphorylation cascade (Belle et al, 1990). These findings made it imperative to study 
the activity of CK2 in this system to determine its exact influence during this process.
1.2.4 CK2 activity during nteuelnpment'.ThGrQ havebeenlimited sludiee onuhe 
activities of CK2 mXenopus oocytes by many different groups which serve to highlight 
the importance of this enzyme in the development of oocytes. The enzyme was first 
purified and characterized Oom Xenopus ovary in 1988 (Mulner-Lgrillgn et al, 1988). It 
was referred to as a casein kinase Il-like enzyme since its exact sequence was unknown. 
The purified enzyme was injected into full grown oocytes and its biological effects were 
investigated. Injection of the enzyme was shown to increase the activity of the MPF,
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thus augmenting meiotic maturation, but it seemed to inhibit meiotic cell division by 
blocking the effects oE progesterone (Mulner-Lorillon et al, 1988).
The sequences of the a and p subunits were first determined for Xenopus in 1992 
using a probe derived from the human and Drosophila sequences (Jedlicki et al, 1992). 
The results showed a very high sequence conservation between human Ynd Xenopus, 
with the a subunits showing a very high conservation at the amino end: about 80%
identity in the first 323 amino acids, and the p subunits showed high conservation with 
only 2 amino acids difference hetween Xenopus and human (Jedlicki et al, 1992). 
Estimates have been made of the amount of CK2 mRNA and enzyme present at different 
stages of oogenesis (II-VI) and it was found that the amount of message actually 
increases 2 to 3 fold from stage II to stage VI for both the a and p subunit. There are 
approximately 5q 107 molecules of CK2a mRNA and 1 qID7 of CK2p mRNA in full 
grown oocytes (Wilhelm et al, 1995). The noted increases are interesting, since it has 
been claimed that peak levels of most stored (maternal) mRNA are reached in oocytes at 
early stages (I-II) (Golden et al, 1980; Davidson, 1986). The graded increase in mRNA 
encoding CK2 throughout oogenesis is puzzling. Another observation is an increase in 
enzymatic activity of about 12-15 fold from stage II to stage V, which means that CK2 is 
being used throughout oogenesis and that its stores must be constantly replaced; 
however the eQact purpose of CK2 during these stages of development is unknown 
(Wilhelm et a/., 1995).
The p subunit has been shown to have an effect on oocyte maturation that is
independent from the a subunit. It has been shown that the p subunit binds to Mos and 
inhibits its ability to stimulate Mos-mediated mitogen-activated protein kinase (MAPK). 
Mos is necessary and sufficient to initiate oocyte maturation, and when CK2P is bound,
this inhibits progesterone induced maturation. Also, when the levels of CK2p enzyme
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are decreased, MAPK activity is increased when treated with low concentration of 
progesterone (Chen and Cooper, 1997). The activity of Mos, MAPK, MMK and MPF 
seem all to be linked, and dependent on phosphorylation activation. Without it the 
oocyte cannot commit to germinal vesicle breakdown, chromosome condensation, 
suppression of DNA replication, entry into meiosis II, and metaphase arrest (Chen and 
Cooper, 1997). It seems that CK2P may possibly set a threshold level for Mos activity 
to activate oocyte maturation.
1.3 Phosphorylation of Proteins in Maternal mRNP Particles
1.3.1 mRNP phosphoproteinse Dining oogenesis,genee^^(?ms’ lanve, theoocytes 
increase many times in size and accumulate cellular components required for early 
embryonic development. Cellular components such as mRNA, tRNA, histones and 
ribosomes are synthesized and packaged for use during the rapid cell divisions of early 
embryogenesis. A pool of about 2x10H molecules of mRNA/oocyte is established by 
vitellogenesis and is mostly maintained until oocyte maturation. This maternal mRNA is 
the source of new protein through maturation, fertilization and embryonic cleavage 
stages. At mid-blastula, zygotic gene expression is initiated and the maternal 
information is replaced (Davidson, 1986).
In early oogenesis (and in spermatogenesis) mRNA is stored as mRNP by the 
binding of specific proteins to the mRNA. This occurs in order to prevent mRNA from 
premature translation and possibly might also protect it from degradation. The mass 
ratio of protein to RNA is about 4 to 1 in ribosome-free mRNA (Darnbrough and Ford, 
1981; Cummings and Sommerville, 1988). Some of these bound proteins could be also 
necessary for the translation of the mRNA later in early embryogenesis, but this has not 
been proven. Protein kinase CK2 activity may be required for the phosphorylation of 
some of these proteins in order to help assemble or to stabilize the mRNP particle.
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There are four main proteins associated with the mRNA which have the apparent masses 
on SDS-PAGE of 60, 56, 54, and 50 kDa (Darnbrough and Ford, 1981; Cummings and 
Sommerville, 1988). In addition, a kinase with the properties of CK2 co-sediments with 
the mRNP particles. The two proteins pp60 and 56 kDa are phosphorylated in vivo 
during the developmental stages in which mRNA is repressed (Cummings et al, 1988). 
These proteins have been identified as FRGY-2a and FRGY-2b, and are members of the 
Y-box family of proteins (Tafuri and Wolffe, 1990). The name Y-box refers to a 
recognition sequence, containing an inverted CCAAT-box, which is found in the 
promoter region of MHC class II genes to which these proteins are known to bind 
(Didier et al, 1988). Y-box proteins are regulators of transcription and translation and 
have been shown to bind to mRNA in order to prevent translation; this process is known 
as "masking" (reviewed in Sommerville and Ladomery, 1996a). The primary structure 
of FRGY2a (pp60) and FRGY2b (pp56) became apparent with the cloning of their 
cDNA (Tafuri and Wolffe, 1992; Murray et al., 1992). The two sequences are very 
similar, indicating that FRGY2a and 2b are encoded by pseudoalleles (fig. 44). This 
situation is not unusual beeause Xenopus laevis is believed to have evolved as a 
tetraploid species. FRGY2a/b consist of a cold-shock domain and alternating regions of 
basic and acidic amino acids. The cold shock domain (CSD) is made of five antiparallel 
P-strands forming a p-barrel structure. This structure binds single stranded RNA and 
DNA very efficiently (Schindelin et al., 1994; Newkirk et al., 1994). This binding of 
RNA and DNA via the CSD suggests that the Y-box proteins are potential regulators of 
transcription and translation. The CSD actually proved essential for the binding of 
FRGY2 to Y-box containing promoters mXenopus DNA (Tafuri and Wolffe, 1992).
The regulation of the binding of Y-box proteins to nucleic acids is one of the 
fimdamental questions that still remains. Examination of the Y-box proteins and the 
CSD revealed that the CSD is associated with a series of alternating basic and acidic
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charged islands. These alternating charged islands are collectively known as the “tail 
domain”. The acidic regions contain potential CK2 phosphorylation sites and these are 
thought to promote protein multimerization and to stabilize RNA-binding (Tafuri and 
Wolffe, 1992). It has been demonstrated that phosphorylation is necessary for mRNA 
masking, but its eQact purpose is still unknown (Kick et al,, 1987; Cummings and 
Sommerville, 1988; Murray et al, 1991; Murray, 1994). Early reports suggest that these 
proteins are phosphorylated at serine residues specifically at position 149 in FRGY-2a 
and b and at position 125 only in FRGY-2a (Deschamps et al, 1997) but what purpose 
this phosphorylation serves is unclear. The phosphorylation studies claim that 
phosphorylating FRGY-2a and 2b does not effect their ability to bind to RNA, and it is 
suggested that their phosphorylation state does not influence the initial masking of 
mRNA in oocytes (Deschamps et al, 1997). Other possibilities are: that 
phosphorylation controls the interaction of FRGY2 molecules to form dimers or 
multimers on the DNA or mRNA with other proteins; and the fate of the assembled 
mRNPs. It has been shown that microinjection of inhibitors of protein kinase into mid­
oogenic oocytes has increased the rate of endogenous protein synthesis by a factor of 
two to three. The increased activity seems to be due to mobilization of mRNA into 
polysomes instead of increased translation efficiency (Sommerville, 1990). Injection 
eQpEriments which introduce reporter RNA and antibodies against CK2 into oocytes 
resulted in about 20% of the potentially translatable RNA being released from masking, 
which points to the importance of CK2 activity in the masking process. Similar results 
were obtained when oocytes were treated with kinase inhibitors such as DRB or 
quercetin, but treatment with rutin (inactive form of quercetin) had no effect (Braddock 
et al, 1994). Progesterone-mediated unmasking of mRNPs, which is needed in 
promoting the maturation of oocytes, has been found to be blocked by phosphatase 
inhibitors, such as okadaic acid, which suggests the phosphorylation is indeed necessary
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to maintain masking, but phosphorylation of which proteins by what kinase is unclear 
(Braddock et al., 1994). These results do point to the importance of CK2 in the control 
of translation of mRNPs, and if correct, the levels of phosphorylation of mRNP particles 
should coincide with the presence of the CK2 activity and with the non-translating state 
of message. Of course the converse should also be true: that during translation of 
message the associated CK2 level should be low as well as the level of phosphorylation
of mRNP.
Protein 1 Protein 2 References
mRNP4 mRNP3 Damborough and Ford, 1981 
Murray et al., 1994
pp60 pp56 Kick et al, 1987
Crawford and Richter, 1987
p56 p54 Murray er al, 1991
FRGY2a FRGY2b Tafuri and Wolffe, 1990
Figure 7; Variations in naming of major mRNA masking proteins in Xenopus oocytes: The
four major variations in nomenclature of FRGY2a and FRGY2b.
1.3.2 Expression of CK2 during oogenesis: The levels of CK2 message would be 
expected to be expressed at different levels during different stages of development, • 
depending on whether maternal mRNA should be stored or translated. However CK2 
has many other functions besides the masking of mRNA, and since its mRNA may itself 
be under translational control, little can be concluded from the levels of message seen. 
The levels of mRNA have been calculated to be, in stage VI, 5x107 mRNA per oocyte 
for the a subunit, and 1x107 for the B subunit (Wilhelm et al, 1995). During oogenesis
the relative levels of mRNA for CK2 increase 2.5 fold for the a subunit and three fold
for the B subunit from earlier stages (II) to later oocyte stages (V-VI) (Wilhelm et al, 
1995). The exact levels of CK2 mRNA is presently being disputed due to comparison 
with earlier work done on levels of other mRNAs, such as GTP-binding protein (100-
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fold less), Ras mRNA (threefold less), and A-type and B-type cyclins which remain 
constant from stage two to stage VI in Xenopus oocytes (Wilhelm et al., 1995). Why the 
levels of CK2 message appear high compared with other messages, and even increase 
through oogenesis while mRNAs for other important growth proteins remain constant, is
unanswered.
It has been shown that CK2 is an abundant protein in the nucleoli, which leads 
to the speculation that CK2 might be required for the synthesis of ribosomal RNAf
(Wilhelm et al., 1995). This would explain the increased levels of CK2 mRNA, since 
the synthesis of ribosomal RNA reaches maximum rates though mid to late oogenesis. 
After fertilization of the oocytes, the levels of CK2 dramatically decrease. The 
FRGY2a/b masking proteins are no longer phosphorylated, although they are still 
present in the mRNP (Sommerville, 1990). During early cleavage to gastrulation, the 
level of activity of mRNP-bound CK2 drops by a factor of seven. This could be due to 
increased levels of protein phosphatase activity and/or kinases inhibitors that are 
observed to accumulate at the end of oogenesis and into embryogenesis (Sommerville, 
1990). These changes in phosphorylation seem to coincide with the formation of 
polysomes and translation of the maternal mRNA (Sommerville, 1990).
1.3.3 Export of RNA from the nucleus’. Export of mRNP particles from the 
nucleus is another mystery of oocyte development. It is well known that after mRNA is 
transcribed it is exported to the cytoplasm for translation. During oocyte development 
mRNA accumulates and is stored in the cytoplasm for future use during fertilization. 
How mRNA is exported has been widely studied and it is thought that there must be a 
nuclear export signal (NES). It is thought that proteins that shuttle between the nucleus 
and cytoplasm act as carriers of RNA. It is on these proteins that the signal for export is 
thought to exists and not on the RNA itself. This signal has been discovered on proteins
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such as iKb, Rev from HIV and TFIIIA and is believed to be a leucine-rich peptide 
sequence. The yeast protein Npl3p is a protein which shuttles back and forth between 
the nucleus and cytoplasm also binds to RNA. Mutation in the NES of this protein has 
shown a marked decrease in export of poly(A) RNA from the nucleus (reviewed by Lee 
and Silver, 1997). The contribution to mRNP export of structures within the mRNA 
itself is another aspect being studied. It is thought that certain modification to the 
mRNA such as a cap addition may facilitate its transport. Also the presence of introns 
may trap the mRNA in spliceosomes which would inhibit premature export of unspliced 
RNA. It is also a possibility that modifications of the bound proteins may facilitate 
export by enhancing their association with export factors like a/p importin, Ran or 
transportin (reviewed by Nigg, 1997). Such modifications could result from 
phosphorylation, dephosphorylation or protein cleavage. Exactly which proteins, and 
what modifications are necessary, continues to be investigated. It is also important to 
establish how these complexes interact with the nuclear pore complex, and to what 
external signals they respond.
1.4 Maternally Expressed Histone Deacetylase and Development
1.4.1 Histone fur^ction and modification'. TdasXonopus laevis clone ABH 
(accession number X78454) was first recognized as a candidate homologue to the yeast 
gene regulator RPD3 (Vidal and Gabor, 1991). This was later shown to be a homologue 
of the human histone deacetylase HDACl (Taunton ec nO, 1996). Histone deacetylase is 
a maternal enzyme expressed throughout oogenesis and into early embryogenesis in 
Xenopus Onevis. Its function is to aid in the formation of tightly packed nucleosomes 
after new chromatin has been replicated. Nucleosomes are composed of core histones, 
one of them being pre-acetylated histone H4. Histone H4 is acetylated at lysine residues
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(residues 5 and 12) by histone acetyltransferase HAT B (Sobel et ah, 1994). When H4 is 
acetylated it reduces it net positive charge, which has been shown to disrupt the tight 
binding of the nucleosome, and thus could allow the binding of transcription factors to 
promoters. The acetylation and deacetylation of core histones plays an important 
regulatory role in the transcription and replication of chromatin.
The interaction of several other protein factors with histone deacetylase results in 
the formation of complexes which function as a regulators of gene expression (reviewed 
by Wolffe 1996, 1997). HDACl has been shown to associate with proteins such as 
RbAp48, Sin 3, and N-Cor (Taunton et ah, 1996; Alland et ah, 1997; Heinzel et al, 
1997). These complexes are believed to function as repressors of gene transcription by 
targeting the deacetylase activity to specific chromatin sites.
1.4.2 Expreesion of HDACm during oogeneeis
During Xenopus oocyte development, a maternal form of histone deacetylase 
(HDm; Ladomery et al, 1997; HDACm Sommerville et al., 1998) is expressed 
thoughout development. It steadily increases, along with non-chromosomal histone 
proteins as components required for the formation of new chromatin during the rapid cell 
cleavages leading to blastula. During maturation and early embryogenesis, transcription 
activity is not detected and maternal stores of histones and assembly factors produced 
new chromatin from the rapidly replicating DNA. It is during this assembly of newly 
formed chromatin that histone deacetylase removes the acetyl groups from the core 
histones, thus stabilizing the chromatin into nucleosomes. The expression ofHDACm 
decreases after fertilization at around mid-blastula. This corresponds to when the cell- 
cycle slows down and cells begin differentiation (Sommerville et al, 1998).
The regulation of activity and transport ofHDACm is one major question still 
left unanswered. Within the HDACm amino acid sequence there are several potential
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phosphorylation sites, specifically motifs recognized by CK2. This protein kinase has an 
expression pattern similar to that ofHDACm (Wilhelm et al, 1995) and, as discussed 
previously, has been shown to regulate the function and nuclear import of many 
substrates (reviewed by Allende and Allende, 1995). The phosphorylation state could be 
a regulatory mechanism controlling the association of histone deacetylase into protein 
complexes, controlling the substrate recognition specificity, level of activity, or nuclear 
import of newly synthesized HDACm.
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1.5 Project Aims
Protein kinase CK2 activity has been shown to be an important part of the control 
of transcription, translation and intracellular transport. Its exact function and regulation 
has been postulated, but more evidence is needed. The work recorded here concerns the 
role of protein kinase CK2 in modifying histone deacetylase, specifically via the 
phosphorylation ofHDACm, and in determining translation of masked messages, 
specifically via the phosphorylation of Y-box proteins. The project aims to measure the 
expression and activity of CK2 in developing oocytes and to study its effects on these 
specific substrate proteins which are also important for oocyte development. Before 
interaction of CK2 with HDACm were studied, CK2 expression was studied, in detail, to 
get a better understanding of its concentration and activity as oocytes develop. The 
nuclear import ofHDACm was suspected to be affected by phosphorylation by CK2, 
consequently this aspect was studied in greater detail. The effect of CK2 on mRNP 
particles had been investigated previously, but further work was considered to be 
necessary in order to understand better the role of phosphorylation of Y-box proteins.
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Chapter 2: Methods
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2.1 ZZap cDNA Libraiy Screening
2.1.1 Library construction: A cDNA library was prepared by Dr. Sommerville 
following the instructions in the ZZAP manual. cDNAs were prepared from. poly(A')+ 
mRNAs extracted from polysomal mRNP from previtellogenic oocytes, the idea 
being to select for mRNAs encoding proteins required at a high levels during this 
phase of development.
2.1.2 Plating bacteriophage X: The plating cells for XZAP transformation 
were a strain called XL 1-Blue. Individual colonies of these plating cells were picked 
from a plate and used to inoculate a 5 ml Luria broth (LB, per litre: Bactotryptone 
lOg, Bacto-yeast extract 5g, and NaCl lOg) which was grown overnight at 37°C.
Next 40 ml of fresh LB was inoculated with 1 ml of the overnight culture 'to which 
maltose and MgS04 were added to a final concentration of 0.2% (w/v) and 10 mM
respectively. The cells were grown with vigorous shaking until they reached an 
OD600 of about 0.5, after which they were spun at 3,000 g at 4°C for 5 minutes, and 
resuspended in 4 ml of ice-cold sterile 10 mM MgS04. 4ml of top agarose (0.8 %
agarose in LB) was melted and placed in a 45°C water bath. 100 pi of plating cells 
were infected with an appropriate dilution of bacteriophage in SM buffer (per litre: 
NaCl 5.8g, MgSO4 2g, Tris base 6.05g, 2% gelatine 5ml and HCl to pH 7.5). Cells 
were infected for 15 minutes at 37°C, and then plated out by mixing them with 4 ml 
of top agarose cooled to 45°C and pouring the mixture onto pre-warmed plates. The 
top layer was allowed to set for 15 minutes on the bench and then the plates were 
placed inverted into a 37°C incubator. Plaques appeared after approximately 6 hours.
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For plating out the library in the primary round of screening, larger plates were 
preferred (150 mm diameter) in order to plate out 10,000-20,000 pfu (plaque forming
units) per plate.
2.1.3 Expression ofplaque fusion proteins: Nitrocellulose filters were 
prepared by wetting them in a sterile solution of 10 mM IPTG and then dried before 
use. When the plaques were sufficiently developed, the filters were carefully overlaid 
on the plaques. The plates were placed back into the oven for a further 3-4 hours. 
This allowed the fusion proteins to be expressed. The filters and the plates were 
marked with a needle, covered in Indian ink, to enable orientation and identification 
of the plaques. The filters were lifted off the agar and labelled for screening. 
Afterwards, they were placed into TBS containing 2% filtered skimmed milk 
overnight. Meanwhile, the agar plates were stored at 4®C for later picking of positive 
plaques.
2.1.4 Identification of positive plaques using antibody screening: The 
nitrocellulose filters were probed with antibodies obtained either from an outside 
source (CKa chicken), or from a rabbit that had been injected with fusion protein 
(CKa). The procedure was the same as described in the antibody production section 
2.14. The DAB reaction produce small brown dots that corresponded to the plaques 
that were making a protein which was recognised by the antibody. The filter was 
place on to a sheet of acetate. The outline of the filter and the position of the 
orientation marks were marked onto the acetate. Next, the position of the positive 
signals were marked and the acetate was aligned with the agar plates.
2.1.5 Picking positive plaques: Positive plaques were cored out using a 1 ml 
Gilson pipette fitted with a truncated tip and transferred to a 1.5 ml microcentrifuge
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tube containing 500 pi of SM buffer. A drop of chloroform was added for storage at
4°C. Phage particles diffused out of the agar plug into the SM buffer; typically, a 
plug gave a titre of approximately 105 pfu/ml. To purify positive plaques, the initial
stocks were plated at lower densities until a single positive isolated plaque could be 
picked.
2.1.6 Recovery of pBlueScript from 2ZAP: 2x 107 XL-1 cells in 200 ml were 
combined with 200ml of the XZap phage (1 x 107 phage) that were obtained from the 
plaque picks. Also 1 pi of R408 helper phage was added (1 x 107 phage). They were 
incubated for 15 minutes in 37°C water bath. The mixture was then heated for 20
minutes in a 70°C water bath and spun at 5,000 rpm for 5 minutes. The supernatant 
was removed and this was stored at 4°C until needed. This phagemid stock was used 
to reinfect XL-1 cells, so that ampicillin resistant transformants were produced 
containing the sequence of cDNA. Only the XL-1 cells that were infected with the 
phagemid carrying pBlueScript would have ampicillin resistance. These were plated 
on agar plates containing ampicillin at 50 pg\ml.
2.1.7 Recovery of plasmid DNA using Wizard Minipreps: Single colonies of 
XL-1 were picked and grown overnight in 5 ml of LB. This culture was spun down 
and supernatant was removed. The DNA from these cells were extracted using the 
Wizard Plus SV Miniprep (Promega). The standard Wizard Miniprep protocol was 
used in obtaining purified plasmid DNA. The kit is a small scale purification of 
plasmid DNA, using spin column to wash bacterial lysate through a filter which 
captures the DNA and then is eluted from filter using nuclease free water.
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2.L8 Analysis of DNA using agarose gel electrophoresis: Samples of DNA 
were digested for 1-2 hours in small volumes (10-20 pi), containing the required 
restriction buffer and restriction enzyme. Removal of RNA was done by adding 
RNase to a final concentration of 50 pg/ml, ribonuclease A, and 50 units/ml of
ribonuclease Ti to the digests, in the final 20 minutes of their restriction. 5 pi of gel
loading buffer (0.25 % Bromophenol blue, 0.25% Xylene cyanol, and 30% Glycerol 
in dH20) was added to the restriction reaction before loading onto an agarose gel for 
electrophoresis. The concentration of agarose in the gels varied between 0.8 and 2%, 
depending on the size of DNA fragments being analysed: 0.8% agarose was best for 
separation of larger fragments (> 2 kb), whereas 2% agarose favoured the separation 
of smaller fragments (500 bp and less). The agarose was dissolved in 30 ml of TAB 
buffer (40mM Tris-acetate and ImM EDTA) by melting in a water bath on a Bunsen 
burner. It was then placed into a water bath at 45°C for at least 30 minutes to bring 
the temperature down to near its setting. Next, ethidium bromide was added to a final 
concentration of 0.5 pg/ml before pouring the gel. The gel was covered in TAB
buffer, and the restriction digests loaded (up to 15 pi per well). Samples were run at 
40-100 V and the DNA bands were visualised using a 300 nm UV-light
transilluminator.
2.1.9 Purification of DNA from agarose: Once the DNA was determined to 
be of the correct size it was often cut from the agarose gel, in order to recover and 
purify it. The band was cut using a sterile razor blade while being viewed on the 
transilluminator, on low power. This was to ensure that only the band representing 
the required DNA was excised. The DNA was removed from the agarose gel by
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purifying it using the Nucleon™ Easiclene Kit: for the rapid isolation and purification 
of DNA (Scotlab). The method used was the standard protocol that was included 
with the purification kit by the manufacturer. The theory behind the kit is that the 
agarose is melted away in 6M Nal and the freed DNA is bound to a silica-based 
matrix (glassmilk). The matrix is washed with a “wash” buffer (50mM NaCl, lOmM 
Tris.HCl pH 7.5, 2.5 mM EDTA, 50% v/v ethanol), which removes the ethidium 
bromide and other impurities, and the purified DNA is then eluted in warm dH2O. In 
general, 5 pi of glassmilk was added to samples containing 5 pg or less of DNA, and 
an extra 1 pi for every 0.5 pg of DNA above 5 pg. This purified DNA could be used 
for various other techniques, such as sequencing or ligation into expression vectors.
2.2 DNA Sequencing
Sequencing was carried out by the DNA automated sequencing unit located in 
the Irvine building. Samples must contain 0.5 pg of DNA, and 4 pmol of primers in a
final volume of 12 pi of dH2O. Oligo nucleotide primers used in the sequencing 
reaction were ordered from PE-Applied Biosystems UK. Results are sent by Send 
Express or e-mail and contain the sequence and a densitometric scan, which was 
viewed using the program Editview.
2.3 Polymerase Chain Reaction
PCR is the method used for the amplification of specific DNA sequences, 
using primers of known sequences. The PCR reactions were made up in a 0.5 ml 
microcentrifuge tube containing: 0.1 pi of cDNA (10 ng), 50 pmoles of forward
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primer, 50 pmoles of reverse primer*, 0.5 pl of Taq polymerase, 4 pl of dNTPs (50 
pm), 1.5 pl MgCla (50mM), 5 pl of lOx buffer (500mM KCl, lOOmM Tris-HCl pH 9,
and 1.0% Triton X-100), and 34.6 pl of dH2O. A layer of mineral oil was placed over 
the reaction mixture to prevent evaporation. The mixture was placed into a thermal 
cycler (MJ Research, Inc.) and run using a program called CKl edited (step 1: 
denaturing at 94°C for 4 minutes, step 2: denaturing at 94°C for 1 minute, step 3: 
primer annealing at 60°C for 1 minute, step 4: extension at 72°C for 2.5 minutes, step 
5: 24 times to step 2, step 6: 72°C for 10 minutes, and step 7: 4°C for indefinite hold) 
After the PCR reaction, DNA was analysed on an agarose gel and ligated into a 
vectors for protein expression and/or sequencing. Oligo nucleotide primers used in 
the PCR reaction were ordered from PE-Applied Biosystems UK and contained 
restriction sites for easy insertion into vectors.
2.4 DNA Cloning into Vectors
2.4.1Restriction digests: PCR transCripts and lptsary subcioyes were placed 
into various plasmids by ligating the DNA into open vectors. The vectors were first 
opened using specific restriction enzymes who's sites were contained within the 
multiple cloning sites of the vector. The enzyme had to be chosen with several 
factors taken into consideration. The restriction site must only exist in the area of the 
vector where the insert is to be placed. Also, a similar site must exist in the DNA 
planned for ligation into the vector. This was usually engineered into the primers for 
PCR, or in the recovered plasmid in library screening. Finally, the DNA must be 
inserted into a vector at a restriction site that will keep the sequence in frame. DNA
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(1-3 pg) and a specific restriction enzyme (2-10 units) were placed into a 1.5 ml 
Eppendorf tube with 1 pl of the corresponding lOx buffer and water up to 10 pl. If 
more than one restriction enzyme was needed then the buffer was changed to either 
One-Phor-All Buffer Plus™ (Pharmacia) or Multi-Core™ (Promega). These buffers 
enabled different restriction enzymes to work in the same reaction tube, without
having to modify the conditions. The tube was placed at 37°C for 1 hour and then run
on a DNA gel.
2.4.2 Ligation of inserts: Ligation of inserts into vectors was accomplished by 
using the Ready-To-Go™ T4 DNA Ligase kit (Pharmacia). A ratio of insert DNA to 
linearized vector of about 5:1 was added to the reaction tube provided and made up to 
a final volume of 20 pl with dHzO. The tube was incubated at 16°C for about 1 hour 
and the ligated plasmid was used directly from the reaction to transform competent
cells.
2.4.3 pBluescript®: This vector (Stratagene) is a 2.96kb plasmid which was 
used to recover AZAP library screens and to place them into bacteria. The vector 
contains a lacZ gene, an IPTG-inducible lac promoter, ampicillin resistance and a 
polylinker region containing 21 unique restriction sites. The lac promoter allows "a- 
complementation" of cells containing a deletion in their lacZ gen (LacZ A Ml 5) to 
produce a P-galactosidase protein. Production of this protein provides a blue/white 
colour selection. Production of active J-galactosidase protein cleaves the substrate 
X-gal, which produces a blue bacterial colony. If an insert has been placed between 
the two parts of the lacZ gene then this protein is not made, thus producing white 
colonies. DNA can then be amplified and used for many techniques, such as
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restriction mapping, in vitro synthesis of RNA transcripts using the T3 and T7 
bacteriophage promoters, DNA sequencing and fusion protein expression.
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Figure 8: pBluescript: Ampicillin resistant plasmid, used for cloning and 
production of RNA. Contains many useful restriction sites and T3 and T7 
bacteriophage promoters.
2.4.4pGEM-T®\ This vector (Promega) was a simple system for the cloning 
of PCR products. The vector has 3' terminal thymidine at both ends of the insertion 
site. They improve ligation by taking advantage of the addition of a single 
deoxyadenosine to the 3'-end of PCR products by certain polymerases. It also
contains a p-galactosidase region for colour selection, T7 and SP6 RNA polymerase 
promoters, a fl origin of replication, to produce single-stranded DNA, resistance to
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100 pg/ml of ampicillin and 16 unique restriction sites. After insertion the plasmid 
was inserted into competent cells and amplified.
Figure 9; pGEM-T: Ampicillin resistant plasmid, used fns amplification nf 
PCR products. The vector contains many useful restriction sites and has 3' 
terminal thymidine at both ends to facilitate ligation.
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2.4.5 pGEX-4p®'. This vector sPhicmacia) is quite an effici ent ey^em forde 
expression and purification of fusion proteins. This plasmid is designed for inducible, 
high level intracellular expression of DNA with Schirtoroma japonicum glutathione 
S-transferase (GST). The vector contains a tac promoter inducible expression for 
protein, an internal lac Iq gene for use in E. coli, resistance to 100 pg/ml of 
ampicillin, six unique enzyme cleavage sites, and a thrombin recognition site for 
cleaving protein from GST fusion. There are three different forms: 4T1, 4T2, and 
4T3 which provides all three translational reading frames. Fusion proteins are 
induced with 0.1-0.5mM isopropyl C-D-th)ogalactoside (IPTG) to produce the 26kDa 
GST and accompanying fusion protein.
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Figure 10: pGEX: Ampicillin resistant plasmid used for expression and 
purification of fusion proteins. The vector contains many useful restriction 
sites and contains a tac promoter inducible expression for protein.
2.4.6 Transformation'.ma.\it\ue and BL21(DE3)P1ysSstrains of£. coli were 
made competent for transformation by uoicg the calcium chloride method (Sambrook 
et al., 1989 pl .82). Overnight cultures were pelleted and washed in cold O.1M CaC^.
These cells were aiiquoted into 200 pl amounts, into separate Eppendorf tubes and
frozen until needed. Vector DNA (50 ng or less) was added to the 200 pl of 
competent cells and left on ice for 30 minutes. Infected cells were then heat shocked 
at 42°C for 1.5 minutes and then place one ice. 1 ml of LB was added and then it was 
placed into a water bath of 37°C for 1 hour. 200 pl samples were then transferred to
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LB agar plates plus ampicillin. Transformed cells were evenly distributed over the 
plate using a glass spreader and placed overnight into a 37°C incubator.
2.5 Fusion Protein Production
GST fusion proteins were produced by pGEX-4Tl, 4T2, or 4T3 vectors that 
had been transformed into XL-1 or BL21(DE3)PlysS cells. The transformed cells 
were stored on agar plates containing 50 pg/ml of ampicillin. Colonies were picked 
from these plates using a sterile toothpick and placed into a tube with 5 ml of LB and 
50 pg/ml of ampicillin. Cultures of selected clones were grown up at 37°C overnight 
on a rotating wheel. The next day 2 ml of these overnight cultures were used to 
inoculate a flask containing from 200-500 ml of LB with 50 pg/ml of ampicillin
added. This culture was grown at 37°C for 4 hours while air was pumped into the 
flask using a Whisper 600 air pump (Tetra). Expression was then induced by adding 
IPTG (usually 0.1-0.5 mM) and placing the culture at room temperature for an 
additional 4 hours. The induced cells were spun down and raised in 4 ml of TBS 
before freezing overnight. The next day the cells were sonicated, on ice, using a 
Sonifier® cell disrupter (Heat-Systems-Ultrasonics, Inc.). After sonication, 1 mM of 
the protease inhibitors: Phosphoramidon, Bestatin, Leucine Aminopeptidase, PMSF 
and E64(Sigma) and 0.5% lysozyme (Sigma) were added, plus 1% Triton X-100 
(BDH Chemicals LTD). The sonicate was spun at 10,000 rpm for 10 minutes to 
separate the soluble protein from the cell pellet. This supemate containing the fusion 
protein was then bound to GST beads, following the protocol set out by the 
manufacture (Pharmacia). The purified fusion protein was eluted from the beads
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using 10 mM reduced glutathione, after which it could be stored frozen or cleaved
with Thrombin.
2.6 SIDS-PolyacrrGel Electrophoresis
Analysis of proteins were performed by running them, on a 12%
polyacrylamide gel, using the Hoefer "Mighty Small II System” for electrophoresis. 
Gels measured 10 x 8 cm and consisted of 4 ml of a separating gel and 1 ml of a 
stacking gel.
2.6.1 The separating gel consisted of 1.6 ml of 30% acrylamide, 0.5 ml of IM 
Tris.SO4 (pH 8.3), 1.3 ml ofdH2O, 0.57 ml of glycerol, 0.06 ml of 10% SDS, 8 pl of
ammonia persulfate, and 6 pl of TEMED.
2.6.2 The stacking gel consisted of 0.2 ml of 30% acrylamide, 0.125 ml of 
0.5M Tris.SO4 (pH 6.9), 0.67 ml of dH2O, 15 pl of 10% SDS, 3 pl of ammonium
persulfate, and 3 pl of TEMED.
Both stacking and separating gel portions were de-gassed using a vacuum 
oven for 10 minutes. The separating gel was loaded first between a glass and 
aluminium plate using a 5 ml pipette, clamped in a gel caster, and allowed to 
polymerise for 15 minutes with a layer of dH2O over the top. The dH2O allows for a 
more efficient polymerisation and to ensure that the top of the separating gel was flat. 
The stacking gel was poured after the polymerisation of the separating gel was 
complete and a comb was inserted into the stacking gel so wells would form as it 
polymerised. The gel was clamped into electrophoresis chamber and a reservoir
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buffer containing 3 g of Tris base, 14.3 g of glycine and 1.5 g SDS per litre was 
added to the top and bottom of the gel.
Higher and lower percentage gels were made by increasing or decreasing the 
amount of 30% acrylamide. Gels were made to 9% acrylamide for better resolution 
of proteins that were above lOOkDa or 20% acrylamide for better resolution of 
proteins that were below 40 kDa. Protein molecular weight markers were obtained 
from Biorad or Sigma and consisted of unstained or prestained markers of broad 
range, high or low molecular weights.
Protein sample buffer was added to the sample protein and boiled for 2 
minutes. The sample buffer consisted of SDS at 2% (w/v), 2-mecaptoethanol at 5% 
(v/v), glycerol at 10% (v/v) and Tris/SC>4, pH 6.9 at lOmM. The samples were loaded 
into the wells and run at 150 V for about 1.5 hours. After proteins had separated, the 
gel was stained in about 20 ml of stain, in a plastic box with gentle agitation, for 
about 30 minutes. The stain (500 ml) contained 1 gram of Coomassie brilliant blue,
50 ml of glacial acetic acid, 250 ml of 96% ethanol and 200 ml of dH2O. After 
staining, the gel was destained to resolve the protein bands in two volumes of 100 ml 
of destaining solution for about 30 minutes each. Destaining solution contains 250 ml 
of 96% ethanol, 100 ml of glacial acetic acid and 650 ml of dH/0. Destained gels 
were then dried down onto blotting paper, using a vacuum drier (Biorad), or placed 
into a sealed plastic bag.
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2.7 Western Blots and Immunoblotting
Instead of staining gels to resolve individual proteins, gels could be
transferred to nitrocellulose paper and used for Western blotting, using antibodies for 
specific proteins (ELISA or ECL). The gel was removed from the Hoefer “Mighty 
Small II System”, after separation was completed, and was placed in a container with 
100 ml of the same buffer as used in the reservoir (now called transfer buffer) for 
about 15 minutes. This is to allow the gel to expand and to wash away any particles 
that might interfere with the transfer. Nitrocellulose paper was then cut exactly to the 
same dimensions of the separating portion of the gel (6 cm, 8.5 cm) and also four 
pieces of 3M Whatman filter paper were cut to the same dimensions, and placed into 
a separated container with 100 ml of transfer buffer. After sufficient soaking in 
transfer buffer, the 3M paper was placed in a Hoefer TE 70 Series Semi-Dry Transfer 
Unit. Two sheets of 3M paper soaked with . transfer buffer were stacked on the anode, 
and then the nitrocellulose paper was placed directly on top. The polyacrylamide gel 
was placed so the separating portion of the gel was in direct contact with the 
nitrocellulose paper. The other two pieces of buffer soaked 3M paper were placed 
over the top forming a sandwich. A plastic rod was rolled over the top of this 
sandwich to remove any air bubbles that might be between the gel and the 
nitrocellulose paper. The cathode portion of the transfer unit was placed on top and a 
current of 35mA was passed between the two plates for 2 hours. After the transfer, 
the nitrocellulose paper was removed and placed into a blocking solution of 10% 
skimmed milk (w/v) and Tris-buffered saline (TBS) made of lOmM Tris.HCl at pH 
7.4 and HOmMNaCL The transffr waa allowed to blo^kz for 1 hour or overnight tit
4°C.
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2.7.1 Immunoblotting using ELISA: The enzyme-linked immunosorbent assay 
(ELISA) is a technique used for identifying specific protein bands, which have been 
transferred to nitrocellulose, by binding immunoglobulins covalently linked to an 
enzyme. Protein gels transferred to nitrocellulose were blocked in 10% milk in TBS 
overnight and then probed with a primary antibody specific for the protein. The 
serum containing the antibody was diluted in TBST, usually 1/1,000, and washed 
over the nitrocellulose transfer for 1 hour at room temperature. The transfer was
washed at least six times in 20 ml of TBST to remove the unbound and non­
specifically bound antibodies. The secondary antibody was then added to the transfer, 
usually at a 1/3,000 dilution. The secondary antibody was a goat anti-rabbit IgG 
which would recognise all rabbit antibodies bound to protein, and would subsequently 
bind to them. These secondary antibodies had a horseradish peroxidase enzyme 
conjugated to them. After binding with gentle agitation for 1 hour the transfer was 
washed several time in TBST and then finally in TBS. The proteins were detected by 
adding 100 pl of DAB (diaminobenzidine) and 3 ml of 30% hydrogen peroxide to 12
ml of TBS. This solution was washed over the transfer for about 1-2 minutes, until a 
colour reaction occurred representing a positive single for the protein band. The 
reaction was then stopped by washing the transfer in distilled water, in order to 
prevent the transfer from becoming too dark.
2.7.2 Immunoblotting using ECL: Enhanced chemiluminescence (ECL) is an 
extremely sensitive technique used for identifying specific proteins, using antibodies 
linked with the same HRP enzyme. The protocol is very much the same as ELISA, 
except after binding of both antibodies (primary IgG at 1/500 and secondary at 
1/10,000), the transfer is treated with a fluid containing luminol which is oxidised by
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HRP and hydrogen peroxide to produce light. The transfer is placed on X-ray film 
and left to expose for about 1 minute depending on the strength of the signal. The 
film was then developed by normal photographic procedures, The transfer can be re­
probed with new antibodies after removing the antibodies with a stripping buffer 
(lOOmM 2-mercaptoethanol, 2% sodium dodecyl sulphate, 62.5mM Tris-HCl pH6.7) 
while incubating it at 50°C for 30 minutes. It must be washed and re-blocked in 10% 
milk in TBS before it is ready to be re-probed.
2.8 Northern Blots
2,8.1 Riboprobe synthesis and purification: Various riboprobes were psepared 
by synthesising run-off transcripts, from appropriately linearized cDNAs, cloned into 
pBlueScript in the presence of |a-32p]CTP. The label was obtained from Amersham 
International at 400 Ci/mmol. Approximately 1-2 pg of DNA was digested in a total
volume of 7 pl, using the appropriate restriction enzyme, at 37°C for 1-2 hours. Next, 
the following were combined: 7 pl of linearised DNA, 4 pl of 5 x salts, 2 pl of 0.1 M 
DTT, 1 nl ofRNase in^ii^btoo 2plofl0x NTP mix, 2 pl of [a-32p]CTP, 1 pl ofT7 
RNA polymerase, 1 pl of DEPC H2O for a total reaction of 20 pl. The 10 x NTP mix
contained: lOmM of ATP, lOmM of GTP, lOmM of UTP, and 0.5 mM of CTP. In a 
typical reaction, there was a 10:1 ratio of 1 nmol "cold" CTP to 0.1 nmol radiolabeled
CTP. The reaction was incubated at 37°C for 1 hour, after which 1 unit of RNase- 
free DNase I was added and incubated for a further 10 minutes at 37°C. 30 pl DEPC 
H2O was added before proceeding to a spin column. Radiolabeled RNA was 
recovered via the spin column containing Sephadex G-50 resin. This resin was
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resuspended in TE buffer (20mM of Tris.HCl, pH 8.0 and ImM of EDTA) and 
autoclaved. The column was prepared in a disposable syringe as described 
(Sambrook et al, 1989): by plugging the syringe with some flock previously boiled in 
TE buffer, then filling it with the Sephadex G-50 suspension. The resin was 
compacted to dryness by spinning the colunm at 3,000 g for 4 minutes. 50 pl of TE 
buffer was added and spun through similarly in order to verify that the volume 
recovered was equal to the volume loaded. The riboprobe labelling mix was added 
and spun, un-incorporated nucleotides remaining in the column while the labeled 
probe was collected in a 1.5 ml screw-cap Eppendorf tube. The syringes and the 
collecting Eppendorf tubes were placed in an appropriate carrier centrifuge tube. The 
riboprobe was aiiquoted into small volumes (usually 10 pl) and stored at -70°C.
2.8.2 Extraction of RNA from. oo cytes: Ooctftes were collectedm groud sof 5­
15 oocytes for vitellogenic stages and 50 for smaller previtellogenic oocytes and were 
placed in separate 1.5 ml microcentrifuge tubes. 500 pl of TNES buffer (lOOmM
Tris.HCl, 300mM NaCl, lOmM EDTA, 2% SDS) and 200 pg/ml proteinase K were
added to each tube, mixed thoroughly by vortexing, and incubated at 50°C for 60 
minutes with further occasional vortexing. Samples were extracted twice with 
phenol-chloroform and once in chloroform. The RNA was precipitated by adding 2.5 
volumes of ethanol and spinning at 10,000 rpm for 30 minutes at 0°C. The pellet was 
washed in 70% ethanol, resuspended in 20 pl of DEPC dH2O and stored at -70°C. To 
extract RNA from embryos, a similar procedure was followed, however, the embryos 
were first placed for a short time in a solution of 2 % cysteine hydrochloride (pH 8.1)
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to remove the jelly coating and rinsed four times in one third strength Modified 
Barth’s Solution with gentle swirling.
2.8.3 Northern blotting: To every 10 pl of RNA solution (equivalent to the
extract of 2 oocytes or embryos), 4 pl of 5 x MOPS (0.2M 3-(N-Morpholino)
propanesulphonic acid, 50mM sodium acetate and 5mM NaEDTA pH 7.0), 7 pl of 
formaldehyde and 20 pl of deionized formaldehyde were added, giving a total volume
of 40 pl. Immediately prior to loading onto the agarose gel, 4 pl of RNA loading 
buffer was added. The RNA gel was prepared by melting 0.9 g of agarose into 35 ml 
of DEPC H2O. Once the agarose had melted, 12 ml of 5 x MOPS was added and the
gel mix cooled to 50°C. Next 13 ml of pre-warmed formaldehyde was added, and the 
gel was then poured, covered in 1 x MOPS buffer, loaded with 20 pl of each RNA 
sample, and run at 20V overnight. The RNA was transferred to a nylon membrane by 
vacuum blotting. Firstly, the gel was washed in dH20 and soaked in 50mM NaOH for 
3-5 minutes to hydrolyse the RNA partially. The transfer buffer consisted of 1 litre of 
10 x SSC (standard sodium citrate: 175.3 g of NaCl, 88.2 g of Nacitrate, per litre, 
final pH 7.0), and was run for three hours. After the transfer, the membrane was 
rinsed in 2 x SSC for 5 minutes, air-dried, and the RNA cross-linked to the nylon 
membrane by UV irradiation, using a Spectrolinker set at optimal crosslink 
(120,000mJ/cm2). As an alternative, the RNA samples could be transferred onto a 
membrane using a ”slot-blot” apparatus.
2.8.4 Hybridisation of RNA probe: The membrane was placed into 50 ml of 
pre-hybridisation solution, containing 1% Blotto (10 g of Skimmed powdered milk, 
0.2% sodium azide and dH2O to final of 200 ml), 1 x SSC and 2% SDS prepared with
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DEPC dH20, and pre-hybridised at 65°C for 2 hours. Next, the membrane was 
covered in 25 ml of fresh pre-hybridisation solution, containing the appropriate 
antisense riboprobe. The riboprobe was hybridised with gentle mixing overnight at
65°C. The next day, the filter was washed twice for 20 minutes at 65°C in 0.5 x 
SSC/0.1% SDS, and then similarly twice in 0.2 x SSC/0.1% SDS. If a high 
background labelling was received then the filter was washed further in 0.2 x 
SSC/0.1% SDS. The membrane was finally rinsed in 100 ml of the last wash solution 
and set up for autoradiography.
2.9 Oocytes
2.9.1 Collection ofoocytes: OocySts were eo llectedfrom mafure Xenopus 
laevis females by dissecting a portion of the ovary, after anaesthetising in a solution 
of 0.1% tricaine (MS222, Sigma) in water. The ovary was then treated with 
collagenase type I (0.2%) in Ca2+ free 0R2 medium (82.5mM NaCl, 2.5mM KCl, 
ImM MgCl2, ImM NaHPO4, 5mM HEPES, 0.05% PVP and NaOH to pH 7.8) for 
1.5-2 hours on a rotating wheel at room temperature. The oocytes were washed four 
times in Ca22 free OR2 and twice in modified Barths’ solution, with 1/200 of 
antibiotic and anthnycotic solution (Sigma) added. Barths’ solution contains 88mM 
NaCl, ImM KCl, 2.4mM NaHCO3, 0.82mM MgSO4, 0.33mM Ca(NO3)2, 0.41mM 
CaCl2, 7.5mM HEPES, and NaOH to pH 7.6. The oocytes were then left m modified 
Barths’ solution and allowed to recover overnight, before any other procedures were 
carried out. This treatment removed the oocytes from the surrounding ovarian tissue 
and allowed isolation of individual development stages according to Dumont (1972).
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Oocytes were used within two days of this procedure or were stored at -70°C until
needed.
2.9.2 Isolationof nuclet: Oocytes Orom etageo III-\gwere sepwrated mto 
individual dishes in Barths' solution. The oocytes were taken up in a glass Pasteur 
pipette and placed on 3M blotting paper at the bottom of a 30 mm petri dish. The 
buffer was soaked up by the 3M paper and 2.5 ml of paraffin oil was poured over the 
top of the oocytes. The dish was placed under a dissection microscope and a small 
hole was made at the animal pole with a fine tungsten needle. The nucleus of the 
oocyte slowly came to the top and it was taken off using a 20 pl pipette and placed
into a 1.5 ml microcentrifuge tube. Nuclei were collected into 20 pl of kinase buffer 
(20mM Tris-HCl pH 7.4, 5mM MgCl, lmM DTT, and lOOmM KCl) in 50% glycerol 
if their activity was to be measured, or 20 pl of homogenisation buffer (O.1M KCl, 
20mM Tris-HCl pH 7.5, 2mM MgCl, 0.2% NP40 and 2mM DTT) if they were to be 
run on a protein gel. On average about 10-50 nuclei were collected at one time. The 
mictocentrifUge tube was spun at 500 rpm. on a microcentrifuge for 1 minute, so that 
nuclei would separate from the oil phase into the buffer phase. The paraffin oil was 
then removed using a 200 pl pipette and the nuclear extract was stored at -20°C. This 
procedure is similar to the method used by Pain et al. (1992).
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Figure 11: Isolation of Nucleus: A stage VIXenopus oocyte, under oil, with a 
protruding nuclei at the animal pole.
2.9.3 Isolations)/hytoplosms: Thecytoplasmsthatwere l^ft, after extraction 
of eha nuclei, ware coftacCad rnd placed into 60 pl of homogenisation buffer in r 1.5 
ml microcenerifUge Cube rnd spun rC 500rpm on r microcenCriauge for 1 minute. Phis 
wrs dona Co ensure ChrC Che cyCoplrsms would seprrrCa from Che oil phrsa rnd prssed 
into Che buffer phrse, rfCer which Che oil wrs Chen removed. Phe cyCoplrsms ware 
Chen homogenised by pipetting Che mixCure up rnd down using r 20 pl pipette. An 
equrl volume of Freon (1,1,2-Crichloroerifruoro-eChrn, Sigmr) wrs rdded Co Che 
homogenrCa, rnd Choroughly mixed by vorCexing. Phe homoganrCe wrs Chen spun rC 
10,000 rpm ffo 10 minutetat4oC inanSsownswuin-oot roooo TPhsuupana^^nt 
containing Cha solubilized proCeia wrs removed using r 200 pl pipette rnd Che Freon 
containing Che lipid rnd yolk wrs discrrded. Phe cyeohlnsmic exCrrcC wrs plrced inCo 
r clera microcenerieUge Cube rnd sCored rC -20°C.
2.10 Glyycrol Gi^r^t^ie^i^ts
Gr^enCs were mrde by using r linerr grrdienC mrker containing 25% rnd 
10% glycerol in r gradie^ buffer (lOOmM KCl, 20mM Pris-HCl pH 7.5, 2mM MgCl, 
ImM DPP rnd 0.1% NP-40). ProCein srmples were preprred in homogenis^^
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buffer, in a microcentrifuge tube and spun at 10,000 rpm for 10 minutes, after which 
the supernatant was removed. Samples could also be treated with a non-ionic 
detergent, such as 0.1% NP-40, or with Freon. This supernatant was added to the top 
of the gradient using a pipette and placed in SW65 rotor of the Beckman L-7 
ultracentrifuge. The samples were spun at 30-36,000 rpm for 16-18 hours at 0°C. 
Samples of 300 pl were collected by carefully pipetting from, the top of the gradient. 
Proteins were precipitated from gradient fractions by adding 900 pl of acetone to each 
300 pl sample. It was left on ice for 30 minutes and then spun at 10,000 rpm for 25 
minutes at 4°C. The supernatant was removed and the pellet was air dried for 10 
minutes. The pellet was raised in 10 pl of 8M urea and 10 pl of SDS-PAGE buffer 
was added prior to loading on a protein gel. Proteins were analysed using
immunodetection.
2.11 Isolation ofProtein Kinase Activity and Phosphorylation ofProteins
2.11.1 Nuclear protein kinase: Nuclei were isolated using the procedure 
described in the "Oocyte" section under "Isolation ofNuclei". Nuclei were isolated 
into kinase buffer and 50% glycerol. The nuclei were spun on a microcentrifuge for 1 
minute and any paraffin oil was removed from the top. The nuclei were broken up by 
pipetting with a 20 pl micropipette fitted, with a white micropipette tip. This
homogenate was stored at -20°C until needed.
2.11.2 Kinase extract: Kinase activity was purified from isolated nuclei by 
binding the nuclear extract to heparin-Sepharose (Pharmacia) and then washing off 
the bound protein kinase. 50 nuclei were isolated in 50 pl of protein kinase buffer
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plus 50% glycerol, using the protocol described in the "Oocyte" section under 
"Isolation ofNuclei". This was diluted with 200 pl of TBS and 40 pl of heparin- 
Sepharose was added to the mixture. The enzyme was allowed to bind over several 
hours at 4°C on a rotating wheel. The unbound nuclear extract was removed and the 
resin was washed four times with ~1 ml of TBS on ice. The resin was then washed
with 1 ml of 0.2M KCl to remove any partially bound protein. The kinase was eluted 
in a 200 pl of IM KCl. Glycerol was added to 50% and it was stored at -20°C.
2.11.3 Poly (A+J RNA-associatedprotein kinase: The poly (A+) mRNP was 
isolated using the same methods as described in the "poly (A+)" section. The 
associated protein kinase would be isolated by affinity chromatography using heparin- 
Sepharose, as described above, and was stored at -20°C.
2.11.4 Fusion protein phosphorylation: GST-fusion proteins were bound to 
100 pl of Glutathione Sepharose 4B beads and washed four times with Ix kinase 
buffer. About 8 pg of these bound proteins in 78pl was added to 10 pl of lOx kinase
buffer, 10 pl of nuclear extract (Nuclei, heparin bound, or A+) and 1 pl of [ P] y- 
ATP (10pCi)(0.033mM). This mixture was incubated for 1 hour at room 
temperature. Beads were washed four times in TBS and then phosphorylated protein 
was removed using lOmM reduced glutathione plus 2% n-Octyl P-D-Glucopyranoside
(Sigma).
2.12 Sequencing of Phosphorylated Protein
GST fusion proteins were labelled using [32P]y-ATP and then digested in
trypsin (20 pg/ml) in .01 M ammonium bicarbonate at 37°C for 4 hours. The sample
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was raised in 50pl of 0.1% trifluroacetic acid and 20 pl of this was applied to a C-18 
microbore column. The elution gradient used was a 5 minute isocat step of 5% 
acetonitrile, followed by a gradient to 50% acetonitrile over 30 minutes and a 19 
minute rise to 95%. The fractions of 80 pl each were collected every minute and 2 pl 
aliquots were spotted on to filter paper and assayed overnight for radioactivity using a 
phosphoimager. The peak radioactive fractions were lyophilised and resuspended in 
10 pl of 30% acetonitrile. These samples were spotted on to a half disk of Sequelon-
AA (Millipore) membrane (PVDF derivitised with aryl groups) and dried at 55°C on 
a heating block. The dried peptide was then attached to the membrane by addition of 
5 pl of 10 pg/ml solution of carbodiimide (EDC). After leaving at room temperature
for 20 minutes, the membrane was washed 3 x in 0.5 ml of 50% methanol and then 
placed in the sequencer. The extracted ATZ derivative from each sequence cycle was 
collected, dried and resuspended in 10 pl of 90 % methanol. Aliquots of 2 pl were 
spotted on to filter paper and assayed overnight for radioactivity using the 
phosphoimager (Llinas et al, in preparation). This experimental procedure was 
carried out by Dr. Graham Kemp of St. Andrews University.
2.13 Microinjection of Protein
2.13.1 Preparation ofinjectedprotein’. 40 nj of 0.sion protein, isolated fsom 
GST beads, was diluted with 0.5 ml of dH2O and placed into a Filtron centrifugal 
concentrator. The mixture was spun on a Sorvall RC-5B centrifuge, at 8,000 rpm for 
30 minutes at 4°C, until a volume of 10 pl was recovered and adjusted to 20mM
56
sodium phosphate (pH 7.2). A 1/20 volume of neutral red (saturated) stain was added 
to provide colour for the injected solution.
2.13.2 Injectionofprotein into oocytes'. OocyOss were collectedand deposited 
on a 1 mm mesh in a 300 mm Petri dish, containing Barths’ solution. 20-50 nl of 
protein was injected into each oocyte's vegetal pole, using a 25 pm micropipette. The 
pipette was housed in a Algal syringe attached to a micrometer screw, which when 
turned would force air from the end of a Teflon line filled with paraffin oil. Thus, the 
protein was injected by increasing the pressure behind the injectant. The protein was 
loaded into the micropipette by decreasing the pressure, thus bring the protein into the 
micropipetfe. After the injection, the oocytes were left sitting in clean Barth’s 
solution, and samples at different time points were taken to measure the import of 
different proteins into the nucleus. Samples were analysed by running them on 
protein gels and immunostaining them, or they were dried down and set up for 
autoradiography.
2.14 Antibody Production
Fusion proteins (CK2a and CK23) were grown and purified using GST 
beads. A solution containing 0.4 mg of purified protein, in 0.5 ml of TBS, was 
emulsified by combining it with 0.5 ml of the oil “Drakeol 6VR”, (Pennsylvania 
Refining Company) which contained 1/10 volume of the emulsifier Arlacel A (Atlas). 
1ml of 2% Tween 80 (Sigma) in 0.14 M NaCl was added and mixed using a 26 gauge 
needle on a 2 ml syringe. This emulsion was injected subcutaneously into Dutch 
rabbits and a test bleed was taken from the marginal ear vein. At six weeks a second 
emulsion was injected, identically as the first as a booster and bleeds of 10 ml were
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collected every two weeks. A second booster was sometimes necessary to increase 
the titre level of antibodies. This was accomplished by injecting 0.2 mg of fusion 
protein, in 0.3 ml of TBS, into the marginal ear vein. Blood samples were taken and 
allowed to coagulate at room temperature for 1-2 hours. The serum was then 
removed and spun at 5,000g for 10 minutes to remove white blood cells, then 
aliquoted and frozen at -70OC. This serum could be used directly for immunoassays, 
or purification of IgG could be performed. 1 ml of serum was incubated with 250 pi
of protein A-Sepharose beads for 1 hour at 4°C with gentle agitation. The beads were 
washed four times with O.1M borate buffer (pH 9), to remove serum protein not 
bound to the beads. IgG was eluted from the beads using O.1M citrate (pH 3), and 
then neutralised by adding one-tenth volume of IM Tris-HCl (pH 9).
2.15 Electronic Autoradiography
The Instantimager® (Packard) is a fully automated quantifier of radioactivity. 
It is computer controlled sensor and recorder of different types of flat radioactive 
sources. Samples could be labelled with Phosphorus-32, Phosphorus-33, Carbon-14, 
Iodine-125 and Sulphur-35. Protein gels that contained protein, labelled with one of 
these sources, were dried down on a piece of 3M paper and placed into the imager’s 
sample drawer on the sample plate. A the sample cover would be placed over the gel 
and the drawer closed. The Imager window would then be opened and the user 
would start the "Acquisition" cycle. Depending on the amount of radioactivity, an 
image would be obtained in a very short time compared to imaging on to film. Exact 
procedures were followed from the Instantimager user manual. Once the image was
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recorded by the computer, the user could print out a picture and/or measure the exact 
amount of radioactivity in each part of the gel. The system comes with software
which allows the user to display the image, annotate the image with text and shapes,
analyse the image by creating a template and produce a report of all quantitative
results specified by the user.
2.16 Cell Culturing
XTC cells are a late embryonic cell line first cultured from Xenopus laevis 
tadpoles in 1969 (Pudney et al, 1973). They are epithelial in nature and have a rapid 
growth rate, which makes them ideal for cell culturing. Cells were cultured according 
to protocols from "Methods of Cell Biology" (Smith and Tata, 1991). Cells were 
grown in a 500 ml culture flask, containing 50 ml of modified Leibovitz L-15 
medium, in a 25°C incubator. The cell culture medium contained 61% L-15, 27% 
sterile H20,10% fetal calif serum, 1% Pen-Strep (10,000 u/ml), and 1% L-glutamine 
(200mM). Once cells had reached confluence they were split into separate flasks or 
collected for experimental use. Cell cultures would be split by treating them with 
trypsin (8 pl trypsin, 20 ml 0.2M EDTA (pH 8)), and 2 ml calcium-free medium 
(88mM NaCl, ImM KCl, 2.4mM NaHC03 and 7.5mM Tris (pH 7.6)). These 
procedures were carried out in a flow cabinet under sterile conditions.
2.17 Tissue Section Immunostaining
2.17.1 XTC cells: XTC cslIs wereprepared for stainino by growiby them on 
glass cover elipe in 90 mm plastic fdtri dishes. After the cells had reached confluence 
the cover slips were removed from the petri dish and placed into a fresh one. They
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were washed with clean Lebowitz solution to remove dead cells. The coverslips were 
placed for 10 minutes into 100 ml Columbia jars filled with methanol at -20°C to fix 
the XTC cells. They were then transferred to another flask containing acetone at 
-20°C for another 10 minutes. The cover slips were air dried for 2 minutes and then 
washed twice in PBS (137mM NaCl, 3mM KCl, 15mM KH2PO4, 7mM Na2HPO4). 
The coverslips were placed in PBS, plus 5% fetal calf serum, and left for one hour to 
block. After blocking was complete the coverslips were placed in PBS, plus 1% fetal 
calf serum, with CK2a antibody at 1/200 dilution and incubated at room temperature 
for 1 hour. They were washed after the primary antibody binding in PBS five times 
for 10 minutes each. The secondary antibody was then added, a Fluorescein 
Isothiocyanate conjugated anti-rabbit IgG (FITC). This was added at 1/500 dilution 
in PBS, plus 1% fetal calf serum, and incubated in the dark for 1 hour. Again, after 
the binding was completed, the coverslips were washed five times with PBS, plus 1% 
fetal calf serum, for 10 minutes each. The coverslips were removed from the final 
wash and placed face down onto a microscope slide with a drop of mounting solution 
(50mM Tris-HCl pH 8, 1.5mg/ml of n-propylgallate, 50% glycerol, 20pg/ml of 
DAPI(4,6-Diamidino-2-phenylindole, Sigma)). The stained cells were examined with 
a fluorescence microscope.
2.17.2 Ovary sections: Previte 1 lor^e^niicovary was dissectedfssm imm^^em 
Xenopus and then fixed for 1 hour with a solution containing 3% paraformaldehyde 
and 0.25% glutaraldehyde in O.1M PBS. Afterwards they were washed in PBS, plus 
0.1% sucrose, for 10 minutes. They were place in 70% ethanol and allowed to sit 
overnight at 4°C. The tissue was then rehydrated, embedded in wax and 7 micrometre
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sections were taken and attached to microscope slides. Before immunostaining could
begin the sections had to be de-waxed. This was done by washing them in the solvent 
Histoclear two times, then absolute alcohol, 96% alcohol, 70% alcohol, and then 
finally in PBS. The immunostaining was carried using the same protocol as with the
XTC cells.
2.18 Isolation of mRNP Particles and Y-Box Proteins
2.18.1 mRNP: Previtellogenic, or early vitellogenic ovary (~0.5g), collected 
from immature Xenopus laevis, was sonicated in 2 ml of column binding buffer 
(0.25M NaCl, 2mM MgClz, ImM DTT, 0.2% NP-40,20mM Tris-HCl (pH 7.5)).
The homogenate was then centrifuged at 10,000 rpm for 15 minutes at 2°C. The 
supernatant was removed, NaCl was added to a final concentration of 0.25M, and 
passed through a 1.5 ml O1igo(dT)-cellulose column (Pharmacia) at 4°C. The column 
had been pre-washed with the column binding buffer. The unbound material was 
passed though the column three times to ensure complete binding of poly (A+) 
mRNP. This was monitored by measuring with A254, which indicates RNA content. 
The unbound material (poly(A)-) was collected, and the column was washed 
thoroughly to remove unbound material with binding buffer, until the A254 returned to 
background levels. The poly (A+) mRNP was eluted from the column in 2.5 ml of 
warm dH^0 and stored at -70°C. This procedure is similar to the method used by 
Cummings et al. (1989).
2.18.2 Y-box proteins. Heat treatment (Deschamps et al., 1991) was used to
purify Y-box proteins from an SNIO, of previtellogenic ovary homogenised in HB
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buffer minus NP40. The SN1O was heated to 80°C for 5 minutes, during which most 
proteins were denatured. The sample was then left to cool on ice for 10 minutes, 
during which most protein precipitated, but the Y-box proteins were able to refold, 
thus remaining soluble. The sample was spun at 10,000 rpm for 10 minutes and the 
supernatant was removed which contained the purified Y-box proteins. The heat 
treatment and cooling steps were repeated for a total of four times to ensure most 
proteins came out of solution, except for the Y-box proteins. The sample was then 
precipitated using 4 volumes of acetone. This was left on ice for 30 minutes and then 
spun at 10,000 rpm for 20 minutes. The supernatant was discarded and the pellet was
raised in 8M urea.
2.19 Antibody Affinity Binding
Antibody affinity binding was done using a standard protocol (Glover and 
Hames, 1995). Antibodies were incubated with protein A beads (Prosep-A high 
capacity, Bioprocessing) and then cross-linked to the beads using dimethyl- 
pimelimidate dihydrochloride. After antibody beads were made, proteins from oocyte 
extract would be bound to the beads using a column chromatography protocol. 
Proteins were eluted from the antibody beads using elution buffers containing high 
salt concentrations (usually 3.5M MgCb) or low pH levels (usually pH 1.5-3.0). This 
technique was used to purify specific proteins or to study protein-protein binding of 
related proteins.
62
2.20 HistoneDeacetylase Activity Assay
Histones (2 mg) purified from rat liver, or peptide representing the terminal
eighteen amino acids of H4 (Img), were dissolved in substrate buffer (0.5 ml of 
50mM Na borate pH 9.0) and subsequently mixed with 6mCi of 3H-acetic anhydride. 
The mixture was incubated for 3 hrs. at 0°C, after which it was adjusted to 0.25M 
HCl and precipitated with twelve volumes of acetone, washed and vacuum dried. The 
activity of histone deacetylase was assayed using the methodology from Li et al. 
(1996). Nuclear extract (lOOpl) was mixed with 150pl of assay buffer (25 mM Na 
phosphate/citric acid pH 7.0), 20pl of 3H-acetylated peptide or histone mix (~1.2 x 
l.O6dpm, dissolved in assay buffer) and dHaO up to 300pl. This was incubated for 1 
hour at 37°C, after which the reaction was stopped by adding 0.12M of acetic acid 
and 0.72M of HCl and 2 ml of ethyl acetate. The samples were centrifuged at 9000 x 
g for 1 minute and then half the volume of acetate was removed and the dissolved 3H- 
acetate was measured by scintillation counting.
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Chapter 3: Results
Protein Kinase CK2 from Xenopus
Oocytes
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3.0 Aim
The aim in this chapter is to study the expression and to define the activity of 
protein kinase CK2 in oocytes. Specifically, the amounts of protein, expressed in 
different stages of oocyte maturation are examined, and levels in the nucleus and the
cytoplasm are compared. The activity of the enzyme was measured using different 
substrates. Addition of selective inhibitors and various buffers was used to study the 
activity of this phosphorylating enzyme. As well as expression and activity, the 
particle size of the enzyme was calculated using glycerol gradients to determine if it is 
most active in its tetrameric form, and if smaller or larger units exist in oocyte nuclei.
3.1. Cloning and Expression of the Xenopus CK2 a-Subunit
3.1.1 Design of PCR primers'. Thefirst clone obtained wasthe product of a 
PCR reaction using synthesised primers to a region of the known Jfepoopo a-subunit 
sequence. The forward primer was 25 nucleotides long
5’[GACTGGGGCTTGGCCGAATTCTACC]’3 which represented the a-subunit 
from nucleotide 523 to 547 (Jedlicki et al, 1992). The primer had a 60% GC content 
which gave it a melting temperature of 60°C. This sequence encodes o conserved 
region of the catalytic domain: 175-D W G L A E F Y H-183. The reverse primer 
was 27 nucleotide long 5’[CTGATGGTCATATCGCAGCAGCTTGTC]’3 and 
represented the a-subunit from nucleotide 904-930. The primer had o 52% GC
content which gave it a melting temperature of 59°C. This sequence encodes o region
close to the carboxyl end of the subunit: 302-D K L L R Y D H Q-310.
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3.1.2 PCR reaction'. The aforementioned primers were added ^oged^e^r with the 
necessary PCR reactants (see Methods, section 2.3) ged lOeg of single stranded 
cDNA (made from isolated Xenopus mRNA) which were then placed into the PCR 
apparatus for 25 cycles taking a total of 3 hours. After the PCR product was made 
and isolated from an agarose gel (see Methods, section 2.1.9) it was inserted into the 
pGEM-T vector (see Methods, section 2.4). This vector was used because it contains 
a 3' thymidine at each end of its insertion site which increases the efficiency of 
ligation of the PCR products. XL-1 cells were transformed with the recombinant 
vector (see Methods, section 2.4.6), clones were selected and the plasmid DNA was
checked.
3.1.3 Sequencing nnd cfoNA screening’. The DNA was seguenqedby Dr. 
Sommerville using standard manual DNA sequencing methodology. This was to 
ensure that no errors had occurred during the PCR and ligation process. This DNA 
was used as the template to make a radioactive probe in order to screen a cDNA 
library for a longer clone (see Methods, section 2.8.1). The cDNA library was 
screened (see Methods, section 2.1) and the positive clone, named 2A, was picked 
and purified. This resulted in a clone very similar to the one that was generated using 
the PCR reaction. It was somewhat different in length than that of the previous clone; 
the new one started from 180-glutamic acid (E) and reedd at the 3' poly (A) tail (350- 
valine (V)). Since it was extracted from a lambda Zap cDNA library, the clone was in 
the pBluescript vector which made it very easy to amplify and purify the DNA.
66
gac tgg ggc ttg gcc gaa ttc tac cac cca gga cag gag tac aat gtc cgt gtt get tec cga tac ttc -591 
DWGLA E FY HP G Q E YNVRVA S RYF -197
aag ggg cog gag ctg ctt gtg gat tac caa atg tac gac tac age ctg gac atg tgg age ctg ggg tgc atg ctg -666
K G P E LLVDY QMYDY S LDMWS LG CML -222 
gcc agt atg att ttc aga aaa gag cca ttt ttc cat ggc cat gat aac tac gac cag ctg gtg aga ata gcg aag gtg -744 
A SMIF RK E PFFHG HDNYDQL V R I AK V-248 
ctg ggc aca gaa gac etc tac gat tat att gac aag tac aac ata gaa ctg gat cca cgc ttt aat gat att ctg ggc -822 
LG TE DLYDY I D KYN I E LD P RFNDI L G -274 
agg cac teg cgc aaa egg tgg gaa aga ttt gta cac agt gag aac caa cat eta gtc agt cet gag gca ctg gat -897 
RHSRKRWERFVHSENQHLVSPEALD -299 
ttc ctg gac aag ctg ctg cga tat gac cat cag acc cga ctg act gcc cgt gaa get atg gac cac cca tac ttc -972 
F LD K LLR Y DHQ T R I- T ARE A^MDHP YF -324 
tat ccc ate gta aag gac cag tcc egg atg gcg get eta ata tgc cca gtg gca gca cac ccg tea gta gcg cca -1047 
YPIVKD Q S RMAALICPVAAHP SV AP -349 
gta tga TGTCAGGTCAGTCCCGGCCAGTGTTCGTG -1082
V * -350
Figure 12; CK2a clone 2A: Nucleic and amino acid sequence cf the CK2a clone 2A. The 
forward and reverse primers are in bold. * represents the step ccdcn in the open reading 
frame. Numbering from Jedlicki et al., 1992, accession number p28020.
3.1.4 Expression The2A insert was removed from the vector and
ligated into a pGEX vector (ree Methods, section 2.4). Thir ir as exprerrios vector 
which allowr rtimvlatios of the rystherir of a protein from the closed tDNW, which 
ir fVred with glvtathiose-S trasrferare. The isrert war removed from pPlvercript by 
cutting it with the rertrictios eszymer EcoRI asd Xhol, after which the DNW war 
irolated from as agarore gel. Thir DNW war thes ligated isto lisearired pGEX-4T2 
cut with the rame rertrictios eszymer to esable proper ligatios. XL-1 bacteria were 
trasrformed with the pGEX + DNW vector. Osce the trasrformatios war complete the 
proteis war exprerred. with the additios of IPTG to the mvltiplyisg bacteria which 
carried the sew vector (ree Methodr, rectios 2.5). The GST fvrios proteis war 
mearvred os SDS-PWGE at 46kDa: 26 kDa for GST asd 20kDa for the fragmest of
the o^-^^^^bvsit. Thir furies proteis war pvrified asd frozes for later vre.
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Figure 13; Bacterial expression of CK2a clone 2A; M represents the marker track 
containing markers of 66, 45 and 29 kDa. El and E2 are elutions of fusion proteins from 
glutathione-Sepharose beads, the fusion protein is 46.3 kDa. B1 and B2 are the beads with 
fusion protein still bound to them. UBl and UB2 represent the unbound supernatant that did 
not bind to the beads. T1 and T2 are the total induced extracts before binding to the beads. S 
represents the sonicated whole pellet fraction.
3.1.5 Antibody production'. Antibodies were produce d against the cion e2Aby 
injecting the purified fusion pcrtein, expressed by the pGEX ventrc, into raSSits (ree 
Methods, section 2.14).
3.2 Cloning and Expression of the Xenopus C1K (Psubunit
3.2.1 Design of PCR primerso The clonefontrrn Prcbnnit was the deduce pf
a PCR reaction similar tr the one for the a-subunit. The forward pcimec war a 20
nucleotide long sequence which war 5’[GATGAAGACTATATCCAGGA]’3 and
represented the p-suSunit cDNA from nucleotide 76 to 96 (Jedlicki et al., 1992). The
o .
primer had a 40% GC content which gave it a melting temperature of 46 C. This 
sequence encoder a region near the amino end of the protein: 26- D E D Y I Q D-32. 
The reverse primer was 21 nucleotides in length and had the sequence
5’[CCCCCTCGAGTTTTTTTTTTT]’3 corresponding to the linker ligated to the 3’ 
end of the cDNAs of the lambda Zap library. This primer had a GC content of 38%
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thus giving it a melting temperature of 52°C; it also has an engineered internal Xhol 
site for easy ligation.
3.2.2 PCR reaction: The PCR reaction was similar to that for the a-subunit.
The product was purified by running on a agarose gel and then ligated into pGEM-T.
3.2.3 Sequencing: The clone was this time checked by the Sequencing Unit in 
the Irvine building of St. Andrews University. The sequence acquired contained most 
of the P-subunit coding region and the entire 3' UTR to the poly A tail.
gat gaa gac tat ate cag gat aag ttt aac ttg aca gga etc aat gag cag gtc cca cac tat aga cag gca ctg gac -153
D E D Y I Q DKFNLTG LNE QV P HYR Q A L D -51 
atg ata ctg gat eta gaa cet gat gag gaa ttg gaa gat aat ccc aat caa agt gac etc att gaa caa get gca gag atg -234 
MILDLEPDEELEDNPNQSDLIEQAAEM -78
ctg tat gga eta ate cat gcc cgt tac ata ttg act aac cgt ggc att get caa atg ctg gag aaa tat caa cag gga gat ttt -318
LYGL I H A RYI LTN RG IAQML E KYQ QGDF -106
ggc tac tgt ccc aga gta tac tgt gag aac cag ccc atg eta cct att ggt etc tea gat ate cet ggg gaa get atg gta -399
GYCPRVYCENQ PMLPIGLSDIPGEAM V-133 
aaa ctg tat tgt ccc aag tgt atg gat gtt tac aca ccc aaa tcc tea egg cat cat cac acc gat gga gca tat ttt ggc -480
KLYCP KCMDVYT P KS SR HHH TDG AY FG -160 
act gga ttt cct cac atg ctt ttt atg gtt cac cct gag tat agg ccc aag agg cct gcc aat caa ttt gtt cca agg tta tat -564
TGFPHMLFMVHP EYR P K R PAN QFVP RLY -188
ggc ttc aaa ate cac cct atg gca tac cag ctt caa eta caa gca gcc age aac ttt aaa agt ccc gtg aag acc atg cgt -645
GF K I HPMAYQ LQLQA A S NFKS P V K TMR -215
tgaGTCTT^C^^TATTAT^'T^^^^^^-T^^^^ATVCA'rGGGTCTGQVCACCCCA'rAAACCCTATTTCCT'
*
TCCATCGACAATGAAGArGTCGTTGCAGTGTArTATTTGCCCACAArTrTGArrTrA
GTCCTCjTTAAAGTCtTATTCC.TGCAATTTCCAGTTGTGGTTAAATAAAATTCTAA.AGA
ATCGTT (poly (A) tail). .
Figure 14: CK2P clone P: Nucleic and amino acid sequence of the CK2P clone p. The forward 
primer is in bold. The * represents the stop codon in the open reading frame. Numbering from 
Jedlicki et al., 1992, accession number p28021.
3.2.4 Expression: The insert was removed from pGEM-T by cutting with 
Ncol and Xhol and was ligated into pGEX-4T2 cut with Sma I and Xhol. The fusion
protein was expressed similarly to the expression of the a-subunit clone. The p-
subunit fragment fused with GST measured 48kDa: 26 kDa for GST and 22kDa for
the p-subunit.
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Figure 15: Bacterial expression of CK2P clone P: M represents marker track containing 
markers of 205, 116, 97,66, 45 and 29 kDa. El is the elutions of fUsion proteins from 
glutathione-Sepharose beads; the fUsion protein is 48 kDa. B is the beads with fUsion protein 
still bound to them. W is the pool of the wash fractions to see how much of the fusion protein 
is removed before the elution. UB represent the unbound supernatant. P represents sonicated 
whole pellet fraction. I is the induced supernatant and UI is an uninduced supernatant for 
comparison.
5.2.5 Antibody production. Fusion protein was purifiedand injected into rabbits 
but no usable serum was collected. Although anti-GST activity was obtained, no 
reactivity was detected with native protein extracts. This may be due to the fact that 
there is such sequence homology between species, that the rabbit did not recognise 
this fusion protein as foreign, and so did not produce antibodies against it. Rabbits 
were boosted many times and also different rabbits were injected with shorter forms
of the clone, however, no useful serum was obtained.
3.3 mRNA Expression
Several attempts were made to probe for the amount of mRNA expressed 
during the different developmental stages, using Northem-blottmg (see Methods, 
section 2.8). These attempts were unsuccessful due to the probable instability of the 
message. Measurements of the amounts of mRNA were made by Wilhelm et al, in
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1995, but they did not use Northern-blotting techniques; instead they used a 
competitive reverse PCR method to estimate the amounts of mRNA in each stage.
This technique is less direct, suggesting that they had similar difficulty probing for 
this particular mRNA, especially when they had used the Northern-blotting technique 
to measure amounts of the same message in tissues.
3.4 Iddndfit^jadtin of the a-Ssubuit During Oogenesis
3.4.1 Oocyte exp^ocssionpf native CKaa\ The sarummade against the Ci- 
subunit clone 2A in rabbits was used to study protein kinase CK2 m Xenopus oocytes. 
This serum recognised both the a and a' subunits of 42 and 38 kDa from oocyte
extracts.
Oocyte proteins were solubilized by bursting approximately 50 oocytes in 
homogenisation buffer which was then extracted with Freon to removed lipids. 
Extracts were then spun at 10,000 rpm to remove the soluble layer from the Freon, 
yolk, pigment and lipid phase (see Methods, section 2.9). A sample of this soluble 
protein was mixed with SDS-PAGE buffer and run on a protein gel (see Methods, 
section 2.6). The proteins were then transferred to nitrocellulose paper and blotted 
with the antibody (see Methods, section 2.7).
The level of CK2 a subunit increases in growing oocytes. The amounts of 
soluble CK2 can be seen to be increasing from its lowest levels in stage I, to a peak in 
stage VI of oogenesis (fig. 16A). The enzyme activity was reported to increases about 
10 fold from stage I to stage VI (Wilhelm et al, 1995) which parallels the increase of 
soluble protein detected here. Levels in nuclei compared to cytoplasms were also 
measured using the same antibodies, and a similar increase in signal can be seen 
through oogenic stages (fig. 16B). The amount of CK2a protein in each sample is
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difficult to estimate since there are large amounts of total cellular proteins, preventing 
identification of specific bands on a Coomassie-stained gel. The ECL and DAB 
immunoblotting reactions were not quantitated. One significant fact is that there is a 
substantial amount of protein in the nucleus (fig. 16B). Although there are more 
nuclei added to this gel then cytoplasms, a ratio of 5 to 1, this is due to the much 
larger amounts of proteins recovered from the cytoplasms, which if added at equal 
ratios would overload the gel. Since the volume of the nucleus is much smaller than 
that of the cytoplasm (approximately 1/50ft), it is clear that there is a higher 
concentration of CK2a in the nucleus compared to the cytoplasm. This supports the 
theory that CK2 is required more for nuclear functions which suggests that after 
translation in the cytoplasm most of it is shuttled into the nucleus.
In order to visualise CK2 in situ, ovary tissue sections were stained 
with anti-CK2a and a secondary fluorescent antibody (FITC-conjugated anti-rabbit 
IgG) was used to locate the primary antibody (see Methods, section 2.17) Ovary 
tissue staining of immature oocytes with anti-CK2a showed high levels of enzyme 
associated with the nuclear envelope as well as some staining of nucleoli (fig. 17). 
This would also lend support to the proposed nuclear compartmentalisation of CK2 
and to the proposed role in ribosomal RNA synthesis which is highly active in 
oogenesis (Pfaff and Anderer, 1988). There also seems to be some staining of 
mitochondria which could point to some yet undiscovered function of CK2.
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Figure 16: Levels of CK2a during oogenesis; A) Anti- CK2a immunoblot of oocyte 
extracts from stages I-VI. Each track contains approximately two oocytes of extracted 
protein. This is a DAB reaction producing a stain of immuno reactive protein. The markers are 
prestained and are not reacting with the antibodies or with the DAB reagents. The first track is 
protein markers of 180, 116, 84, 58, 48, 36 and 26 kDa. The two a-subunits are seen at 42 
and 38kDa. There may be under-representation of the reactivity from stage 111 oocytes in this 
particular blot. B) Anti-CK2a immunoblot of nuclear (N) and cytoplasmic (C) protein 
extracts from stages 1I1-VL Each nuclear track contains approximately 10 nuclei worth of 
extracted protein and each cytoplasmic track contains approximately 2 cytoplasms. The fusion 
protein GST-HDAV is present at 48 and 40 kDa as a positive control. It reacts with anti- 
CK2a because the GST portion of the antigen is present in both.
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Figure 17: Immunostaining of sectioned ovary: A) Image of stage Ill oocytes stained with 
anti-CK2a using a fluorescence secondary antibody at 1/100 dilution. B) Phase partner to 
section in A. The nuclear envelope, mitochondria and nucleoli are positive for CK2a. 
Magnification x392.
3.4.2 The CK2 particle during oogenes^^:I^ ^r^^r to stuidy the characteristics 
of CK2 io ssryats, ia was necessary as sacdy aCt atatametir complex itself. Siort aCt 
rlsots expressing CK2 did ooa Cave any eozymaair araiviay, aooaCet way was needed 
ao Celp iovesaigaae aCe araiviay of CK2. TCe size and araiviay of aCe oaaive form of 
CK2 Cad ao be sacdied diteraly. TCis was done by tcooiog ooryae exararas oo glyrerol 
gtadieoa ao deaetmioe aCe aracal parairle size and ao rCerk roinrideore of 
immcnorearaiviay and enzyme araiviay. One qcesaioo ao answer was wCeaCet CK2a 
exisaed as a free scbcoia, para of a aearametir romplex, ot para of any larger romplexes 
of proaeins.
74
Sample of whole oocytes, nuclei and cytoplasms were solubilized using the 
same method as described above (see Methods, section 2.9). The gradients were 
loaded with oocyte extracts usually treated with Freon to remove the lipid which 
could interfere with the migration of particles. The samples were run at 36,000 rpm 
for 16 hrs in a 10-30% glycerol gradient (see Methods, section 2.10) These gradients 
were then fractionated into sixteen 150 pl samples, plus an insoluble pellet fraction.
The fractions were acetone precipitated, raised in lOpl of 8M urea and lOpl of SDS- 
PAGE buffer, and run on a protein gel (see Methods, section 2.6). The gel was then 
Western blotted (see Methods, section 2.7). Marker sizes were obtained by running a 
gradient containing marker proteins and protein complexes in parallel with the 
samples which was fractionated, separated by SDS-PAGE and stained to identify the
sedimentation rates.
Gradients of different oocyte extracts were run in an attempt to locate the 
CK2a associated particle, and to determine if this particle occurred at the same size 
throughout oogenesis. Stage I, IH, and VI oocytes were blotted after the gradient was 
fractionated to identify the particle size. The fractions were precipitated with four 
volumes of acetone in order to concentrate the proteins and the precipitate was run on 
SDS gels. These were transferred to nitrocellulose paper and immunoblotted with 
anti-CK2a. Stage VI oocytes were separated into cytoplasmic and nuclear fractions 
to see whether CK2 was associated with different sized particles in the cytoplasms 
compared to the nuclei. Figure 18 shows that the particle size appears to be constant 
throughout oogenesis. Fraction 3, 5 and 7 seem to contain most of the CK2a subunit, 
with a peak in fraction 5. These fractions from the gradients correspond to a particle 
of approximate size of 130 kDa, which is the predicted size of CK2 in its tetrameric
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Figure 18: Sedimentation analysis of protein complexes that contain CK2a protein: A)
Protein size markers B) Immunoblot with anti-CK2a of soluble extracts from 100 stage VI 
nuclei recovered from alternati-ve fraction of a glycerol gradient. The material pelleted in the 
gradient (P) and fusion protein GST-HDAV are included in the blot. C) As in A), but from a 
gradient used to separated the Freon-treated extract of 100 stage VI cytoplasms. D) As in A), 
but from a gradient used to separate the Freon-treated extract of 50 stage I oocytes. GST- 
HDAV was not added as a marker. E) As in C), but from a gradient used to separate the 
Freon-treated extracts of 50 stage III oocytes.
form. The figure 18 E shows higher cross reacting bands across the gradient, but this 
was a reprobed western blot which was not completely stripped of a previous 
antibody reaction. Also in figure 18E, the signal for CK2a appears in lower fraction 
numbers compared to the other gradients, this gradient was spun slower (30,000 rpm)
than those shown in B-D.
3.4.3 CK2 actwity inc nuclear gradientfractd^nsr oMer to confirm that tlie
particle sizes that were being identified by the immunoblots actually represented the 
active protein kinase, a suitable protein substrate GST-HDAV (see Chapter 4) was 
added to the fractionated gradients along with [32P]y-ATP, to identify which fractions 
had the ability to phosphorylate this substrate.
Gradient fractions were incubated with tpl of [32P]y-ATP and 2pl of GST- 
HDAV for one hour at room temperature. The samples were then precipitated with 
acetone to concentrate the phosphorylated protein, and to remove un-incorporated 
counts. The precipitated protein was raised in 8M urea and SDS-PAGE buffer and 
run on a protein gel, stained with Coomassie blue and destained to resolved the 
protein bands (see Methods, section 2.6). The gel was dried down onto 3M paper 
using a vacuum dryer and placed with X-ray film to visualised the radioactivity.
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to figcte 19 ia ran be seen aCaa indeed GST-HDAV is pCospCorylaaed io 
fraraion 5 and 7 wCirC rtprtsenas aCe CigCesa levels of CK2a immcnoblotting. OaCer 
kinase araiviaies ate repres ed, as ran be dedcred from aCe saroog p^pCor'y^aron 
of eodogeoocs ncrleat proaeins. TCe mosa promineoa pCospCorylaaion is apparena in 
fraraion 9; aCis was mainly pCospCorylaaion of larger proaeins. TCis is ao be experaed 
sinre aCe ncrlecs rooaaios many kinases, bca aCe fara aCaa aCey do ooa pCospCorylaae
GST-HDAV is roosisaena wiaC aCe obsetvaaion aCaa CK2 siaes ate aCe mosa abcndana
siaes orrcttiog on aCe GST-HDAV scbrlone of HDACm (see CCapaer 4), aod 
pCospCotylaaion of aCis fusion proaein is likely ao be by CK2.
1 3 5 7 9 11 13 15 P
Figure 19: Protein kinase activity in gradient fractions of stage VI nuclei: Activity gel of
100 stage VI nuclei separated on a glycerol gradient. GST-HDAV is added as the substrate and
[32P]j-ATF added as the label.
TCis pCospCorylaaion was qcanaified and grapCed ao give an arrcraae piraorial 
ttprtstnaaaihn of aCe kinase araiviay (fig. 20).
TCe dried proaein gel aCaa was csed ao make aCe acaotadiograpC was sranned 
ao meascte aCe aoaal ocmbet of inrotphraatd rotmas. TCe araiviay io earC band and 
atark was meascted csing an insaana imaget (see MeaCods, seraion 2.15). EarC atark
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was measured both for the GST-HDAV radioactive band and for the endogenous 
protein activity in the highest molecular weight block.
In figure 20, the X axis represents the gradient fractions and the Y axis 
represents the total number of counts found in each. The blue line is a measurement 
of phosphorylation of GST-HDAV. The blue line records the highest level of counts 
in fraction 5 and 7, which corresponds to particles at 130 kDa, the expected size of the 
CK2 tetramer. The red line represents the total number of counts of the higher 
molecular weight proteins found in each fraction; these are endogenous nuclear 
proteins. The highest activity is in fraction 9, which probably represents some other 
active nuclear kinase. The broken black line represents the size markers; the X axis 
represents the fraction number and the YY axis the molecular weight. The number of 
total counts as estimated for all the GST-HDAV fractions and also for the larger 
nuclear proteins. The graph (fig. 20) shows that the greatest phosphorylation of GST- 
HDAV was in 5 and 7, while the greatest activity phosphorylating endogenous 
proteins was in fractions 9 and 11. As stated earlier, this is understandable, because 
the nucleus contains many kinases; the crucial point here is that the highest number of
counts measured for GST-HDAV correspond to the immunoblotted CK2a fractions..
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Figure 20: Graph of gradient for stage VI nuclear activity: Activity profile of soluble 
extracts from 100 stage VI nuclei using GST-HDAV as a substrate (blue circles) and 
endogenous nuclear proteins as a substrate (red circles). Peak sedimentation positions of 
molecular mass marker (Mr) are shown (black circles).
3.5 Activity Studd of CK2 with Various SSbstrrtes, Ir^fc^ii^itt>rr and Buffer
The activity studies discussed in this section contained many different 
substrates and inhibitors but the reaction were generally carried out using the same 
procedure. A reaction mixture was made which contained 1 pi of either nuclei or 
kinase extract, 1 pi of lOx kinase buffer, tpl of ^Pfy-ATP (0.03 mM), 2pl of a 
substrate (GST-HDAV, a-casein, or Y-box protein), tpl of an inhibitor (varying
concentrations) and 4pl of dHiO. These samples were left to incubate at room
temperature between 30 minutes and an hour. lOpl of SDS-PAGE buffer was added 
to these samples which were then run on a protein gel. The gels were stained, 
destained, dried on to 3M paper, and set up for autoradiography (see Methods, section
2.6).
3.5.1 Heparin inhibition', Heporie is onr o ftho moft widelystudied inuibitors 
of CK2 (Hathaway nt et, 1980; Taylor nt el., 1987; Allende and Allende, 1995). tt
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works by binding to the substrate binding site of CK2, thus preventing the enzyme 
from phosphorylating other substrates. Heparin is an efficient inhibitor of CK2 
activity, as can be seen from figure 21. The equivalent of one nucleus, as the source 
of CK2, is added to the reaction, as well as the substrate GST-HDAV at the final 
concentration of .04pg/pl. Heparin is effective at lOOpg/ml concentrations, inhibiting
almost all CK2 activity.
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Figure 21: Autoradiographs showing inhibition of nuclear CK2 activity by heparin: Both 
panels represent phosphorylation of GST-HDAV with stage VI nuclei after the addition of 
increasing amounts of the inhibitor heparin. The GST-HDAV samples are marked as 48 and 
43 kDa and the other most predominant proteins to be phosphorylated are Nl, N2 and 
Nucleoplasmin at 110, 100 and 30 kDa.
3.5.2 DRB inhibitiorr.Abthough the irdiibitorDRB oa s ^ot been usedfor as 
long as heparin has, as an inhibitor of CK2 activity, its use as an inhibitor is well 
documented (Zandomeni et al., 1984; Vancurova et al., 1995; and Egyhazi et al.,
1998). It works differently from heparin in that it binds to the ATP binding site of 
CK2, thus inhibiting its ability to bind ATP. In order to help define the activity of 
CK2, a DRB titration was carried out using nuclei and heparin-bound fraction as the 
sources of protein kinase activity to phosphorylate the substrate GST-HDAV. This 
was done in the presence of [32P]y-ATP as a label. A sufficient concentration of DRB
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in inhibiting phosphorylation by nuclear CK2 seem to be around 50pM and, when 
using extracted CK2, a somewhat higher concentration of 150pM seemed to be 
required (fig. 22).
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Figure 22: Autoradiographs showing inhibition of CK2 activity by DRB: The two panels 
represent the titration of the inhibitor DRB with stage VI nuclei (left) and extracted kinase 
activity (right) using GST-HDAV as the substrate and [32P]y-ATP as the label. The figures 
show increasing concentrations of DRB and its effect on labeling of GST-HDAV substrate.
5.5.5 Quercetininhibitiotc. Quercetin, likc DRB, el ooinhibits CK2by 
blocking the ATP-binding site. Its use as an inhibitor has also been well documented, 
and like heparin, seems to be very specific towards CK2 (Cochet bi al., 1982; 
Braddock bi al., 1994). A titration of quercetin was performed using the same 
technique as that used in the DRB titration. Stage VI nuclei and heparin-bound 
fraction were used as the sources of CK2 which was incubated in the presence of 
GST-HDAV and [32P]y-ATP. As can been seen from figure 23, quercetin was very 
effective against stage VI nuclei with effective inhibition at levels as low as .06pM. 
Against the extracted CK2 it was also very effective, but at a slightly higher
concentration of 0.3 pM.
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Figure 23: Autoradiographs showing inhibition of CK2 activity by quercetin: The two
panels are the titration of the inhibitor quercetin with stage VI nuclei (left) and extracted 
kinase (right) using GST-HDAV as the substrate and [32P]y-ATP as the label. The figures 
show increasing concentrations of quercetin and its effect on labeling of GST-HDAV 
substrate.
3.5.4 Rutin inhibition:Rutm. is an inactive analogofquercetirqthusit was 
used ft v nscviigs centrel (Cechst ei al., 1982; Brvddeck ei al., 1994). TSs iitrviient 
wsrs repevtsd usinc the svme procedure vs thvt fer the quercetin titrvtiens. Stvge VI 
nuclei vnd Sepfrin-beuqd frvctien were vcvin used vs the seurces ef kinvse vctigity. 
The substrate fer this revctien wvs GST-HDAV, vnd [32P]y-ATP wvs used vs the 
lvbel. As cvn be seen frem figure 24, there wvs ne inhibitien using the svme 
cencentratiens used fer rutin vs used fer quercetin when testing the stvge VI kinvse 
vctigity. Seme inhibitieq wvs seen with extracted CK2, but it wvs net nevrly vs
0 .03 .06 .16 3 .6 1.6 3 nM ° .03 .°6 .16 3 .6 1.6 3 jiM
Figure 24: Autoradiograph showing inhibition of CK2 activity by rutin: The two panels 
represent the titration of the rutin with stage VI nuclei (left), and extracted kinase (right), 
using GST-HDAV as the substrate and [Pp]y-ATP as the source of label. Rutin 
concentrations increases left to right.
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sensitive to rutin as with quercetin. The sudden decrease in activity at 0.6 pM was
probably due to non-specific inhibition at this rftativfty high concentration.
3.5.5 Varying buffer conditionsnCKOactivtiy is reported Op bet s^ensitie eto
concentrations of certain metal ions and salts (Gatica et ah, 1993; Allendf and 
Abends, 1995). MgCl2, specifically Mg2+ ions, are a necessary cofactor for 
phosphorylation activity of CK2. To help define the activity of CK2, varying salt 
concentrations were added to a phosphorylation reaction to seo how this would affoct 
tho activity of the kinase. In figure 25 NaCl and KCl were added to the reaction 
mixture which contained nuclei from stage VI as the source of the kinase activity, 
GST-HDAV as the substrate and f^Pfy-ATP as the source of label. The salts were 
added in increasing concentrations, and as can be seen from figure 25, NaCl, even at 
low concentrations, had a negative effect on kinase activity. KCl at low 
concentrations of 100 mM had lime effect, but as soon as the concentration was 
raised to 200mM and especially at 400mM, the kinase activity dropped steeply below 
its normal levels. The MgCla level is also very important to activity. The addition of 
2mM EDTA, which chelates divalent cations such as Mg3+ and Ca3+, ^d an 
inhibitory effect on the efficiency of phbsphb2ytarion, and the addition of moderate 
amount ofMgCk (20mM final) improved the phosphorylation activity greatly 
compared to tho lower MgClZ (lOmM final) reaction and tho EDTA reaction (2mM).
84
NaCl (M) KCl (M) MgCl2
+M .1 .2 .4 .1 .2 .4 — edta 10 mM
kDa 
48 - 
43
Figure 25: Autoradiograph showing phosphorylation of GST-HDAV with CK2 from 
Stage VI nuclei with varying buffer conditions: The first three tracks illustrates the effects 
of adding increasing amounts of NaCl from 100mM-400mM. The next three tracks illustrates 
the addition of increasing amounts of KCl. The final three tracks shows the effect of: no 
addition of MgCl2, the removal of divalent cations with the addition of 2mM EDTA, and the 
effect of the addition of an extra lOmM MgCb to the reaction mixture. Ix kinase buffer is 
lOOmM KCl, lOmM MgCb, 20mM Tris and 1 mM DTT.
3.5.6 Polypeptide,poly(EY), rnhibitionofphacpaoiylatlon'. PalyiY] wys 
used as a competitor inhibitor for CK2 activity due to the fact that it contains the 
acidic residues glutamic acid intermixed with tyrosine at a ratio of 4 to 1. This 
compound binds very efficiently to the substrate binding site of CK2. CK2 
recognises S/T XX D/E sequences, normally in an extended acidic region in potential 
substrates, so poly(EY) added in high concentration competes out other substrates
containing those sites. Figure 26 shows that the substrates GST-HDAV, p60/56 and
a-casein are not phosphorylated after the addition of poly(EY); this indicates that all
these substrates are phosphorylated by a kinase which recognises the aforementioned
acidic substrate
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Figure 26: Autoradiograph showing inhibition of phosphorylation of CK2 substrates by 
the synthetic polypeptide poly(glutamic acid: tyrosine): This first track is the 
phosphorylation of GST-HDAV. In the second track phosphorylation after the addition of 
poly(EY) to Ipg/ml. The third track is the phosphorylation of purified RNP proteins. The 
fourth track is as 3, but after the addition of poly(EY). The fifth track shows phosphorylation 
of a-casein (a-Ca). The sixth track is after the addition of poly(EY).
binding motif. This is again evidence that CK2 is the major protein kinase which 
phosphorylates these substrates.
In order to learn more about the binding ability of CK2, another potential 
inhibitor was added to a phosphorylation reaction, but this substrate was composed of 
multiple glutamic acid residues, poly(E). The binding of CK2 is dependent on 
specifically placed acidic residues, but how important other residues, specifically 
those providing a hydroxyl group, are for binding of CK2 needed to be evaluated.
The poly(E) competitor was added to a phosphorylation reaction with stage VI nuclei 
and GST-HDAV used as the substrate (fig. 27). The ability of poly(E) to inhibit 
phosphorylation is very poor compared to the ability of poly(EY), which illustrates 
the point that not only are the acidic residues necessary for binding to CK2 but that 
neighbouring hydroxylated side chains are also important. In the form of serine or
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Figure 27: Autoradiograph showing a comparison of inhibition of CK2 phosphorylation 
by poly (glutamic acid: tyrosine) and poly (glutamic acid): The first track is 
phosphorylation of GST-HDAV. The second is phosphorylation of GST-HDAV with 1 pg/ml 
of poly(EY) added. The third track is phosphorylation of GST-HDAV with 0.1 pg/ml of 
poly(EY) added. The fourth track is phosphorylation of GST-HDAV with 1 pg/ml of poly(E) 
added. The fifth track is phosphorylation of GST-HDAV with 0.1 pg/ml of poly(E) added.
threonine they may be phosphorylated by CK2, in the form of tyrosine some binding 
affinity may be provided but modification is not achieved.
3.5.7 Inhibition of CK2 phosphorylation by anti-CK2a\ The last potential 
inhibitor of CK2 activity to be tested was the antibody against the 2A clone. If the 
sites recognised by the antibody were part of the substrate binding site, or the ATP 
binding site, then it may have an effect on the activity of CK2. Figure 28 shows a 
phosphorylation of GST-HDAV using stage VI nuclei after the addition of increasing
dilutions of anti-CK2a serum. The gel shows that at 1/10 dilution, there is no change 
in phosphorylation levels. This result may be due to the fact that there is a very high 
concentration of serum which for some reason gave an anomalous result. The second
dilution of 1/100 showed significant inhibition of phosphorylation of GST-HDAV. A
similar result was observed for the next dilution of 1/1000. A control antibody was
used in the same manner and there was a less significant loss of phosphorylation 
using the control. This seems to show that the antibody can reduce the activity of the 
native kinase. Although it must be stated that even though an antibody does bind to a
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particular enzyme, it does not necessarily mean that the antibody can affect its 
activity. This antibody seems to be able to effect the phosphorylation activity of the 
CK2 only to a limited extent and was judged to be of little use for further inhibition
studies.
0 a(-l) a(-2)a(-3) C(-l) C(-2) C(-3)
Figure 28: Autoradiograph showing the effect of preincubation with immune and non­
immune serum on phosphorylation by nuclear CK2; The gel shows the effect of increasing 
dilutions 1/10 (-1), 1/100 (-2),and 1/1000 (-3) of an^^-iC^L2^ (a) and of a control antibody (C) 
on the phosphorylation of GST-HDAV by CK2.
3.6 Summary
The protein kinase CK2 is expressed in increasing amounts during oogenesis, 
reaching the highest levels in large oocytes: stage IV, V and VI. Although the 
amounts of CK2 are high in both the cytoplasm and nucleus, it seems to exist in a 
higher concentration in the nucleus. In tissue sections, it is seen to be most widely 
associated with the nuclear envelope and nucleoli. Sedimentation analysis of the 
native enzyme shows that it exists mostly as a 130 kDa particle thoughout oogenesis, 
and that the phosphorylation activity for known CK2 substrates corresponds with this 
particle.
Analysis of its activity shows that the inhibitors DRB, quercetin and heparin 
all have the ability to inhibit both the nuclear and partially purified form of CK2. 
Varying salt and Mg2+ ion concentrations significantly affect the activity of the 
kinase; this is an observation which has already been reported for CK2 from other
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sources (Gatica et al., 1993; Allende and Allende, 1995). Specific substrate 
competitors such as the synthetic polypeptide poly(EY) show efficient reduction of 
phosphorylation levels of test substrates while control, poly(E), shows little effect.
All of the tests carried out and described in this chapter indicate that the 
phosphorylation activity being studied is indeed due to ‘the protein kinase CK2. Since 
stage VI nuclei are a good source of the native tetrameric complex, nuclear extract 
and CK2 partially purified from nuclei provide a convenient source of enzyme activity 
for further experimentation.
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Chapter 4: Results
Expression and Regulation of Histone
Deacetylase
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4.0 Aim
A histone deacetylase (HD) expressed in Xenopus oocytes, HDACm 
(Sommerville et al., 1998), contains several putative CK2 phosphorylation sites, 
suggesting that CK2 could be a regulator of HD enzyme activity, or some other 
functions such as, nuclear import of HD. This chapter explores the expression of
HDACm in Xenopus oocytes, nuclei and cytoplasms in order to understand how its 
activities may relate to phosphorylation by CK2. The effects of phosphorylation on 
HD activity and the effects of phosphorylation on the kinetics of nuclear transport of 
HDACm are studied. The issue of how phosphorylation mediates the interaction 
between the nuclear localisation signal (NLS) of HDACm and the nuclear shuttling 
protein a-importm is also studied to try and discover what specific function CK2 
could have on the nuclear import mechanism.
4.1 Cloning of HDACm Gene
4.1.1 Xenopus ABOlu TheAewopes form uf histone deacetylase was first 
cloned by a student named Scott Lyons working in John Sommerville’s lab in 1994. 
The clone named AB21 (accession number X78454) was recognized as a candidate 
homologue of the yeast global transcription regulator RPD3 (Vidal and Gaber, 1991) 
This was fellowsa by the later cloning of a mammalian histone deacetyla^ (Taunton 
et al, 1996) which made it evident that both RPD3 and AB21 were members of this 
same enzyme family.
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MQAVAEDSIHDDSGEEDEDD 
CCCGACAAGCGTATTTCAATTCGGTCATCAGATAAAAGGATTGCCTGTGATGAGGAGTTC 12 60
P D K__ R I S 1 R S S D K__ R I A C D E E F
TCAGATTCTGAGGATGAAGGGGAGGGAGGTCGCCAAAACGTGGCCCAATTTCAAAAAAGTA 1320
SDSEDEGEGG R__ K NVANFKKV
AAACGGGTTAAAACTGAAGAGGAAAAGGAAGGAGAGGACAAGAAAGATGTTAAAGAAGAG 1380
K R VK.TEEEKEGEDKKDVK&E 
GAGAAAGCTAAAGATGAGAAGACGGATAGCAAACGGGTAAAAGAAGAGACCAAATCAGTC 1440
EKAKDEKTDS K__ R VKEETKSV
TGATCCTTCAACTATGGGGAGCAAAA<CCG^AAGACCCAAkCT<AATTCTCATGGTTTTATATT 1500 
TTGTATATGCCCTGTACAGAGCCCTACTATGAAATATAAGTCCACA<CATTCTAAATTATT 1560 
TCTGTCCCACTGGTTGAGGGGGGGTG.AAGTGGTCGCTGTAGTGGATTAGCTTCACATCT 1620 
GTTACCTTTTTTTAAGATTCACATCTGTTACCTTTTTACCAGATGTTTCCAGCTCTTTGG 1680 
CrTTTTTTrr'r TTTTTGACCAAAAACTTTCCATGTTTTCCTGTGCCTCTGTAATCTTCGG 1740 
TGGTGCCAATGCATTACGGATTTATTTCCCTGCTCCCTTCTATACACACrrTGCTGTCAGA 1800 
CTACAGACTrrrGCTACAGTACATGAAATATGTACACTTAr’GCTCAGGA,rCAGGCArArG 1860 
rACACTTATGCrCAGGATCAGGCAGTGAGAAGGAGGTGGGTTCCAGCTGTCrTCCAAATG 1920 
AArrrGAGAGGGrrACCTTGAGGGATGGAAGGGGGCA\GCTG7AACCTCCTCTTAAACTAAA 1980 
CTArTCAGGGATrCCCr,GTTCACTTAATGCTGCTAACCCrCCTCCAGATTAGrrCAr,GAA 2040 
GCAGATTTTTAGATGTGTGGAAACCTGGrCCACAGTTACCTTATAAr?GGGGArTGTGGGG 2100 
ATTTGCAATTTGGGTTTCTGCCTTTAATCTTAGTGGGTTGGAGAGTGTCTGGATTCATGG 2160 
AGTGAAGCAAAArGGAGAATTTTTATGTCTrAV^TTTTGTGATGGG2AAA,TTCTTTTTTTTT 2220 
rrrTTTATGGTTGAGrr’GTAGAAAAGCTrTGTAATAAAATCTGGTACTrArACAAAAAAA 2280 
AAAAAAAAAAAAAA 2305
Figure 29: AB21 cDNA Sequence: Nucleotide and amino acid sequence of AB2L Potential 
CK2 phosphorylation sites are in bold and potential cleavage sites for trypsin are underlined. 
A putative bipartite NLS is in red italics.
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4.1.2 Subclones ofAB21: Subclones of AB21 were made by Michael 
Ladomery and consisted of glutathione fusions with varying lengths of the AB21 
cDNA. These clones were thought to represent important sequences coding for 
functional domains of the native enzyme. The three most commonly used subclones 
were GST-HDAV, AR and AR/AH, after the flanking restriction enzyme digestion
sites. The GST-HDAV subclone consisting of the tail domain, coding for the 
potential regulatory region of HDACm from an internal Pvu II site to the end of the 
clone. The GST-HDAR subclone consists of most of the HDACm gene but missing
20 amino acids from the N-terminus to the internal Eco RI site. The GST-HDAR/AH
subclone represents the middle portion of the sequence, containing neither the N-
terminus or C-terminal domain, after being cut with Eco RI and Hind III. This
conserved region is thought to represent the enzyme core (Ladomery et al., 1997a).
R P BDVHFE H V H 
L L L-L LJL L . ...1   L  L L
2305 bp
CPE
------------- Up.
P(A)
GST
AUG ORF (480 aa) UGA
bbbsbbqiim^bh AR/AH
AV
Figure 30: HDACm subclones: The three subclones of HDACm. ORF represents the open 
reading frame consisting of the sequence conserved between various histone deacetylases 
(gray) and the highly variable C-terminal region (black). The top line represents the 
approximate positions of existing restriction sites within the HDACm cDNA and within the 
subclones. R=Eco RI, P=Pst I, B=Bgl II, D=Dra I, V=Pvu II, H=Hind III, F=Fsp I, and E=Eae 
I.
4.1.3 Antibodies agoinet HDACm cloees’. Antdeodies abadist HDACm 
subclones (anti-AV, anti-AR, and anti-AR/AH) were produced by injection of the
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glutathione fusion proteins into rabbits (see Methods, section 2.5 and 2.14). A fourth 
antibody (anti-Cpep) against a synthetic peptide which represents the terminal
seventeen amino acids of HDACm was received from Dr. Brian Turner. These four
antibodies all recognized the 57 kDa HDACm protein present d Xenopus oocytes 
extracts separated on protein gels.
4.2 Expression and Activity of HDACm in Xenopus Oocytes
4.2.1 HDACm levels duringoogenes Oo The levels ofHDACm protein, ip
oocyte extracts were measured by immunoblotting protein transferred to
nitrocellulose paper from SDS-PAGE gels. Oocytes proteins were solubilized by 
bursting approximately 50 oocytes in homogeneization buffer (see Methods, section 
2.9.3). Extracts were then spun at 10,000 rpm to separate the soluble fraction from 
the yolk and pigment pellet and the top lipid phase (see Methods, section 2.9.3). A 
sample of this soluble fraction was mixed with SDS-PAGE buffer and run on a 
protein gel (see Methods, section 2.6). Proteins from the gel were then transferred to 
nitrocellulose paper and reacted with the primary and secondary antibody (see 
Methods, section 2.7). Figure 31A shows that the levels of soluble HDACm 
increases steadily throughout oogenesis to peak in matured stage VI oocytes (stage 
VI treated with progesterone for 16 hrs). Immunoblots of nuclear and cytoplasmic 
levels (fig. 3 IB) show that there is a similar steady increase of HDACm in the 
nucleus as is seen in the whole cell extracts. The levels in the cytoplasm are low 
compared to that of the nucleus. Although the gel tracks contained material from 10 
nuclei compared to 2 cytoplasms, the lack of signal seen in the cytoplasm tracks 
indicates a much lower level per-nucleus. This observation would tend to suggest 
that HDACm is transported efficiently into the nucleus.
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4.2.2 HDAC activity during oogenesis: reneiactivrh' of HDAC in the cnn 
extracts was assayed by the group of hr. Brian Turner using an ie niteo assay (see 
Methods, section 2.20). The deacetylase substrates were prepared using the same 
methodology stated in Sendra et al. (1988).
The activity of the HDAC from these same oocyte samples showed (fig. 31C) 
that the amount of activity correlated with levels of expressed HDACm protein. 
Furthermore the total amount of enzyme activity per embryo at cleavage, blastula and 
gastrula remained essentially the same as in the full-grown oocyte. However, the 
difference between the per cell amount of HDAC activity from oogenesis though 
early embryogenesis is worth attention. Due to the early embryonic cell divisions 
approximately a 10,000 fold higher level is present in oocytes compared with mid- 
blastula on a per cell basis. The higher levels of available enzyme activity in oocytes 
suggests that ie vivo its regulation is efficient, because the lampbrush chromosomes 
of oocytes contain hyperacetylated histones (Sommerville et al, 1993) and stored H4 
remains di-acetylated during oogenesis (Almouzni et al, 1994). Thus, it would seem 
that the bulk of the deacetylase activity is kept separated from its potential substrates, 
but by what means is unclear.
Past experiments on Zea mays histone deacetylase showed a sensitivity of 
substrate specificity to treatment with alkaline phosphatase (Brosch et al, 1992). A- 
dependence of activity on the phosphorylation state of the Xenopus enzyme was 
suggested by the effect of treating extracts with alkaline phosphatase. Oocyte and 
embryo extracts were treated with 50 units/ ml of alkaline phosphatase (Sigma, type 
III), adjusted to pH 8.3, and incubated for one hour at 22°C. Figure 32 shows that a
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Figure 31: Levels of HDACm Protein and HDAC Activity During Oogenesis: A)
Immunoblot of oocyte extracts from stage I-VIM (VIM=progesterone treated for 16 hrs.) 
using anti-Cpep. Two oocytes-worth of protein added to each track. 0.1 pg of GST-HDAV 
was added as positive control at 48kDa. B) Same as in (A) except whole oocytes range from 
stage III-VI and each are separated into nuclei (N) and cytoplasms (C). Nuclei tracks contain 
the equivalent of ten nuclei. C) Activity assay of histone deacetylase in oocyte stages I-VIM 
and embryos stages C (8-cells), B (mid-blastula) and G (gastrula). The activity is expressed 
as dpm of 3H-acetate released from histone by extracts of one oocyte or embryo (represented 
by the column’s total height). The relative amount per cell is also indicated (%, black 
column height), which becomes smaller as cell divisions increase in number.
3
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70-90% loss of HDAC activity was observed with this treatment in the in vitro assay 
compared to the activity without the phosphatase treatment. These assays were 
carried out on extracts supplied to the group of Dr. Brian Turner.
This dramatic drop in activity after incubation of extracts with alkaline 
phosphatase indicates the importance of phosphorylation to histone deacetylase 
activity. Which phosphorylation sites influence activity , and which protein kinase is 
responsible are not known.
Oocytes - stage VI ■
Embryos - blastula g|
Phosphatase
Figure 32: Sensitivity of HDAC Activity to Phosphatase Treatment: Extracts of 
oocytes (black column) or embryos (lined column) were incubated in the presence 
(+) or absence (-) of 2U/pl alkaline phosphatase.
4.3 Size of Prc^tc^iii Complexxs with Histone Deacctylase Activity
The size of particles containing histone deacetylase activity were measured by
rate-centrifugation of extracts, from Xenopus stage VI oocytes. Supernatants of 
oocyte extracts were layered onto 10-25% linear glycerol gradients and centrifuged 
until an IgM 19S marker reached the bottom of a gradient run in parallel with the
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samples (see Methods, section 2.10). The gradients were then fractionated into 16 
equal portions plus the pelleted material. These fractions were analysed for HDACm 
by immunoblotting and enzyme activity by the in vitro assay. Figure 33A shows that 
the activity in whole oocyte extracts, spun at 36,000 rpm for 16 hrs, peaks sharply at 
a position in the gradient corresponding to a particle size of ~360 kDa. This would 
indicate that the active form of histone deacetylase exists as part of a large protein 
complex of about 360 kDa. An immunoblot of proteins from the same gradient 
fractions (fig.33D) shows that the activity seen corresponds to a immunoreactive 
protein of 57 kDa which corresponds to HDACm. Gradient separation of material 
from nuclei isolated from stage VI oocytes shows a similar peak of activity at ~360 
kDa (fig. 33B). Immunoblots of the same fractions again shows that the activity 
corresponds to the 57 kDa protein, which is most abundant in the nucleus than in the 
cytoplasm (fig. 33B and C). Pretreatment of stage VI oocytes with progesterone 
shows no change of HDAC activity levels or sedimentation rates.
Data indicates that HDACm exists as part of a protein complex and is 
contained mainly in the nucleus during the later stages of oogenesis. As was shown 
in Section 3.4.2., CK2 also accumulates in the nucleus becoming most abundant at 
the later stages of oogenesis. The protein complex containing CK2<a and showing 
kinase activity is noticeably smaller than the protein complex containing histone 
deacetylase, and so there is no evidence for CK2 in the HDACm particle itself. Any 
modifications of HDACm by CK2 is likely to be due to a transient association.
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Figure 33: Sedimentation analysis of particles containing HDACm protein and HDAC 
activity: A) HDAC activity from extracts of 50 stage VI oocytes (black circles) and oocytes 
pretreated with progesterone (white squares) separated on glycerol gradients. Molecular 
weight markers shown (crosses). B) HD activity from extracts of 100 stage VI nuclei 
gradients (black circles). C) Immunoblot using anti-Cpep, of stage VI nuclear material from 
odd fractions in B). Pellet (P) and GST-HDAV fusion protein are included in the blot. D) 
Same as in C) except sample stage VI cytoplasmic material from odd fractions.
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4.4 Phosphorylation of Histone Deacetylase by CiK
4.4.1 Potential phosphorylation sites’. HDACm has six potential
phrsphrrylctirn eitae that cruld ba racrgnizad cnd pOrepOrrylctad by CK2. TOa 
errraeprnding targat sita is (S/T X X D/E). Fiva prtantial sitas ara lrcatad within tha 
chargad tail drmain rf tha HDACm prrtain (fig. 34). Alsr within this tail drmain is 
a pctantial yipartita NLS: 438-KKVKRVKT EEEKEGEDKKDVK-458 similar tr 
tha NLS frund in tha nuclaar prrtain N1/N2 in Xesnpus (Dingwall and Laskay, 
1991). Ona rf tha fiva prtantial phrsphrrylatirn sitas lias within tha prtantial NLS 
(rad) and cruld ba imprrtent frr ragulatirn rf nuclaar imprrt. Tha glutathirna fUsirn 
prrtain callad GST-HDAV contcins fiva rf thasa sia CK2 sita and crntains tha antira 
chargad tail drmain (fig. 34).
Thrombin Fusion
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Figure 34; Map of the glutathione fusion protein HDAV: The potential phosphorylations 
sites are marked on serines (S) or threonines (T) with the symbol *. Also marked is the 
potential NLS and the region recognised by anti-Cpep. A dotted box shows the position of a 
predicted a-helix and arrows mark the major cleavage sites predicted from proteolysis.
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Phosphorylation with [32P]y-ATP of the GST-HDAV fusion protein, and 
fusion proteins representing varying portions of HDACm, illustrates the approximate 
location of these CK2 phosphorylation sites. Potential sites within the fusion 
proteins produced from HDACm are represented in figure 3 5A. These represent 
proteins containing: the N- terminus, catalytic core and one potential CK2 site 
(AR/AH); the charged tail domain containing five of the potential CK2 sites (GST-
HDAV) and the majority of the HDACm excluding a small portion of the amino
terminus but all six potential CK2 sites (GST-HDAR). Incubation of these fusion 
proteins with nuclear extract (as a source of CK2) and [32P]y-ATP (see Methods, 
section 2.11) shows that only proteins containing the charged tail domain (GST- 
HDAV-48 kDa and GST-HDAR-85 kDa) are phosphorylated (fig. 35B). Multiple 
phosphorylated bands can be seen in some of the tracks due to limited proteolysis, 
especially with GST-HDAV, occurring during extraction and incubation. This
results in multiple bands being observed at 48,43 and 39 kDa of GST-HDAV due to 
cleavage from the carboxyl end of the fusion protein (fig. 35B). The 42 kDa protein 
is phosphorylated as efficiently as the 48 kDa fusion protein which means that the 
phosphorylation sites beyond 5 kDa from the carboxy-terminus must be 
phosphoiylated. Labelling of some endogenous proteins can be seen in the 
phosphorylation gels, the histone chaperones N1/N2 at 120/115 kDa and 
nucleoplasmin at 35 kDa which conveniently provide internal markers of 
phosphorylation (fig. 35B). There were no significant differences seen in the pattern 
of phosphorylation when using either whole nuclear extract or isolated CK2 activity 
except for the presence of these endogenous substrates. Activity from both nuclei 
and purified CK2 were inhibited by low concentration of heparin and also showed
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Figure 35: Phosphorylation of HDACm fusion proteins: A) Pictorial representation of 
HDACm fusion proteins GST-HDAR, GST-HDAR/AH and GST-HDAV showing varying 
lengths of HDACm regions and potential CK2 phosphorylation sites. B) GST-HDAV track 
shows breakdown products of the fusion protein at 43 and 39 kDa. GST-HDAV and GST- 
HDAR tracks shows the efficient phosphorylation of fusion proteins containing the carboxy­
tail domain. Also represented is the breakdown product of GST-HDAV at 43 kDa and the 
endogenous nuclear proteins N1/N2 and nucleoplasmin. The GST-HDAV and GST- 
HDAR/AH tracks shows that fusion proteins without the carboxy-tail domain do not get 
phosphorylated. The GST-HDAV, GST-HDAVh and Y2 tracks shows that GST-HDAV 
phosphorylation is inhibited by heparin (h) and that the CK2 extract also efficiently 
phosphorylates the Y-box proteins FRGY2a/b.
N1/N2
85-
kDa
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phosphorylation activity towards a known CK2 substrate, FRGY2a/b (fig. 35B).
4.4.2 Phosphorylation sites ofthc HD A Cm cloee GST-HDAV detected by
peptide sequencing'. The fUsion protein GST-HDAV was phosphorylated using 
extracted CK2 and [32P]y-ATP as a label. The labeled GST-HDAV was then 
digested with trypsin and sequenced using an amino acid sequencer (see Methods, 
section 2.12). Two peaks of radioactivity were obtained by separating the digest on 
fine-bore HPLC (fig. 36A). The peptides corresponding to the peak fractions were 
then sequenced and the material from each cycle was collected on filters and assayed 
for radioactivity. In peptide 1, peaks of radioactivity were observed in cycle 8 and in 
cycle 10 which represented the phosphorylation of two serine residues at these 
positions. These same results were found in two separate runs of this same material. 
Radioactivity was recovered from peptide 2 only during cycle 22 which meant that 
the serine at position 22 had been phosphorylated by CK2 (fig. 36C). The serine at 
position 17 was not labelled, in spite of being contained within a CK2 consensus site. 
The site TEEE located in the NLS was also found not to be phosphorylated under the 
conditions used which might discount this site as a regulator of nuclear import. 
However, it must be pointed out that since this site lies within the portion of the 
carboxyl-tail domain that tends to be lost by proteolysis, this site would be under­
represented during the sequencing steps. Also, the phosphorylation of this site might 
be strictly controlled and these conditions might not be met by (h vitsa labeling 
system. It appears that only three of the potential five sites in the tail domain of 
HDACm are phosphorylated by CK2 under in vitsa conditions. These sites were all 
serines and were located at positions 393,421 and 423 of HDACm. The peptide 
separation and sequencing was carried out by Dr. Graham Kemp.
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Figure 36: Peptide sequences showing phosphorylated residues: A) Separation of trypsin 
digest of phosphorylated GST-HDAV showing peaks of radioactivity in fractions 15 and 26. 
B) Sequence of peptide 1 showing radioactive serine residues at positions 8 and 10. C) 
Sequence of peptide 2 showing radioactive serine residue at position 22.
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4.5 Nuclear Import of HDACm
4.5.1 Nuclear import is dependent on the presence of the C-terminal domain'. 
In an effort to determine if the C-terminal domain was necessaiy for nuclear 
transport ofHDACm fusion proteins, labeled proteins were injected into the 
cytoplasm of stage VI oocytes. The complete histone deacetylase HDACm and a
truncated form HDAH were translated in reticulocyte lysate from run-off transcripts 
using the TnT (Promega) system incubated 2 hrs at 30°C in the presence of 10 
mCi/ml of 35S-methionine (1,000 Ci/mmol, Amersham) by Dr. John Sommerville. 
Transcription was from either the complete cDNA template (HDACm) in 
pBluescript (Promega) or from a 3’truncation at the Hind III site (HDAH), to produce 
a protein missing the charged tail domain. The labelled proteins were separated from
unincorporated label using Sephadex-G50 spin columns. Approximately 20 pl 
(~50pg) of labelled protein was injected into the cytoplasm of stage VI oocytes 
which were left to incubate at room temperature (see Methods, section 2.13). At 
specified time points, oocytes were collected and the nuclei were removed under oil 
(see Methods, section 2.9). Five nuclei and the corresponding five cytoplasms for 
each time point were collected on 3MM filters. Protein on the filters was 
precipitated by placing the filters in 10% trichloroacetic acid (TCA), the filters were 
washed thoroughly in 5%TCA and the radioactivity was counted with a scintillation
counter.
The injection of the 35S-labelled HDACm proteins into the cytoplasm of 
Xenopus laevis oocytes resulted in a 10-fold concentration of the protein in the 
nucleus after a period of 24 hrs (fig. 37). On injecting the truncated form of the 
protein (HDAH), which lacks 16 kDa off the terminal end of the charged tail domain, 
it failed to concentrate substantially in the nucleus compared to the HDACm protein
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(fig. 37). This indicates that at least part of the carboxyl-tail domain is needed for 
efficient transport into the nucleus. The fact that the putative NLS is located in this 
region lends support to the notion that it is used for nuclear uptake of HDACm.
HDACmAH
HDACm
AH
Time (h)
Figure 37: Nuclear import of 35S labelled HDACm and AH: The picture on the left is an 
autoradiograph depicting the 35S labelled forms of HDACm (57 kDa) and GST-HDAH (40 
kDa), below is a pictorial representation of each, the black block representing the C-terminal 
domain. The graph on the right plots the ratio of nuclear concentration to cytoplasmic 
concentration of injected 35S labelled HDACm (black circles) over a 30 hour period. This 
same ratio of nuclear to cytoplasmic concentration of injected 35S labelled protein, (AH) 
missing the C-terminal domain, is represented by the white squares.
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4.5.2 Nuclear import is dependent on the presence of the putative NLS: Two
forms of HDACm fusion protein GST-HDAV and GST-HDAV-5, which represents
the GST-HDAV with 5 kDa lost from the C-terminal domain, were phosphorylated 
with CK2 (using pPPy-ATP) and injected (~50 pg) into stage VI oocytes (see 
Methods, section 2.11 and 2.13). These two forms were injected to determine 
whether the last 5 kDa, which contains the putative bipartite NLS, was actually 
necessary for nuclear uptake of the fusion protein. The fusion protein was labelled 
with [32PPy-ATP primarily to enable the protein to be localised, but another reason 
was to see if the phosphorylated protein had improved import kinetics compared to 
the 33s labelled injection experiments. When injections were completed, oocytes 
were incubated at room temperature, after which, at specific time points, sets of five 
oocyte nuclei and cytoplasms were separated (see Methods, section 2.9). These 
nuclei and cytoplasms were solubilized and loaded onto SDS-PAGE gels after which 
gels were dried down for autoradiography (see Methods, section 2.6). The protein 
gel was also placed into the Instantlmager (Packard) to enable a accurate, specific 
quantification of labelled protein of each sample (see Methods, section 2.15).
The injection of these proteins showed that only the phospolabelled protein 
containing the complete C-tail domain (GST-HDAV -48 kDa) accumulated in the 
nucleus (fig. 3 8A). The truncated form, GST-HDAV-5 (43 kDa), is not detected in 
the nucleus and after 50 hrs phospholabel is completely lost from the cytoplasm (fig. 
38A and B). This loss could be due either to degradation of the protein or to loss of 
the label by dephosphorylation. The kinetics of nuclear uptake of the GST-HDAV 
fusion protein showed a rapid and efficient translocation: over 80% of the protein is 
isolated within the nucleus 10 hrs after injection (fig. 38B). Total protein uptake in
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Figure 38: Nuclear import of GST-HDAV and GST-HDAV-5: A) Autoradiograph 
showing a GST-HDAV band at 48kDa in the nucleus (from 10 oocytes) at 10 and 25 hrs after 
injection. The cytoplasmic sample (from 2 oocytes) shows both the GST-HDAV and GST- 
HDAV-5 bands at 2 hrs. B) Graph depicting the efficiency of transport of the GST-HDAV 
(black circles) after 10 hrs over 80% of the protein is recovered in the nucleus. The AV-5 
protein (black squares) is not efficiently transported to the nucleus. The amount of 
degradation is represent by the white circles for GST-HDAV and the white squares for GST- 
HDAV-5.
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these experiments amounts to more than 1 ng/oocyte, which compares favourably 
with a synthetic rate of core histones in full-grown oocytes of 0.5ng/h.
4.5.3 Nuclear uptake is improved by phosphorylation with CK2: The GST- 
HDAV fusion protein was injected into the cytoplasms of stage VI oocytes, after 
treatment with inhibitors of CK2, to determine if the kinetics of nuclear translocation 
were affected by preventing phosphorylation. Before injection, some oocytes were 
bathed in the kinase inhibitors DRB and quercetin to ensure that no phosphorylation 
of the GST-HDAV fusion protein would occur in the cytoplasm. Oocytes were also
treated with the inhibitors of CK2, 0.16pM of quercetin (see figure 23 for 
sensitivity), and 50 pM DRB (see figure 22 for sensitivity), for ~ 2hrs. prior to 
injection. Rutin, an inactive analogue of quercetin served as a control. The GST- 
HDAV fusion protein (~50 pmols) was injected into sets of 100 stage VI oocytes and 
left at room temperature for ~20 hrs (see Methods, section 2.13). The GST-HDAV 
fusion protein had been treated with alkaline phosphatase for 2 hrs prior to use in 
injection experiments to ensure that no sites were pre-phosphorylated. Alkaline 
phosphatase was removed by extensive washing of the GST-HDAV bound to 
glutathione-Sepharose beads (see, Methods, section 2.5). After incubation of the 
injected oocytes for 20 hrs, the nuclei (20 for each sample) were isolated from the 
cytoplasms and proteins were separated by SDS-PAGE gel (see Methods, section 2.9 
and 2.6). Separated proteins were transferred to nitrocellulose and immunoblotted 
with the anti-HDACm antibody (see Methods, section 2.7).
The injected oocytes that were not treated with inhibitors of CK2 or were 
treated with rutin showed rapid and efficient nuclear import of the 48 kDa fusion 
protein GST-HDAV (fig. 39A). The oocytes treated with the inhibitors quercetin and
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Figure 39: Effects of the injection of GST-HDAV into the cytoplasms of Stage VI 
oocytes treated with kinase inhibitors: A) An immunoblot of isolated nuclei injected with 
GST-HDAV fusion protein. The 57 kDa band is endogenous HDACm and the 48 kDa band 
is injected GST-HDAV that has been transported to the nucleus. Injected = whether they 
were injected with GST-HDAV (+ or -), Treatment = if they were treated with inhibitors: Q= 
quercetin, R= Rutin, and D= DRB, and Isolated = what fraction was examined: N= nuclei 
and C= cytoplasm. B) Graph representing the relative % of the injected GST-HDAV found 
in the nucleus. The symbol (-) means not treated, (Q) means treated with quercetin, (R) 
means treat with rutin, and (D) means treated with DRB. Each set of bars (white, black and 
striped) represents a different experiment.
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DRB showed drastically reduced import of the GST-HDAV fusion protein compared 
to the untreated and rutin control (fig. 39A). The 57 kDa band, shown in figure 39A, 
represents endogenous histone deacetylase that is also stained with the anti-HDACm 
antibody. The control nuclear extract, in this same figure, shows that no 
immunoreactive bands are present at 48 kDa, if the oocytes are not injected. The C 
track (fig. 39A) represents isolated cytoplasm, which shows that no detectable GST- 
HDAV remains in the cytoplasm after 20 hrs. The graph (fig. 39B) shows the results 
of scanning immunoblots from these separate experiments. In all instances the 
highest levels of nuclear GST-HDAV were found in untreated and rutin-treated
samples. Quercetin gives an average of only 15% relative nuclear uptake, and DRB
gave less than 5% nuclear uptake.
4.6 Binding °0 a-Importin to GST-HDAV is Influenced by Phosphoiylation
4.6.1 a-importin birmls moot effitientty to unphhsphhrylated GST-HDAV:
One further question that had to be addressed was how the phosphorylation of the
GST-HDAV fusion protein affected its nuclear import. One idea was to study how 
this phosphorylated form of HDACm associated with a well known nuclear transport 
protein, a-importin. If it could be determined that phosphorylated forms of GST-
HDAV bound more readily than the unphosphorylated form, then a particular 
mechanism could be proposed. But as it happens, this was not what was observed, 
but actually quite the opposite was seen.
The fusion protein GST-HDAV was bound to glutathione-Sepharose beads, 
but instead of eluting the protein with excess glutathione it was left bound to the 
beads (see Methods, section 2.5). One sample of purified GST-HDAV was
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phosphorylated while still bound to the glutathione-Sepharose beads. This was done 
by adding the equivalent of 5 stage VI nuclei, and 1 mM ATP and leaving to 
incubate at room temperature for 1 hr (see Methods, section 2.11.4). An SN1OO was 
made from homogenised stage V/VI oocytes (see Methods, section 2.9). This 
fraction contained a-importin as detected by immunoblotting and was used as the
source for the binding assays. The SN1OO was added to the GST-HDAV bound to 
the glutathione-Sepharose beads and incubated at room temperature for 1 hour with 
mild agitation. After the 1 hour unbound protein was removed and the beads were
washed 5 times in cold TBS to remove any unbound protein. The GST-HDAV and
bound a-importin were removed by eluting the sample with lOmM reduced 
glutathione (see Methods, section 2.5). The eluted proteins were separated by SDS- 
PAGE, then transferred to nitrocellulose and immunoblotted with anti-a-importin 
(provided by Dr. Dan Gorlich), (see Methods, section 2.6 and 2.7).
This procedure was carried out with three forms of the GST-HDAV fusion
protein. The first was the complete unphosphorylated GST-HDAV, the second was 
the complete GST-HDAV fusion protein phosphorylated with CK2 from stage VI
nuclei and the third was the unphosphorylated GST-HDAV-5 fusion protein (lacking 
the C-terminal 5kDa portion). Figure 40 shows that the unphosphorylated GST- 
HDAV fusion protein gave the most efficient binding of a-importin (60 kDa) while
the phosphorylated form of GST-HDAV gave relatively poor binding of a-importin.
The GST-HDAV-5 clone also showed poor binding of a-mportin, but this might be 
expected since this protein is missing the NLS, the region to which a-importin most
likely binds. No binding of a-importin is seen with glutathione alone, and no
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Figure 40: Effect of phosphorylation on a-importin binding to GST-HDAV: The first 
track is an immunoblot of stage VI nuclei (VIN) in order to represent the amount of a- 
importin added from the source of CK2. The second is an immunoblot of the binding of a- 
importin to unphosphorylated GST-HDAV. The third track is an immunoblot of the binding 
of a-importin to phosphorylated GST-HDAV(AVp). The fourth is an immunoblot of the 
binding of a-importin to GST-HDAV missing 5 kDa from the carboxyl-tail domain (AV-5). 
The fifth tract is an immunoblot of the binding of a-importin to glutathione S transferase.
significant amounts of native a-importin blotted from the amounts of stage VI nuclei
used for phosphorylation.
4.6.2 Phosphorylation promotes the release of a-importin binding to GST-
HDAV’. Since there seemed to be no enhanced binding of a-importin to GST-HDAV
after phosphorylation of the CK2 sites in the GST-HDAV, an alternative was
considered; that phosphorylation enhanced release of the bound a-importin. This
was tested by binding a-importin to the bound GST-HDAV as before, but then 
phosphorylating the GST-HDAV and a-importin with CK2 afterwards, to see if the 
addition of phosphates would disrupt the interaction of these two proteins.
The GST-HDAV was bound to glutathione-Sepharose beads as before, and
then incubated with SNIOO using the same procedures as stated in the previous 
section. Components from the SN I OO were left to bind and then the beads were 
washed several times with cold TBS. The beads were raised in protein kinase buffer; 
then stage VI nuclei and 1 mM ATP were added and the mix was left to incubate at 
room temperature for 1 hour. Samples were also incubated with inhibitors of CK2 at 
the same time to see if the phosphorylation-induced release could be inhibited. The
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inhibitors were added at final concentrations of: 50fM DRB, - 0.16jiM of quercetin,
and 0.16pM of rutin as a control. After this incubation with gentle agitation, the 
unbound supernatant was removed from the beads and was acetone-precipitated and 
loaded onto a protein gel (see Methods, section 2.6). The separated proteins were 
transferred to nitrocellulose and blotted with anti-a-importin (see Methods, section
2.7).
Control samples were added to this gel as well, one being stage VI nuclei 
alone (VI in fig. 41) and also GST-HDAV bound to beads, but with no protein kinase 
or inhibitors added. ATP was added and incubated as with the other samples (B in
fig. 41). The second track does show some release of a-importin with 1 mM ATP 
added which might mean that ATP may aid disrupting activity by components 
already bound to the beads, but the amount released is less than that released after 
adding CK2. The sample with ATP and nuclear extract (third track in fig, 41) shows 
a large release of a-importin after phosphorylation, which would seem to suggest 
that phosphorylation with CK2 may promote efficient release of the NLS of GST- 
HDAV from a-importin. The samples that were also incubated with CK2 inhibitors
gave mixed results. The DRB reaction showed complete blockage of release of a- 
importin, but the quercetin reaction (Q in fig. 41) showed a relatively small change in 
the amount released compared to that of rutin (R in fig. 41), the inactive analogue of
quercetin.
The DRB inhibition of release was repeated and this time examining the 
remaining a-importin still bound to the beads. The procedure was the same as in the
previous experiment except after the bound a-importin was eluted, the beads were
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Figure 41: The effect of phosphorylation on the release of a-importin from GST- 
HDAV: The first track is a immunoblot of proteins from 10 stage VI nuclei with an^^^ta- 
importin. The second track is the release of a-importin from GST-HDAV after incubation 
with 1 mM ATP. The third track is the release of a-importin after incubation with stage VI 
nuclei and 1 mM ATP. The fourth track is the release of a-importin after incubation with 
stage VI nuclei, 1 mM ATP and 50pM DRB. The ISIOO track is the release of a-importin after 
incubation with stage VI nuclei, 1 mM ATP and 0.16pM of quercetin. And the sixth track is 
the release of a>importin after incubation with stage VI nuclei, 1 mM ATP and 0.16pM of 
rutin.
stripped using 1% SDS and 0.1 mM DTT. This was done to ensure that the a-
importin that was not being released from the GST-HDAV by the incubation
conditions was still bound to the GST-HDAV on the beads. Also instead of using
ATP, GTP was used at the same concentration of 1 mM. The use of GTP was to
check that the protein kinase could use either GTP or ATP to promote release. These 
samples were acetone precipitated and the proteins were separated by SDS-PAGE, 
after which they were transferred to nitrocellulose paper and immunoblotted with
anti-a-importin.
Again, figure 42 shows that 50 pM DRB inhibits the release of a-importin 
compared to the track containing CK2 and GTP without the inhibitor. However, the 
effect of DRB inhibition is much less than seen in the previous experiment. One
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possibility is that this could be due to the use of GTP instead of ATP as the 
phosphate donor. The relative amount of a-importin retained on the beads is quite 
high in the DRB track compared to that of the uninhibited track, confirming that 
release had indeed been inhibited. The tentative conclusions from these experiments 
is that inhibition of CK2 activity results in the lack of phosphorylation of the
HDACm tail domain and hence failure to disrupt the binding of a-importin.
CK2 : - + +
GTP : + + +
DRB : - - 4-
- 60 kDa
Retained : - 60 kDa
Anti-a-importin
Figure 42: Release and retention cf a-importin after phcsphcrylaticn: The samples are 
identical for tcp and fcr bcttcm blcts, except the tcp is the released fraction and bcttcm is the 
retained fraction. The first track is a control showing release and retention after the addition 
cf 1 mM GTP and 1 hour incubation. The second track shows release and retention after the 
addition of CK2 enzyme, 1 mM GTP and 1 hour incubation. The third track shows release 
and retention after the addition of stage VI nuclei, 1 mM GTP, 50mM DRB and 1 hour 
incubation.
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An apparent difference seemed to exist in the a-importin release experiments, 
between using GTP and using ATP as a co-substrate. To determine if there was any
basis to this observation, a titration was performed using ATP and GTP in the 
absence of added CK2. This was to discover if ATP and GTP had any direct effect 
on binding, and if increasing concentrations would effect the level of a-importin
release.
The procedures were similar to the previous experiments. GST-HDAV was 
bound to glutathione-Sepharose beads and then washed with cold TBS. The GST- 
HDAV beads were then incubated with SNIOO and washed again with TBS. The 
samples were then incubated with increasing concentrations of ATP and GTP. The 
concentrations for both ATP and GTP were 0, 0.05,0.1,0.5 and 1 mM. After
incubation with ATP or GTP the released material was collected, treated as in the
previous experiment, and immunoblotted with anti-a-importin.
The results of the immunoblots show that increasing concentration of ATP 
promotes an increased level of a-importin release (fig. 43). Increasing levels of GTP
did not raise the release of a-importi.n above the basal level. The differences 
between these two substrates is puzzling, since there should be no difference in the 
ability of CK2 to use either of these phosphate donors. The difference may lie in the
ability of a-importin to use GTP and not ATP for the catalysis of its transport
function. But this does not explain why ATP is more efficient at promoting release 
of a-importin than GTP. The observation that ATP and GTP can promote a basalm 
level of release without the addition of a source of CK2 activity also requires 
explanation. The protein a-importin might be sensitive to the presence of ATP or
117
GTP as part of the disassociation reaction, but more likely, it could be that the
reaction was contaminated with CK2, which was bound to the GST-HDAV from the
SN1OO extracts. Another possibility is that slow release is due to GST-HDAV
breakdown, thus release of some bound a-importin may occur as the tail domain is
lost.
Anti-a-importin
Figure 43: The effect of increasing concentrations of ATP and GTP on the release of a- 
importin from GST-HDAV: The left blot is an immunoblot with anti-a-importin of release 
after incubation with increasing concentrations of ATP. The right blot is an immunoblot 
with anti-a-importin of release after incubation with increasing concentrations of GTP. The 
range of concentration is 0, 0.05, 0.1, 0.5 and ImM for both ATP and GTP.
Released: 60 kDa
4.7 Ssmmary
This chapter illustrated the findings that the HDACm protein accumulates
mainly in the nucleus during oocyte maturation to reach a relative peak at stage VI of
oogenesis. The rate of accumulation and location of protein is similar to that of CK2, 
which also reaches its peak in stage VI nuclei. The histone deacetylase activity was 
measured, and corresponded on rate sedimentation analysis to a protein complex of
360 kDa which is larger than the complex found for CK2. Histone deacetylase 
activity seems to be sensitive to treatment with alkaline phosphatase. Thus it seems
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that the phosphorylation state could be a potent regulator of the deacetylase activity 
of the complex.
Nuclear import of HDACm fusion proteins was shown to be dependent on 
the presence carboxyl-tail domain which contains the majority of the CK2 sites 
present in HDACm. The nuclear import rate of HDACm fusion proteins was also 
shown to be increased, during injection into oocytes, by the phosphorylation of these 
sites by CK2. This illustrates another potential regulatory fimction of CK2 on the 
enzyme histone deacetylase. How the phosphorylation state of histone deacetylase 
affects nuclear import was examined by studying the binding of a well-know nuclear 
transport protein, a-importin, with the potential nuclear localizaton signal of
HDACm. Phosphorylation by CK2 seemed to disrupt the binding of a-importin to 
the region that contained the NLS. The interpretation favoured here is that 
phosphorylation might lead to improved protein disassociation once the complex has 
reached the inside of the nucleus. Release of bound proteins was also affected by 
increased levels of ATP. Why this occurs is not clear, but high ATP concentrations, 
approximating to that found in nuclei in vivo, might be one of the prerequisites for 
release of transported protein by a-importin.
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Chapter 5: Results
mRNP-Associated Protein Kinase
Activity
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5.0 Aim
The mRNP particle has been studied for many years because of its
importance in the long term storage of maternal mRNA. The storage of mRNA 
is necessary to continue the production of important proteins after fertilization, 
when continuous cell divisions mean that there is no time to transcribe genes. 
Several of the protein constituents of mRNP have been identified and three of the 
major components are FRGY2a and b (Y-box proteins), and RNA helicase p53. 
In addition an associated protein kinase activity, which is thought to be CK2, has 
been described (Cummings and Sommervile, 1988). This chapter will study the 
phosphorylation of the proteins FRGY2a/b in an attempt to define what type of 
kinase they are phosphorylated by, and what possible effect this phosphorylation
could have on their function.
5.1 mIRNA-Associated .Proteins FRGY2a and b
The proteins FRGY2a and FRGY2b are major RNA binding proteins of 
mRNP particles. Their binding to RNA has been widely studied, and the • 
regulation of their binding is thought to influence the translation of stored mRNP 
in immature Xenopus oocytes. The two proteins have a very similar amino-acid 
sequence (fig. 44) containing virtually identical cold shock domains (CSD) 
thought to be instrumental in their ability to bind to RNA. They also contain 
many potential CK2 phosphorylations sites which might suggest a regulatory 
pathway governed by this enzyme. It has been considered, in the past, that the 
phosphorylation state of these two proteins might
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Figure 44: FRGY2a and FRGY2b sequence alignment: Areas ol sequence homology 
are boxed in black. The CSD domain is boxed in blue. Red shading represent acidic 
residues, blue represents basic residues, yellow represents non-polar residues and green 
represents uncharged polar residues. The orange triangles represent potential CR2 
phosphorylation sites. The red circles represent PRC phosphorylation sites.
affect their binding to RNA, but this has yet to be fully explored. There is, 
associated with these mRNP particles, a protein kinase thought to be protein 
kinase OK2, which would play a regulatory role (Sommerville, 1992).
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5.2 Phosphorylation ofFRGY2aab by a Nuclear Protein l&nase
Purified FRGY2a/b was used as a substrate for stage VI nuclear extract in 
an attempt to show that the phosphorylation of Y-box proteins resembled that of 
other CK2 substrates. These two Y-box proteins were purified from immature 
oocytes using a method of successive heat treatments in order to precipitate 
contaminating proteins, while leaving the Y-box proteins soluble (see Methods, 
section 2.18.2). After purification, these Y-box proteins were phosphorylated 
using stage VI nuclei and [32P]y-ATP under varying conditions which might 
influence CK2 activity. The phosphorylation assays were lOpl reactions which 
consisted of: Ipl of stage V! nuclear kinase (equivalent to 1 nucleus), Ipl of 
[33p]y-ATP (0.033mM final), ltd of 10 x kinase buffer (final: 20mM Tris-HCl, 
(pH.7.4), lOmM MgCb, ImM DTT, and lOOmM KCl), 2pl of the substrate Y-
box protein (~0.5pg), Ipl of various phosphorylation conditions (diluted
inhibitors or salt concentrations) and 4pl of dHzO. These reactions were left to
incubated at room temperature for ~1 hr, after which lOpl of SDS-PAGE buffer 
was added to each reaction and the samples loaded onto an SDS-PAGE protein 
gel. Gels were stained with Coomassie blue and destained, dried onto 3M paper 
and setup for autoradiography (see Methods, section 2.6).
The results of these various phosphorylation assays are shown in figure 
45. The first gel shows the effect of varying concentrations of NaCl, KCl and 
Mg ions on the phosphoiylation of the Y-box proteins by nuclear protein kinase 
(fig. 45A). As seen in previous assays for the GST-HDAV substrate (fig. 25, 
chapter 3), the phosphorylation of the Y-box proteins (of 60 and 56 kDa) by 
nuclear protein is sensitive to increasing salt and Mg3+ concentrations. However,
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the phosphorylation of the Y-box proteins is not completely inhibited even in 
high concentrations ofNaCl and KCl (fig. 45A: 0.4mM NaCl and KCl). The Y- 
box proteins are still phosphorylated even when all phosphoiylation of 
endogenous proteins is eliminated. This could be explained by a high binding 
affinity that the protein kinase may have for this particular substrate, which is 
stable even in high salt concentrations. The phosphorylation is somewhat
reduced after the addition of 2mM EDTA which reduces the amount of divalent 
cations such as Mg2*, a required cofactor of CK2. The phosphorylation is 
improved several-fold after the addition of MgCb to a final concentration of
20mM (last track in fig. 45A).
The next assay was to determine if the kinase that was phosphorylating 
the Y-box proteins was sensitive to the CK2 inhibitors. The inhibitors used were 
DRB, quercetin, rutin (as a negative control) and heparin, (all in increasing 
concentrations), (fig. 45B). The first track (-N) is a negative control to show that 
the Y-box proteins themselves have no intrinsic protein kinase activity. The 
second track (-) is a control representing the phosphorylation of the substrate 
proteins by added nuclear extract. The following tracks all represent addition of 
inhibitors to the phosphoiylation reaction. The track (Q) represent the 
phosphorylation with 20 ng/ml of quercetin added; this shows total inhibition of 
phosphorylation. The next track (R) is the addition of rutin, the inactive analogue 
of quercetin, used here as a negative control. The addition of 20ng/ml of rutin 
fails to inhibit phosphorylation of the Y-box proteins by the nuclear extract. The 
addition of DRB, seen in the (D) track, also shows efficient inhibition of 
phosphorylation, demonstrating the sensitivity of Y-box protein phosphoiylation 
to this CK2 inhibitor. The next three tracks represent a serial
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Figure 45: Phosphorylation of Y-box proteins by protein kinase from stage VI 
nuclei; A) Phosphorylation of Y-box protein under varying salt concentrations. The first 
three tracks: NaCl from 100mM-400mM. The next three tracks: KCl (100mM-400mM). 
The final three tracks: no addition ofMgCl2, addition of 2mM EDTA, and addition of an 
extra lOmM MgCl2 to the reaction mixture. B) Phosphorylation inhibition of Y-box 
proteins using various CK2 inhibitors. The first track labeled (-N) is a negative control, 
representing Y-box proteins with no protein kinase added. The next track (-) is a 
positive control showing normal phosphorylation of Y-box proteins by nuclear kinase. 
The 3rd and 4* tracks show the effect of 20ng/ml of quercetin and rutin (Q and R). The 
5* track shows the effect of the addition of 50pM/ml of DRB. The 6*-8* tracks show a 
serial dilution of heparin (lOOpg-lpg/ml). C) Phosphorylation inhibition of Y-box 
proteins by the addition of a competitive inhibitor poly(EY). The first track is a control 
phosphorylation of Y-box proteins (60 and 56 kDa). The second track is with lpg/ml of 
poly(EY) added. The third track is with 0.1 pg/ml of poly(EY) added. The fourth track 
is with lpg/ml of poly(E) added.
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dilution of the inhibitor heparin. The additions are 100, 10, and 1 pg/ml of
heparin in respective tracks. The sensitivity of phosphorylation is evident in the 
higher concentrations of heparin added (100 and 10 pgml), but some inhibition
of phosphorylation is also observed with the lowest concentration of 1 pg/ml.
This result also suggest that the kinase activity phosphorylating the Y-box protein 
is in fact protein kinase CK2. The final assay is a reaction involving the 
phosphorylation of Y-box proteins with the nuclear kinase in the presence of a 
synthetic peptide containing multiple tyrosine sites and glutamic acid sites, 
poly(EY), to act as a competitive inhibitor. This substrate binds very efficiently 
to CK2 and thus should reduce the phosphorylation of the Y-box proteins, if they 
are indeed being phosphorylated by CK2. A negative control was also used, 
namely the addition of poly-glutamic acid,
poly(E). The results show (fig. 45C) that the poly(EY) does partially inhibit 
phosphorylation of the Y-box proteins. The poly(E), on the other hand, has no 
effect on phosphorylation. This suggests that the kinase involved in this 
phosphorylation recognises acidic residues surrounding tyrosine sites, which is a
characteristic of CK2.
5.3 Endogenous mRNP Protein Kinase Activity
5.3.1 Purification ofprotein kinase activity from mRNP\ The pprrfication 
of mRNP kinase was a multi-step process involving separation of material on two 
types of columns. The flow chart in figure 46 shows the purification steps taken 
to isolate the mRNP kinase activity. The absorbance during each of the column 
steps was measured at a wavelength of 254nm by a flow spectrophotometer. 
Although this records more efficiently the RNA present, peaks of eluted protein
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are also detected. mRNP particles were isolated from a homogenate of
previtellogenic ovary (~0.5g), passed through an oligo (dT) cellulose column (see
Methods, section 2.18.1). The column binding buffer used was 20mM Tris-HCl 
(pH.8), 2mM MgCl2 1mM DTT and 200mM NaCl. The homogenised ovary (2,5 
ml) was Freon extracted and spun at 10,000rpm for 15 min to separate the yolk, 
pigment and lipids from the soluble proteins. The supernatant (-2 ml) from this
spin was then spun at lOOg for 3 hrs to separate the
Homogenate
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P I I SN
Centrifugation l OOg x 3 hrs 
P |-------- “I--------—| SN
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Elution using increasing [NaCl]
Ftguon 46: rsonftcaituo uf mRNr-aesociatnO prutnto ktoaen; A fluwchart gf ehn 
psrificaituo etnpe onnOcO tu ubiata ktoaen activtty fnom mRNP particlne. Starting wtth 
humugnoatn uf previtellugnotc uucyine, whtch wae iakno through a enrine uf culumo 
chrumaiugraphy sinpe. Thn culumoe uenO wnre ultgu (OT) Cnlluluen aoO hnpario- 
Snpharoen.
ribosomes mRNP particles from smaller protein-containing complexes. This 
pellet containing the mRNP particles was solubilized in -1ml column binding
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buffer and then passed over the oligo (dT) cellulose column. The solubilized
pellet fraction was passed over the column three times after which the unbound 
material (A)- was removed and the column was washed with the column binding 
buffer until the absorbance trace returned to the baseline (see fig. 47). The 
column was then treated with warm dHi^O (-3 ml), to release the poly (A)+ 
fraction, until the absorbance trace returned again to the base line (fig. 47). The 
OD reading of the eluted peak was calculated to be 3, which is equivalent to 
-120 pg/ml of RNA, and approximately 480 pg/ml of protein in mRNP particles. 
The next step was to bind the associated protein kinase from the A+ fraction to a 
heparin column. A 1 ml heparin-Sepharose column (Pharmacia) was pre-washed 
with column binding buffer (20mM Tris (pH 8), ImM EDTA, ImM DTT, and 
50mM KCl) and the A+ fraction was then loaded, after being adjusted to the 
binding buffer solution. The EDTA was included to destabilise the mRNP 
components, thus facilitating the disassociation of the associate protein kinase 
from the rest of the particle. The A+ fraction was cycled through the column 
multiple times, after which the unbound material was removed, and the column 
was washed with binding buffer until the absorbance trace returned to the base 
line (fig. 48). Bound protein was eluted using increasing concentrations of NaCl 
in 1ml aliquots of column binding buffer. The salt concentrations used were 
0.05, 0.1,0.2, 0.3, 0.4, 3 x 0.5, 3x1 and 1.5 M NaCl. The bound protein kinase 
was expected to elute at around 1 M NaCl (John Sommerville unpublished). The
column was therefore washed 3 times with 0.5 M NaCl to ensure most of the
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Figure 47; Elution of poly(A+) mRNP from an oligo (dT) Sepharose column:
Elution of mRNP was measured via OD readings at A254 using a quartz 3mm path-length 
cell. Oocyte extract was loaded onto the column (P1 OO) and recycled three times. The 
unbound material was collected (End) and the column was washed until it returned back 
to baseline. Warm H2O was added to elute the poly (A+) mRNP (H2O), producing a 
peak of OD 3. The A+ was collected in 3 ml of dH2O.
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Figure 48: Elution of mRNP-associated protein kinase from an heparin-Sepharose 
column: Elution of RNA and proteins was measured via OD readings at A254. Poly (A+) 
mRNP was loaded onto the column (A+) and recycled three times. The unbound 
material was collected (End) and the column was washed until it returned back to the 
baseline. Increasing NaCl concentrations were added to elute bound protein (0.05­
1.5M) and were collected in 1ml tractions labelled 1-12. The largest peak, representing 
the highest concentration of eluted proteins, was seen in fraction 9 at the first IM NaCl 
elution. It produced a peak of OD 2.6.
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weakly-bound proteins were eluted and 3 times with 1 M NaCl to ensure all the 
protein kinase activity was eluted. The absorbance after each salt elution was 
recorded in order to determine in what fraction the protein kinase might be 
eluting from the column (fig. 48). 1 ml of each elution step was collected off the 
column and placed on ice, or frozen for later use.
The absorbance trace of salt elutions (fig. 48) shows that the largest peak 
of eluted proteins was seen during the 1 M NaCl wash. Other smaller peaks can 
be seen before this elution step, representing more weakly bound proteins. The 
first large peak represents the bulk of the unbound mRNP, probably including 
most of the poly (A)+ RNA.
5.3,2 Activity ofpartially purified mRNPprotein kinase-. Theactivity of 
the eluted protein kinase from mRNP was measured by phosphorylation of a 
known CK2 substrate (GST-HDAV) in the presence of [ipty-ATP. 10 pi of 
each of the salt elutions was incubated in kinase buffer (20 mM Tris (pH 7.4), 
20mM MgCl2, ImM DTT and lOOmM KCl) with 1 pl of GST-HDAV (~20pg) 
and 0.03 mM of [3lP]y-ATP in a final volume of lOOpl. Samples were incubated 
at room temperature for 1 hr with gentle agitation. The samples were then loaded 
onto a protein gel which was then stained with Coomassie brilliant blue, 
destained, dried down onto 3M paper using a vacuum drier, and set up for 
autoradiography (see Methods, section 2.6). This same gel was then scanned 
using an instant imager to record the exact counts in each track which were then 
graphed (see Methods, section 2.15).
The results of this assay can be seen in figure 49 which shows the stained 
protein gel, the autoradiograph and the graph of the incorporated label. The 
stained gel showed (fig. 49A) that equal amounts of GST-HDAV had been added
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to each track, and that although the protein eluted from the column has been 
added to each sample, the amount is too small to be visualised as discrete protein
bands on this gel. The phosphorylation of GST-HDAV can be seen in the 
autoradiograph (fig. 49B), but only in the 1 M NaCl, 1.5 M NaCl and unbound 
fractions. This phosphorylation pattern indicates that the protein kinase has 
eluted mainly in the 1 M NaCl wash, and to a smaller extent in the 1.5 M NaCl. 
Also it illustrates that there is still protein kinase activity in the unbound fraction, 
but this is to be expected since the heparin column is probably saturated and 
cannot bind all the A+ proteins. The majority of the incorporated counts are in 
the GST-HDAV substrate which has been phosphorylated with the protein kinase 
activity from the 1 M NaCl wash (fig. 49C).
5.3.3 Identification of mROnP-ossociatedprotein kinase'. Immimoblots of 
the salt washes from the heparin column were analysed in an attempt to verily 
that there was indeed CK2 present in those elutions. Since the highest protein 
kinase activity was observed in the 1 M NaCl elutions, these samples and the 
samples directly preceding and following the IM elution were blotted with anti- 
CK2a. A 200pl sample was taken from each elution fraction and were 
precipitated in four volumes of acetone. The samples were left on ice for 30 min 
after which they were spun at 10,000 rpm for 20min. The supernatant was 
removed and the precipitated proteins were dried down in a vacuum oven for 10
min. These pellets were raised in 20pl of SDS-PAGE buffer and loaded on an 
SDS-PAGE gel (see Methods, section 2.6). Protein was transferred from the gel
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Figure 49: Protein kinase activity assay of heparin-Sepharose column fractions: A)
Coomassie stained protein gel of the phosphorylation assay showing GST-HDAV (48 
kDa) at equal concentration across the assay. GST-HDAV is the only protein 
concentrated enough to be visualised on this gel. Markers at 66 and 45 kDa are also 
shown. B) Autoradiograph of [32P]y-ATP labelled GST-HDAV catalysed by elutions 
from the heparin column, ranging from 0.05M-1.5M NaCl and the unbound fraction 
(UB). GST-HDAV (48 kDa) is predominately phosphorylated by the 1M NaCl elution 
and the unbound fraction and to a lesser extent by the 1.5M elution. C) Graph depicting 
the total counts in GST-HDAV phosphorylated by each elution fraction. The blue line 
represents the extent of phosphorylation of GST-HDAV in each track, the highest counts 
being recorded in fraction 7 which in this figure represents the 1M NaCl elution. The 
red line represents the increasing NaCl concentration used to elute each fraction.
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to nitrocellulose paper and immnoblotted with anti-CK2a (see Methods, section 
2.7). After detecting the antigen using ECL, the transfer was stained with amido 
black (1.5g of amido black, 45 ml of methanol, 10ml of glacial acetic acid, and 
up to 100 ml with dH^0), for 15 min with gentle agitation and then destained 
(180 ml of methanol, 4 ml of glacial acetic acid, adjusted to 200 ml with dl-LO), 
for 15 min with gentle agitation.
Figure 50A and B shows that the two CK2 a-subunits (42 and 38 kDa) 
are present in the highest concentration in 1A, which represents the first 1M 
NaCl elution fraction from the heparin column. This same fraction is also shown 
to have the highest activity of all the 1M NaCl elutions (fig. 50C). The 
remaining 1M elutions: B and C show little immunoreactivity (fig. 50B), and 
correspondingly less protein kinase activity in their inability to phosphorylate 
GST-HDAV (fig. 50C). The 0.5 M and 1.5 M elutions, show negligible 
immunoreactivity for CK2a (fig. 50B) and also negligible phosphorylation 
activity of GST-HDAV (fig. 50C). Stage VI nuclei (—^10) were loaded on this gel 
as a positive control for anti-CK2a, which shows immunoreactivity for CK2a at 
identical positions (molecular weights) for each of the two a-subunits.
5.3,4 Inhibitor Ie of mtOUPiasoo dated paotrtn piuasef In erder Io verify that 
the CK2 associated with mRNP was similar in most respects to that CK2 found 
in the nucleus, activity assays were preformed in order to test the sensitivity of 
this protein kinase to well established inhibitors of nuclear CK2 activity.
Phosphorylation of the substrate GST-HDAV was used to test the inhibitory
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Figure SO: Identification of the protein kinase activity eluted from the heparin- 
Sepharose column: A) Nitrocellulose transfer stained with amido black showing the 
protein content of the immunoblotted samples. The main bands of interest are the Y-box 
proteins (60 and 56 kDa) and the CK2 a-subunits (42 and 38 kDa). Prestained markers 
are present in the first track. B) The ECL immunoblot of (A) with anti-CK2a. The 
immunoblot shows that CK2a is most abundant in fraction 1A, with some lesser signal 
in IB. The N track is stage VI nuclei added as a positive control. C) Phosphorylation of 
GST-HDAV with protein kinase purified with 1 M NaCl (1 A, IB, 1C) and with 1.5 M 
NaCl using [32P]y-ATP. The highest kinase activity is seen in the 1A fraction with a 
lesser amount also seen in the IB fraction.
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affects of the various established CK2 inhibitors (quercetin, DRB and heparin) on 
the mRNP-associated protein kinase. The phosphorylation assays were lOpl 
reactions which consisted of: 2pl of the eluted 1 M NaCl fraction (containing the 
mRNP-associated protein kinase), Ipl of [32P]y-ATP (0.03mM final), Ipl of 10 x 
kinase buffer (final: 20mM Tris (pH.7.4), 20mM MgCfr, ImM DTT, and no 
NaCl), 2pl of the protein substrate GST-HDAV(~lpg), Ipl of various diluted
inhibitors and 3pi of dH20. These reactions were left to incubate at room
temperature for ~1 hr, after which lOpl of SDS-PAGE buffer was added to each 
reaction and the samples were loaded onto an SDS-PAGE protein gel. Gels were 
stained with Coomassie blue, destained, dried onto 3M paper and setup for 
autoradiography (see Methods, section 2.6).
The results from the assay can be seen in figure 51 and show that the 
known CK2 inhibitors all have a significant inhibitory effects on the 
phosphorylation of GST-HDAV (48 kDa) and on the endogenous Y-box proteins 
(60 and 56 kDa) by the mRNP-associated protein kinase. The first track called 
(C) is a control representing the phosphorylation of the substrate protein with no 
addition of protein kinase inhibitors. The following tracks all represent addition 
of inhibitors to the phosphorylation reaction. Track (Q) represents the 
phosphorylation with 20 ng/ml of quercetin added; this shows considerable 
inhibition of CK2 phosphorylation. The next track (R) is the addition of rutin, 
the inactive analogue of quercetin, used here as a negative control. The addition
of 20ng/ml of rutin fails to inhibit phosphorylation of GST-HDAV by CK2. The 
addition of DRB seen in the D) track also shows efficient inhibition of protein 
kinase activity, thus showing the sensitivity of this eluted protein kinase to the
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CK2 inhibitor. The next three tracks represent a serial dilution of the inhibitor 
heparin. The additions are 100, 10, and 1 pg/ml of heparin in respective tracks. 
The sensitivity of the protein kinase is evident in the higher concentration of 
heparin added (100 and 10 pg/ml), but also some inhibition of the protein kinase
is observed at the lowest concentration of 1 pg/ml. Thus it can be seen from this
result that the protein kinase associate with mRNP is sensitive to all the known 
inhibitors of CK2 and at similar concentrations. This provides compelling 
evidence that the protein kinase eluted from the mRNP is indeed CK2.
Heparin
C Q R D 100 10 1 pg/ml
Figure 51: Phosphorylation of GST-HDAV by mRNP-associated protein kinase: 
effects of various inhibitors: The C) track is a control phosphorylation of the substrate 
GST-HDAV (48 kDa) by kinase from mRNP, using [32P]y-ATP as a label.
Phosphorylation of eluted Y-box proteins (60 and 56 kDa) can also be seen. Q) Same as 
in C) except that 20 ng/ml of the inhibitor quercetin added. R) The same as in C) except 
that 20 ng/ml of rutin added. D) Same as in C) except that 50mM/ml of the inhibitor 
DRB added. 100) Same as in C) except that 100 pg/ml of the inhibitor heparin added. 
10) Same as in C) except that 10 pg/ml of the inhibitor heparin added. 1) Same as in C) 
except that 1 pg/ml of the inhibitor heparin added.
5.4 Sequence of the Y-box Proteins Phosphorryated with CK2
5.4.1 Sequence of Y-box proteins phosphorylated by nuclear CK2y Y -box 
proteins were phosphorylated using stage VI nuclei and [32P]y-ATP in order 
identify the sites phosphorylated by this source of CK2 activity. Y-box proteins 
were purified from immature oocytes using a method of successive heat
137
treatments in order to precipitate contaminating proteins (see Methods, section 
2.18.2). This substrate was then treated with alkaline phosphatase for 1 hr at 
37°C in CIP buffer (lOOmM.. Tris (pH. 8.3), lOmM MgCb, and lOmM ZnCh) to 
remove any pre-existing phosphates from potential sites. The phosphatase was 
inactivated and effectively removed by successive heat treatments (see Methods, 
section 2.18.2). The Y-box proteins were added to a phosphorylation reaction 
containing stage VI nuclei and [32P]y-ATP. The phosphorylation reactions were 
lOOjpl reactions which consisted of: 10p.l of stage VI nuclear kinase (equivalent 
to 10 nuclei), lOpl of [32P]y-ATP (0.03mM final), lOpl of 10 x kinase buffer 
(final: 20mM Tris (pH.7.4), lOmM MgCb, ImM DTT, and lOOmM KCl), 20pl 
of the protein substrate Y-box (~5pg), and 50pl of dH20. These reactions were 
left to incubate at room temperature for 1 hr. The samples were then acetone 
precipitated using 4 volumes of acetone and the pellets were dried down in a 
vacuum oven. A portion of the pellet was raised in 8M urea and SDS-PAGE 
buffer after which lOpl the sample was loaded onto an SDS-PAGE protein gel. 
Gels were stained with Coomassie blue, destained, dried onto 3M paper and 
setup for autoradiography (see Methods section 2.6). The rest of the sample was 
given to Dr. Graham Kemp in order to sequence labelled peptides from trypsin 
digests of the proteins and to identify the phosphorylated residues. The protein 
gel and autoradiograph were presented to him to aid in identification of 
phosphorylated proteins. Sequencing and identification of the labelled residues 
were preformed using the procedure written in the Methods section 2.12.
The sequencing of the Y-box proteins has not been completed, but 
preliminary results indicate that only some of the phosphorylation sites are
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labelled by nuclear CK2. The FRGY2a/b protein was digested with trypsin and 
separated by fine-bore HPLC. Labelled peptides were sequenced to determine 
which residues were phosphorylated. Of the several small peptides recovered 
only one was sequenced accurately. Other short peptides either did not bind to 
the hydrophilic column or precipitated out of solution. The sequence shown in 
figure 52 indicates that of the three possible phosphorylation sites only one, the 
serine at position 155, seems to be labelled. Since these are only preliminary 
results not much can be stated about this finding. The possibility that this site is 
necessary for the binding ofFRGY2a/b to mRNA is unknown. This information 
does show however, that only some of the potential target sites are used by 
nuclear CK2, leaving other sites free for possible phosphorylation by CK2 in the 
cytoplasm or at a later stage of development.
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Figure 52; Sequence of FRGY2 showing phosphorylated residues: FRGY2 
phosphorylated by nuclear CK2 (YN). The sequence shows that the first two potential 
sites (bold) are not phosphorylated (-) but the third site may be (*). Arrows indicate the 
sites of trypsin digestion.
5.4.2 Sequence ofY-boc proteins phosphorolateh by mRNP-associated 
CK2\ Y-box proteins bound to mKNA were phosphorylated using native mRNP 
particles in order to determine if the residues phosphorylated by the associated 
CK2 were the same as those phosphorylated by the CK2 from nuclei. The mRNP
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was purified from homogenated oocyte extracts using an oligo(dT) column and 
eluted with ~ 1ml dHaO (see Methods, section 2.18.1) The clarified homogenate 
was pre-incubated with alkaline phosphatase prior to the column step, to remove 
any pre-existing phosphates. The de-phosphorylated poly(A)+ mRNP was then 
incubated with 0.03mM [32P]y-ATP at room temperature for 1 hr. The rest of the 
procedure is identical to the previous section.
No data on the phosphorylation state of FRGY2a/b, by mRNA-associated 
protein kinase, is available at this time.
5.5 Summary
The Y-box proteins, specifically the Xenopus oocyte FRGY2a/b, of 60
and 56 kDa have several potential phosphorylation sites for the protein kinase 
CK2. In order to determine if these proteins were in fact phosphorylated by CK2, 
a number of assays were performed to describe the activity of the
phosphorylating protein kinase. The Y-box proteins were phosphorylated by the 
oocyte nuclear protein kinase activity described in Chapter 3, under varying 
conditions of added salts, ions and kinase inhibitors. The phosphorylation 
conditions detected were very similar to the conditions that define CK2 activity 
(reviewed in Allende and Allende, 1995). The phosphorylation is sensitive to 
DRB, quercetin, heparin, salt concentration, Mg2^ concentration and the 
competitive inhibitor poly(EY).
In vivo, the Y-box proteins are found associated with mRNP and it is 
thought that their association with mRNA is facilitated by phosphorylation 
(Sommerville, 1992). There is also an associated protein kinase found within 
these mRNP particles which is thought to be CK2 (Dearsly et al. 1985; Kick et
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al, 1987; Cummings and Sommerville, 1988; Braddock et al. 1994). In this 
study, the kinase was found to bind to heparin-Sepharose columns, and to be 
eluted in IM NaCl, retaining its activity. Y-box proteins and GST-HDAV 
protein were used as substrates in order to determine which elution fractions 
contained protein kinase activity, and also to confirm that this activity did indeed 
phosphorylate these two substrates. The fractions were also immunoblotted with 
ant.i-CK2a, which showed a strong signal of the appropriate size (42, 38 kDa) in 
the most active fraction, thus providing strong evidence that CK2 is indeed the 
associated kinase that phosphorylates the Y-box proteins. The protein kinase 
associated with mRNP was further purified and tested against the known 
inhibitors of CK2. The sensitivity of this protein kinase to DRB, quercetin, 
heparin, salt concentrations, Mg2+ concentrations and the competitive inhibitor 
poly(EY) was consistent with the activity defined in earlier work (reviewed in 
Allende and Allende, 1995) and to CK2 activity found in assays done in previous 
chapters of this thesis (Chapters 3 and 5).
The sequence of the Y-box proteins, after phosphorylation with the 
nuclear and mRNP-associated CK2 kinase, was begun in order to investigate 
which sites were used for nuclear and for cytoplasmic phosphorylation. Once 
these sites are identified the function of each of the phosphorylated sites could be 
studied by site-directed mutagenesis. This experiment is still ongoing, but 
preliminary results indicate that only some of the potential sites are 
phosphorylated in the nucleus, possibly leaving other sites for cytoplasmic 
phosphorylation later in development.
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Chapter 6: Discussion
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6.1 Nuclear Activity of CK2
The protein kinase CK2 has recently been extensively studied in 
embryonic and proliferating cells, which prompted the study in oocytes, since 
oogenesis represents one of the initial stages of development. The results
reported illustrate that the level of CK2 steadily increases during oogenesis, and 
that its highest concentrations appear in the nucleus (fig. 16). The observation 
that it exists as a ~130 kDa particle seems to indicate that it is predominantly not 
part of a large protein complex, since ~130 kDa is the expected size of the 
tetrameric protein (fig. 18). CK2 may form only transient complexes with other 
proteins when enzymatically active. The fact that nuclei isolated from stage VI 
Xcnoeus oocytes supply such a rich source of CK2 activity would indicate that 
CK2 is an important protein kinase during this stage of development. The 
activity isolated from stage VI nuclei fits all the criteria known to distinguish 
CK2 activity: use of ATP and GTP as co-substrates, inhibition by heparin, DRB, 
quercetin, stimulation by spermine, and sensitivity to monovalent and divalent 
cations. The fact that CK2 has so many possible substrates, and seems to 
participate in so many diverse processes, suggests at least some involvement in 
early development (Allende and Allende, 1995). There are many possible 
functions that CK2 can preform in the nucleus, and it has indeed been implicated 
in many nuclear mechanisms. It is shown, in this report, that nuclear CK2 is 
found in high concentrations around the nuclear envelope, and in the nucleoli 
(fig. 17). It is also thought to be associated with the nuclear matrix (Tawfic co 
aly 1996). Given these observations, CK2 has the potential to be involved in 
numerous nuclear mechanisms involving nuclear proteins such as: histone 
deacetylase, nucleolin and nucleoplasmin. Nuclear CK2 could be involved in
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transcription activation (Sommerville et al., 1998), RNA synthesis (Pfaff et al., 
1988; Bouch et al., 1994), signal transduction (Csermely et al., 1993) and nuclear 
import (Vacurova et al., 1995).
6.1.1 Regulation of a maternal histone deacetylase'. One possible nuclear 
role of CK2, investigated in this thesis, was the regulation of HDACm activity by 
phosphorylation. HDACm has several potential CK2 phosphorylation sites (fig. 
29, 34, 35, 53), and is shown to exists in different phosphorylation states in the 
oocytes (Llinas et al., in preparation). HDACm has been immunoblotted from 
nuclear extracts and shows that HDACm exists as multiple bands, possibly 
representing the varied phosphorylation states of this protein. These bands were 
resolved to a single immunoreacting band when the extracts were pretreated with 
alkaline phosphatase (Llinas et al., in preparation). Immunoreactive HDACm 
bands have been observed migrating slower and probably represented 
phosphorylated forms from extracts of embryos at midblastula (Llinas et al., in 
preparation). This observation is similar to the changes seen in Xenopus 
nucleoplasmin migration reported to occur just after the midblastula transition 
when nucleoplasmin is dephosphorylated (Burglin et al., 1987). Results have 
shown that treatment of extracts containing the 360 kDa histone deacetylase 
complex with alkaline phosphatase leads to a loss of 60-90% of enzyme activity 
(fig. 32). Other forms of histone deacetylase have been shown to lose substrate 
specificity when treated with alkaline phosphatase (Brosch et al., 1992). The 
phosphorylation state could provide an important control mechanism in 
preventing the premature deacetylation of accumulating histones that takes place 
during oocyte development. The core histones accumulate in acetylated forms in 
order to be incorporated with newly synthesised DNA, after fertilization, to form
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nucleosomes. The histone deacetylase activity has been shown to be high in 
stage VI nuclei (fig. 33), so a nuclear regulatory mechanism for this enzyme is 
necessary and could involve phosphorylation by CK2. There are other potential 
kinase sites within the HDACm protein, such as: protein kinase C, tyrosine 
kinase and cyclic AMP-dependent kinase sites (fig. 53), which may be involved 
in regulating activity, but there is, so far, no data to suggest the involvement of 
protein kinases, other than CK2.
6.1.2 Regulation of pre-mRN Pn yV^^d^e^r p<^f^sible puclear fraction of 
CK2, investigated in this thesis, is the regulatory role of CK2 on the masking of 
mRNA by Y-box proteins. Past research has discussed a protein kinase activity 
associated with mRNP, but the identity of the kinase, and what purpose it served 
was not determined (Cummings nr al., 1988). The masking of mRNA is reported 
to be dependent on the position of introns within the pre-mRNA. It is thought 
that introns, positioned at the 5' end of the message, block the ability of mRNA 
to be masked, but introns located at the 3' end do not interfere with this masking 
process (Matsumoto nr al., 1998). It could be that the spliceosomes involved in 
removal of these introns might interfere with the binding of masking proteins, but 
the mechanism is still unknown. The position of these introns seems to be a 
method of controlling whether certain messages are masked and thus stored, or 
whether they are actively translated. CK2 is unlikely to take part in this splicing 
mechanism, but earlier studies have shown that the binding of the masking 
proteins is affected by phosphorylation (Braddock nr al, 1994). This report 
showed that the kinase “protein kinase CK2” is associated with mRNP particles 
and that its activity is responsible for the phosphorylation of the two associated 
Y-box proteins FRGY2a and FRGY2b (fig. 50). The mechanism involving this
145
kinase is still unclear, but microinjection experiments have shown that nuclear 
phosphorylation of the YB proteins is essential for mRNA masking to occur 
(Braddock co al, 1994). It could be that the phosphorylation state of the Y-box 
proteins could have a direct effect on their ability to bind mRNA. Other work 
has complemented these findings by showing that mRNA masking is initiated in 
the cell nucleus (Bouvet and Wolffe, 1994), but the role of phosphorylation is 
still debated. Further information on a nuclear role comes from oocyte 
microinjections experiments which showed that masking could be reversed by 
the co-injection in the nucleus of anti-pp60 and anti-p54 IgG with reporter 
mRNA constructs, but not by co-injection of control IgG (Braddock co al, 1994). 
The point most relevant to this thesis is that messenger RNA masking was also 
blocked by delivering, into nuclei, either chemical inhibitors of casein kinase II, 
or IgG raised against chicken casein kinase II (CK2) subunits (Braddock co al, 
1994).
Another possible effect of CK2 phosphorylation, which was not 
investigated here, could be the regulation of the interaction between Y-box 
protein, or the mRNA itself, and a reporter protein designed to facilitate nuclear 
export, such as transportin (Wozniak co al, 1998). Although no work has been
done to show this relationship, it is thought that the nuclear import and export 
pathways might use similar mechanisms (Wozniak co al, 1998). CK2 has indeed 
been implicated in the nuclear import pathway, examples being: SV40 T-antigen,
nucleoplasmin and nucleolin (Ribs co al, 1991; Vancurova co al, 1995; Schwab 
and Dreyer, 1997).
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6.2 Cytoplasmic Activity of CIK
The atiiviiy of CK2, in ootyie cytoplasms, is reportedly quite high 
(Wilhem et aL, 1995), so the possible functions of this compartmentalised 
enzyme must be elucidated . One possible function of CK2 in the cytoplasm, 
could relate to the compartmentalisation of the HDACm enzyme.
6.2.1 Cytoplasmic retention ofOistotie deacetylaeao lixt^^e^s taken trom 
all stages ef Xeoepue oocyte development have histone deacetylase activity; this 
would seem to indicate that the separation of HDAC activity from its potential 
substrates (stored acetylated histones) might involve a form of
compartmentalisation within the cells, instead of the regulated expression of 
inhibitory factors. Since it is quite difficult to extract, in a soluble form, all of the 
HDACm protein from early stage oocytes, this might suggest that there are 
structures responsible for the anchorage of HDACm in the cytoplasm which, in 
turn, might act in a regulatory role to limit the activity of this deacetylase. The 
HDACm antigen, from early stage oocytes (I-III), was recovered more efficiently 
when the organic solvent Freon was used, which solubilizes membranous 
material. When this solvent is not used, HDACm is lost in the pellet fraction 
after low speed centrifugation. This non-soluble, fast sedimenting HDACm 
fraction appears localised on observing immunostained sectioned oocytes. It is 
seen that a significant fraction of HDACm is associated with the oocyte 
membranes and particularly in vesicular structures close to the cell perimeter. It 
is possible that these sites represent structures responsible for the early anchorage 
of HDACm in the cytoplasm. This compartmentalisation of HDACm may be 
responsible for the lack of association of this protein with chromosomes.
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Experiments have indicated that that lampbrush chromosomes isolated from 
nuclei of mid-stage oocytes are not associated with HDACm, but are shown after 
injection with excess HDACm to be associated with immunoreactive protein. 
Oocytes treated with sodium butyrate, an inhibitor of deacetylase activity, 
showed that hyper-acetylation of histone H4 in tamparush chromosomes did not 
occur, indicating that acetylation of the chromatin was not in a dynamic state 
(Sommerville nr al., 1993). This suggests that the deacetylase activity is 
sequestered away from the chromosomes. Injection of excess amounts of 
recombinant HDACm into oocytes leads to a release from the constraints which 
might anchor the endogenous HDACm in the cytoplasm. Import of recombinant 
HDACm into the nucleus appears to lead to chromatin binding and eventually 
premature condensation of the chromosomes. This condensation is blocked by 
low concentrations of irichoctatin A (TCA), specific inhibitor of HD activity. It 
would therefore seem important that the native histone deacetylase activity 
remains separate from the chromosomes by possible comparimenialisation in the 
cytoplasm. This sequestration of HDACm in the cytoplasm might be achieved by 
membrane attachment mediated by phosphorylation of the protein.
Phosphorylation of proteins has been linked to cytoplasmic sequestering of 
normally nuclear proteins, such as nucleolin (Schwab and Dreyer, 1997), but 
most were proposed to be regulated by cell cycle kinases, such as cdc-2 kinase. 
Research involving the cytoplasmic anchoring of nuclear-imported proteins have 
shown that there is, usually associated near to the NLS, a cell-cycle dependent 
cdc2 kinase phosphorylation site, as is the case with large T-antigen (Jans, 1995). 
HDACm does not have such a site within its amino acid sequence, but other 
unknown kinase sites may ftmction in similar ways. Also, a sequence has been
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described that is thought to be specific for cytoplasmic retention,
EEYYAHYVGLNRRQNEWVDKSR, which exists in the Xenopus protein 
nuclear factor 7 (xnf7). The protein xnf7 has been shown to be a cytoplasmic 
protein until it is dephosphorylation at mid-blastula, when it then becomes 
nuclear (Li et aL, 1994). Although this particular sequence is not present in 
HDACm, other alternative sequences serving the same function may exist: in fact 
other proteins retained in the cytoplasm lack the xnf7 sequence (Schwab and 
Dreyer, 1997). An alternative sequestering mechanism may involve the NLS of 
HDACm being somehow masked in the cytoplasm, thus preventing its nuclear 
import. The NLS ofNF-kB has been shown to be masked by IkB, until IkB is 
phosphorylated by PKC which initiates IkB degradation (Diaz-Meco et al.,
1994). Although this could be a possible mechanism for the masking of 
HDACm, there has been no information to support this hypothesis. An 
alternative possibility is NLS masking by phosphorylation. Nuclear transport of 
lamin B2 has been shown to be inhibited by the phosphorylation of two PKC 
sites near the NLS (Hennekes et al, 1993). There are multiple PKC sites in 
HDACm, one of which is quite close to the NLS (504-506, SVK), (fig. 53). 
Although, the PKC site near the NLS is not seen to be phosphorylated during 
nuclear import of the GST-HDAV fusion protein, which could mean that it is 
dephosphorylated to allow nuclear import, there is no evidence for 
phosphorylation of PKC sites while HDACm is in the cytoplasm and so no firm
conclusion can be drawn.
6.2.2 Nuulear import ofhhstorn deacetylasse foiooner cytoplasmicrolefor 
CK2 is the enhancement of nuclear import, which has been widely studied with 
many diverse proteins (Rihs et cl., 1991; Jans and Jans, 1994; Vancurova et cl.,
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1995; Schwab and Dreyer, 1997). Observations made in this thesis suggest that 
phosphorylation by a cytoplasmic form of CK2 enhances the kinetics of nuclear 
import of HDACm. Studies were carried out using the fusion protein GST- 
HDAV. This fusion protein is phosphorylated at multiple sites by CK2 and also 
has a bipartite nuclear localization signal at its carboayl tail domain (fig. 34). It 
is thought that the function of the NLS can be regulated by phosphorylation of 
specific sites, which may either accelerate or inhibit nuclear import. The nuclear 
import of proteins such as nucleolin, nucleoplasmin and SV40 T-antigen have 
been shown to be increased in some cases as much as 40 fold by phosphorylation 
of specific CK2 sites (Rihs ei at., 1991). Serine1 11/112 are examples of such a 
sites where this occurs. This phosphorylation may regulate protein-protein 
interaction between the NLS and nuclear import proteins. The sequence that has 
been identified as a possible NLS in HDACm consists of residues 438- 
KKVKRVKTEEEKEGEDKKDVK-458 existing within the carboayl-terminal 
region of this protein. The injection experiments described in this thesis show 
that fusion proteins missing this region of the carboxyl tail domain are imported 
into the nucleus less efficiently (fig. 37). The NLS of HDACm is similar to the 
one described for the Xeoepue protein N1/N2, which consists of residues 531- 
LVRKKRKTEEESPLKDKDAKK-551 (Dingwall and Laskey, 1991). The 
function of HDACm and N1/N2 are directly related to each other in that they 
both function with histones during early development ef Xeoepue. N1/N2 acts as 
a chaperone for acetylated histones H3/H4 (Kleinschmidt ei at., 1985) which are 
incorporated into chromatin, after which they are deacetylated by histone
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Figure 53: Phosphorylation sites in large T-antigen and histone deacetylase:
Potential phosphorylation sites in SV40 Large T-antigen and histone deacetylase 
(HDACm). PKC= Protein kinase C sites, TRY= Tyrosine kinase sites, CK2= Protein 
kinase CK2 sites, p344c= cdc-2 kinase (MFP) sites, CAMP= Cyclic AMP dependent 
kinase sites. Positions of CK2 sites are shown in relation to the nuclear localisation 
signal (NLS) for both HDACm and Large T-antigen.
NLS CK2 NLS
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deacetylase to form new nucleosomes (Wade et al., 1997). Thus, it seems 
feasible that these two proteins may be regulated in a similar manner. The 
specific sites in HDACm that were shown to be phosphorylated were at -15, -17 
and -45 (fig. 36) from the start of the NLS in GST-HDAV. The location of these
sites are similar to the ones described for SV40 T-antigen, which were the CK2
sites at -14 and -15 from the NLS and were shown to enhance the rate of nuclear
import (Rihs et al., 1991; Jans and Jans, 1994). The CK2 site in GST-HDAV 
fusion protein that was observed as not being phosphorylated was 145-TEEE- 
148, which lies within the NLS in both HDACm and in the protein N1/N2. 
Although it was not observe as being phosphorylated, it maybe phosphorylated 
under different conditions not met by the phosphorylation assay described here. 
The mechanism of CK2-mediated enhanced nuclear import has always been 
unclear, even for well-studied proteins such as large T-antigen. It has been 
thought that the mechanism operates by accelerated or facilitated interaction with 
the NLS binding proteins, or by enhanced docking with the nuclear pore complex 
(NPC), (Jans, 1995). An attempt was made to investigate this relationship in this 
project. One of the possible functions of CK2 phosphorylation, in relation to 
nuclear import, was the relationship between the phosphorylation state of 
HDACm and binding of the transport protein a-importin. The results presented
indicate that binding of a-importin to the NLS is influenced by the
phosphorylation state of the carboxyl tail domain of the HDACm fusion protein 
GST-HDAV (fig. 40,41, 42). Speculation has existed regarding the mechanism
of dissociation once a-importin has been transported, with the substrate, into the 
nucleus. It was suggested that since there is such a high concentration of NLSs
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in the nucleus, that a-importin must be converted into a form with low affinity 
for the NLS (Gorlich and Mattaj, 1996). It is suggested here that the 
phosphorylation of specific residues, in or close to the NLS, might disrupt this 
protein-protein interaction. Other processes that inactivate binding by a-importin 
might also occur simultaneously, in order to facilitate the release of cargo and to 
enhance the export of the a-importin from the nucleus. The association of a- 
importin with NLSs has been shown to be dependent on the presence of Ran- 
GTP, but not Ran-GDP (Kutay ei al, 1997). This is consistent with the 
observation that Ran-GTP is necessary for export (Moroianu ei at., 1997) and 
that Ran-GTP interrupts the a-p importin interaction (Rexach and Blobel, 1995). 
It is likely that Ran-GTP is predominant in the nucleus and Ran-GDP is 
predominant in the cytoplasm, thus creating a gradient that seems purposeful in 
its shuttling of a-importin (Wozniack ei at., 1998). This high concentration of 
GTP in the nucleus might also point to a parallel activity for the phosphorylation 
induced disassociation studied here, since CK2 can use GTP efficiently as a co­
substrate. Although ATP is present at higher concentration in the nucleus than 
GTP, and there seems to be a greater disassociation effect on GST-HDAV and a- 
importin with ATP (fig. 43), it might be important that CK2 be able to use both 
co-substrates, or be at least sensitive to the levels of each as a potential regulatory
mechanism.
CK2 was shown (fig. 39) to facilitate nuclear import of the GST-HDAV 
fusion protein, after injection into the cytoplasm. So how does this finding relate 
to the observations made with a-importin? One possibility is that cytoplasmic 
CK2 is part of a shuttling mechanism at the entrance to the NPC and its activity
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is necessary for the initial steps of transport across the membrane. CK2 has been
i
!
shown to be highly concentrated around the nuclear envelope (fig. 17). The
envelope-associated CK2 could phosphorylate GST-HDAV in the region of the
nuclear envelope, thus facilitating the disassociation of a-importin from GST-
HDAV as they pass through the pore complex (fig. 54). Another possibility is
that phosphorylation by cytoplasmic CK2 is necessary for efficient protein-
protein interaction with an alternative shuttling protein. This phosphorylation
could take place at an alternative residue from the one required for release of a-
importin, which may require conditions not met by the assays preformed. The
TEEE phosphorylation site within the NLS was shown to be unphosphorylated in
our assays using CK2 activity obtained from isolated nuclei (fig. 36). However,
this site may be phosphorylated under different conditions, requiring specific
regulatory units which were not present during our tests.
6.2.3 Unmasking of maternal mRNP'. The other cytoplasmic function of
CK2 relevant to this discussion is a possible role in unmasking of mRNP
particles in response to cell signaling. It is known that in response to cellular
signals, such as progesterone induced maturation, certain kinases (MPF-kinases)
are activated, promoting specific signaling pathways. CK2 does contain a p34cdc2
kinase site, p34cdc2 being one of the major MPF kinases, which makes CK2
involvement in this pathway possible. Also, results presented by Mulner-
Lorillon et al. (1990) and Litchfield et al. (1992) illustrate that p34cdc2 did indeed
phosphorylate CK2 and led to its increased cytoplasmic activity. It is theorised
that as a result of this progesterone induced activity, phosphatases are activated
which might be responsible for dephosphorylating the Y-box proteins leading to
154
Nucleus
Figure 54: CK2 promotes release of a-importin from NLS: Possible roles of 
phosphorylation by CK2. CK2 facilitates nuclear import by phosphorylation of the NLS 
leading to binding of transport proteins. The phosphorylation of the NLS could alter the 
binding of a-importin as proteins pass through the nuclear pore complex or once inside 
the nucleus. The individual importin subunits then exit through the NPC and bind to 
other proteins to be transported.
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the translation of the stored mRNA (Kick ei at. 1987), (fig. 55). Kick ei at. 
(1987) have shown that reconstituted FRGY2a:gIobin mRNA complexes were 
translationally inactive in wheat germ lysate, but became translationally active 
after dephosphorylation. This work was confirmed using the rabbit reticulocyte 
mRNP protein p50 (homologue of FRGY1) which was also shown to be 
phosphorylated, io vive and io viire. On reconstituting phosphorylated p50 with 
globin mRNA, the mRNA was rendered translationally inactive in wheat germ 
lysate: dephosphorylation led to translation activation (Minich and Ovchinnikov, 
1992). Other work reported that treating Xeoepue oocytes with progesterone 
reversed masking, and resulted in the translation of the previously masked 
reporter constructs (Braddock ei al, 1994). Progesterone acts, io vive, to 
promote the maturation of oocytes, which involves the recruitment of various 
maternal mRNAs for translation (maternal mRNA recruitment starts at oocyte 
maturation and continues throughout fertilization and early embryogenesis). The 
progesterone-induced unmasking process has been blocked by okadaic acid, an 
inhibitor of phosphatase, in a dose-dependent response (Braddock ei at. 1994). 
This is in agreement with the findings that the phosphorylation of YB proteins is 
necessary to maintain mRNPs translationally repressed (Kick ei at., 1987). 
Although phosphorylation of FRGY2 by CK2 may have little effect on the 
binding of FRGY2 to RNA io viire (Deschamps ei at, 1997), it does lead to 
more stable protein-protein interactions within the mRNP particles (Ladomery 
and Sommerville, 1994). It has been reported that the activity of CK2 towards 
some substances is enhanced during progesterone-induced maturation (Cicirelli 
ei at., 1988; Kandror ei al, 1989), thus providing a convenient signalling 
pathway for unmasking by CK2. The phosphorylation by cdc2 kinase might
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change the substrate specificity of CK2, thus preventing re-phosphorylation of 
the Y-box proteins once they have been dephosphorylated by progesterone- 
induced phosphatase. On the other hand, it may also induce CK2 to 
phosphorylate the Y-box proteins at alternative sites which aid in disrupting the 
protein-mRNA interaction. Or, it might also help regulate the specificity of the 
phosphatase activity towards the Y-box proteins, but data confirming either of 
these possibilities is not available.
The phosphorylation of proteins designed to initiate the unmasking of 
mRNAs is another possible function for the associated CK2, A possible 
mechanism of unmasking is the association of masked mRNA with the nuclear 
protein nucleoplasmin (Meric et al. 1997). Nucleoplasmin is an abundant 
nuclear chaperone protein, which has been cross linked to mRNA in the 
cytoplasm during the unmasking process. It is thought that once the oocyte 
nucleus has broken down, after maturation with progesterone, nucleoplasmin is 
hyper-phosphorylated, possibly by CK2. Nucleoplasmin then associates with the 
cytoplasmic mRNP particle in order to unmask these messages for translation 
(Meric et al., 1997). Nucleoplasmin has been shown to partially relieve 
translational repression of H4 mRNA caused by the FGRY2 tail domain in vitro 
(Meric et al., 1997). The tail domain of FRGY2 contains many basic/aromatic 
islands, which are thought to facilitate proteimprotein interactions via 
electrostatic interactions between charged domains (Taftiri and Wolffe, 1992). 
On the other hand, nucleoplasmin is a very acidic protein and so could 
spontaneously bind to the basic islands of FRGY2, lending support to this 
interaction theory. Although the CSD is thought to be the main mRNA-binding 
domain of the Y-box proteins, it has been suggested that the CSD and tail
157
A. Masked mRNA in Oocytes
mRNA
+1^1 fwl
TRANSLATION
BLOCK
B. Unmaaked mlRNA in Eaaly Embryoo
Figure 55: Binding of Y-box proteins to mRNA mediated by CK2: A) binding of Y- 
box proteins to mRNA is facilitated by CK2 phosphorylation (red dots) in the nucleus. 
B) Translationally inactive mRNP particles are unmasked by phosphatases during early 
embryogenesis.
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domain bind cooperativity (Ladomery and Sommerville, 1994; Horwitz ei at., 
1994). Thus the binding of nucleoplasmin to the tail domain of the Y-box ■ 
proteins could directly affect the masking capabilities of the Y-box proteins. ' It 
must be said that this mechanism seems to lack specificity, since the 
nucleoplasmin is only one of many acidic proteins and already has a well-defined 
role of chaperoning H3/H4, a role which is continuing during the unmasking
process.
Another identified mechanism for unmasking is the extension of the 
mRNA polyadenylation signal for some masked messages. The extension of the 
poly(A) tail that occurs at maturation is thought to affect the translational ability 
of mRNPs (Standart, 1992). It is unclear how the extension of the poly(A) 
should facilitate unmasking. Binding experiments have shown that the Y-box 
proteins are unable to bind poly(A) sites (Ladomery and Sommerville, 1994), so 
the interactions between these two seemingly unrelated events is unknown. The 
unmasking process is probably associated with mobilization of mRNPs by a 
polyadenylation-dependent mechanism which would involve the binding of 
unmasking proteins, which could be regulated by CK2 phosphorylation. The 
exact molecular mechanism is still yet undescribed.
6.3 Conclusion
It is clear that protein kinase CK2 is an important enzyme for oocyte 
development, whose diverse functions make it an integral part of the regulatory 
mechanisms which controls Xeoepue oogenesis. It has important functions in 
both the nucleus and cytoplasm and may even act as part of the compartmentation 
mechanisms that exist between them. The control of activity of nuclear enzymes,
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such as maternally expressed histone deacetylase, suggests an involvement of 
CK2 in the mechanism of chromosomal condensation and regulated gene 
inactivation. The association of CK2 with mRNPs, both in the nucleus and in the 
cytoplasm suggests that there might also be a regulatory role in translational 
masking and unmasking of the stored messages vital for oocyte maturation and 
early embryogenesis. The role of CK2 in regulating nuclear translocation, via the 
NLS, is only beginning to be understood. The compartmentalisation of proteins 
is one of the fundamental aspects that separate the eukaryotes from prokaryotes. 
The formation of an independent nucleus has provided the evolutionary stepping 
stone for the development of all higher organisms. Nuclear-cytoplasmic 
exchange is a fundamental process which must be fully explored and understood , 
and its potential applications in fields such as gene therapy. For example, 
complexes containing nuclear localisation signals could aid in the delivering of 
replacement DNA or with the targeting of specific toxins to cancerous cells. 
Techniques that allow the block of nuclear transport of signalling molecules 
could be used to control gene expression and cell proliferation. Information 
obtained on protein transport into the nucleus could aid in the development of
antiviral treatments.
6.4 Future Work
Much more research must be done (and is being done) in order to fully 
understand the function of CK2 in oocytes development. More work is needed to 
understand the interaction between a-importin and the NLS of HDACm, and 
how this might be mediated through phosphorylation by CK2. Other research, 
currently underway in this lab, is the attempted purification of enzymatically
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active native HDACm in order to study its native phosphorylation state in vivo 
and to determine which phosphorylation sites are required for activity.
Attempts are being made to mutate individual CK2 phosphorylation sites 
within the GST-HDAV clone. This would allow injection of the fusion protein, 
missing specific phosphorylated sites, in order to determine which sites are 
required for nuclear uptake. The new clones could also be used to study the 
effects on binding of a-importin with the NLS. Attempts should be made to 
mutate the surrounding acidic residues to block the binding site of CK2, thus 
keeping the phosphoiylation sites intact while still preventing their 
phosphorylation. This would show which is important for nuclear import: the 
over all level of phosphorylation, or phosphorylation of specific serine/threonine 
amino acid residues within the transported protein. It has been found in 
experiments with large T-antigen that substitution of aspartic acids for 
phosphoserine/threonine sites results in the same increase in nuclear localisation 
as with the phosphorylated residues. It is thought that the overall negative 
charge, normally provided by phosphorylation, is what is important in regulating 
nuclear import (Jans and Jans, 1994). This indicates that the sequences 
themselves may be relatively unimportant, and that the phosphorylation state is 
simply affecting the ability of a number of possible sequence to bind the nuclear 
import proteins.
The purification of large quantities of native HDACm by 
immunoprecipitation, should be attempted in order to identify the 
phosphorylation sites that are used in vivo. It is important to determine the 
phosphorylation state of native proteins, because identification of these sites can
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only be tentatively assigned by looking at the phosphorylation state of fusion
proteins.
The identification of phosphorylated sites in the Y-box proteins must be 
completed, and the answers obtained will undoubtedly lead to more questions. 
What are the functions of the individual sites? Do they influence binding to 
mRNA and how? What other factors controls the phosphorylation of the Y-box 
proteins? Are some sites used by nuclear CK2 and are some used by cytoplasmic 
CK2? AYy must CK2 be associated with the mRNP particle itself? Other 
experiments should be plaimed to investigate further the function of the Y-box 
proteins and the control of their binding activity to mRNAs. Attempts to mutate 
the specific phosphorylation sites within Y-box the proteins, FRGY2a and 
FRGY2b, should be undertaken, in order to show which sites are required for in 
vivo nuclear binding. The mechanism of unmasking of maternal mRNP should 
be studied to identify the role of the CK2 still associated with the cytoplasmic 
mRNP particles just prior to their translation. Interactions with other protein 
bound to the mRNP particles, such as the RNA helicase p54 (Ladomery et al., 
1997), should be studied to see if phosphorylation at specific stages of 
development influences the unwinding activity of this mRNP-associated protein.
CK2 has proven to be a multifunctional ubiquitous enzyme. Its potential 
in the regulation of cellular mechanisms cannot be denied. Many man hours 
have been devoted to the study of this enzyme and some questions have been 
answered, but undoubtedly many more questions have been raised.
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Appendix A: Protein Kinase CK2 a Data Base Entry
SWISS-PROT: P28020
ID KC22„XENLA STANDARD; PRT; 350 AA.
AC P28020;
DT 01-AUG-1992(REL. 23, CREATED)
DT Ol-AUG-1992 (REL. 23, LAST SEQUENCE UPDATE)
DT Ol-NOV-1995 (REL. 32, LAST ANNOTATION UPDATE)
DE CASEIN KINASE II, ALPHA' CHAIN (CKII) (EC 2.7.1.37).
OS XENOPUS LAEVIS (AFRICAN CLAWED FROG).
OC EUKARYOTA; METAZOA; CHORDATA; VERTEBRATA; TETRAPODA; AMPHIBIA 
ANURA.
RN [1]
RP SEQUENCE FROM N.A.
RC TISSUE=OVARY;
RX MEDLINE; 92183811. [NCBI, Geneva, Japan]
RA JEDLICKI A., HINRICHS M.Y., ALLENDE C., ALLENDE J.E.;
RL FEBS LETT. 297:280-284(1992).
CC -!- FUNCTION: CASEIN KINASES ARE OPERATIONALLY DEFINED BY THEIR 
CC PREFERENTIAL UTILIZATION OF ACIDIC PROTEINS SUCH AS CASEINS 
CC AS SUBSTRATES.
CC -!- FUNCTION: THE ALPHA AND ALPHA' CHAINS CONTAIN THE CATALYTIC 
SITE.
CC -1 - SUBUNIT: TETRAMER COMPOSED OF AN ALPHA CHAIN, AN ALPHA' AND 
TWO
CC BETA CHAINS.
DR EMBL; X62375; G64628; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
DR PIR; S18897; S18897.
DR PIR; S20404; S20404.
DR PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1,
DR PRODOM [Domain structure / List of seq. sharing at least 1 domain]
DR PROTOMAP; P28020.
DR SWISS-2DPAGE; GET REGION ON 2D PAGE.
KW TRANSFERASE; SERINE/THREONINE-PROTEIN KINASE; ATP-BINDING.
FT DOMAIN 39 324 PROTEIN KINASE.
FT NP BIND 45 53 ATP (BY SIMILARITY).
FT BINDING 68 68 ATP (BY SIMILARITY).
FT ACT SITE 156 156 BY SIMILARITY.
SQ SEQUENCE 350 AA; 41454 MW; 8956ED02 CRC32;
MSGPVPSRAR VYTDVNTHRP RDYWDYESHV VEWGNQDDYQ LVRKLGRGKY SEVFEAINIT 
NNEKVVVKIL KPVKKKKIKR EIKILENLRG GPNIITLADI VKDPVSRTPA LVFEHVNNTD 
FKQLYQTLTD YDIRFYMYEI LKALDYCHSM GIMHRDVKPH NVMIDHEHRK LRLIDWGLAE 
FYHPGQEYNV RVASRYFKGP ELLVDYQMYD YSLDMWSLGC MLASMIFRKE PFFHGHDNYD 
QLVRIAKVLG TEDLYDYIDK YNIELDPRFN DILGRHSRKR WERFVHSENQ HLVSPEALDF 
LDKLLRYDHQ TRLTAREAMD HPYFYPIVKD QSRMAALICP VAAHPSVAPV
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ProtParam tool
KC22_XENLA (P28020)
DE CASEIN KINASE II, ALPHA’ CHAIN (CKII) (EC 2.7.1.37). 
OS XENOPUS LAEVIS (AFRICAN CLAWED FROG).
The computation has been carried out on the complete sequence.
Number of amino acids: 350
Molecular weight: 41454.4 
Theoretical pi: 7.30 
Amino acid composition:
Ala (A) 17 4.9%
Arg(R) 26 7.4%
Asn (N) 15 4.3%
Asp (D) 29 8.3%
Cys (C) 3 0.9%
Gln(Q) 10 2.9%
Glu(E) 20 5.7%
Gly (G) 14 4.0%
His (H) 17 4.9%
He (I) 2 1 6.0%
Leu (L) 31 8.9%
Lys (K) 23 6.6%
Met (M) 11 3.1%
Phe (F) 13 3.7%
Pro (P) 18 5.1%
Ser (S) 15 4.3%
Thr(T) 11 3.1%
Trp(W) 5 1.4%
Tyr(Y) 23 6.6%
Val (V) 28 8.0%
Asx (B) 0 0.0%
Glx (Z) 0 0.0%
Xaa(X) 0 0.0%
Total number of negatively charged residues (Asp + Glu): 49 
Total number of positively charged residues (Arg + Lys): 49
Extinction coefficients:
Conditions: 6.0 M guanidium hydrochloride
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0.02 M phosphate buffer
pH 6.5
“1 “1
Extinction coefficients are in units of M cm .
The first table lists values computed assuming ALL Cys 
residues appear as half cystines, whereas the second table
assumes that NONE do.
276 278 279 280 282
nm nm nm nm nm
Ext. coefficient 60785 60581 59595 58250 55960
Abs 0.1% (=1 g/1) 1.466 1.461 1.438 1.405 1,350
276 278 279 280 282
nm nm nm nm imi
Ext. coefficient 60350 60200 59235 57890 55600
Abs 0.1% (=1 g/1) 1.456 1.452 1.429 1.396 1.341
Estimated half-life:
The N-terminal of the sequence considered is M (Met).
The estimated half-life is: 30 hour (mammalian reticulocytes, in vitro). 
>20 hour (yeast, in vivo).
>10 hour (Escherichia coli, in vivo).
Instability index:
The instability index (II) is computed to be 44.10
This classifies the protein as unstable.
Aliphatic index: 86.00
Grand average of hydropathicity (GRAVY): -0.524
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Appendix B: Protein Kinase CK2 (3 Data Base Entry
SWISS-PROT: P28021
ID KC2B_XENLA STANDARD; PRT; 215 AA.
AC P28021;
DT Ol-AUG-1992 (REL. 23, CREATED)
DT 01 -AUG-1992 (REL. 23, LAST SEQUENCE UPDATE)
DT Ol-NOV-1995 (REL. 32, LAST ANNOTATION UPDATE)
DE CASEIN KINASE II, BETA CHAIN (CK II) (EC 2.7.1.37) (PHOSVITIN).
OS XENOPUS LAEVIS (AFRICAN CLAWED FROG).
OC EUKARYOTA; METAZOA; CHORDATA; VERTEBRATA; TETRAPODA; AMPHIBIA; 
ANURA.
RN [1]
RP SEQUENCE FROM N.A.
RC TISSUE-OVARY;
RX MEDLINE; 92183811. [NCBI, Geneva, Japan]
RA JEDLICKI A., HINRICHS M.V., ALLENDE C., ALLENDE J.E.;
RL FEBS LETT. 297:280-284(1992).
CC -!- FUNCTION: CASEIN KINASES ARE OPERATIONALLY DEFINED BY THEIR 
CC PREFERENTIAL UTILIZATION OF ACIDIC PROTEINS SUCH AS CASEINS 
CC AS SUBSTRATES. THE EXACT FUNCTION OF THE BETA CHAIN IS NOT 
KNOWN .
CC (BY SIMILARITY).
CC -!- SUBUNIT: TETRAMER COMPOSED OF AN ALPHA CHAIN, AN ALPHA' AND 
TWO
CC BETA CHAINS.
CC -!- PTM: PHOSPHORYLATED BY ALPHA CHAIN (BY SIMILARITY).
DR EMBL; X62376; G64630; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
DR PIR; S18898; S18898.
DR PIR; S20405; S20405.
DR PROSITE; PSOllOl; CK2_BETA; 1.
DR PRODOM [Domain structure / List of seq. sharing at least 1 domain]
DR PROTOMAP; P28021.
DR SWISS-2DPAGE; GET REGION ON 2D PAGE.
KW TRANSFERASE; SERINE/THREONINE-PROTEIN KINASE; PHOSPHORYLATION. 
FT MOD_RES 2 2 PHOSPHORYLATION (AUTO)) PROBABLE).
FT DOMAIN 55 664 APP/GLU-RICHAACIDIC).
SQ SEQUENCE 215 AA; 24960 MW; 010460F4 CRC32;
MSSSEEVSWI SWFCGLRGNE FFCEVDEDYI QDKFNLTGLN EQVPHYRQRkL DMILDLEPDE 
ELEDNPNQSD LIEQAAEMLY GGIHGRRPHT NRGIAQMLEK YQQGDGEFGP RVYCENQPML 
PIGLSDIPGE RMVKLYCPKC MDVYTPKSSR HHHTDGAYFG TGFGHMLFMV VPEYRPKRPA 
ngfvprlygf khhpmryglg llgrrnncks VKTMR
ProtParam tool
KC2B_XENLA (P28021)
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DE CASEIN KINASE II, BETA CHAIN' (CK II) (EC 2.7.1.37) (PHOSVITIN).
OS XENOPUS LAEVIS (AFRICAN CLAWED FROG).
The computation has been carried out on the complete sequence.
Number of amino acids: 215
Molecular weight: 24960.4
Theoretical pi: 5.33 
Amino acid composition:
Ala (A) 11 5.1%
Arg (R) 10 4.7%
Asn (N) 9 4.2%
Asp (d) 12 5.6%
Cys (C) 6 2.8%
Gln(Q) 13 6.0%
Glu (E) 16 7.4%
Gly (G) 13 6.0%
His (H) 8 3.7%
He (I) 10 4.7%
Leu (L) 19 8.8%
Lys (K) 9 4.2%
Met (M) 11 5.1%
Phe (F) 11 5.1%
Pro (P) 16 7.4%
Ser (S) 11 5.1%
Thr (T) 6 2.8%
Trp (W) 2 0.9%
Tyr(Y) 13 6.0%
Val (V) 9 4.2%
Asx (B) 0 0.0%
Glx (Z) 0 0.0%
Xaa (X) 0 0.0%
Total number of negatively charged residues (Asp + Glu): 28 
Total number of positively charged residues (Arg + Lys): 19
Extinction coefficients:
Conditions: 6.0 M guanidium hydrochloride 
0.02 M phosphate buffer 
pH 6.5
-1 -1
Extinction coefficients are in units of M cm .
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The first table lists values computed assuming ALL Cys 
residues appear as half cystines, whereas the second table 
assumes that NONE do.
276 278 279 280 282
nm inn nm nm nm
Ext. coefficient 30520 30162 29525 28740 27520
Abs 0.1% (=1 g/1) 1.223 1.208 1,183 1.151 1.103
276 278 279 280 282
nm nm nm nm nm
Ext. coefficient 29650 29400 28805 28020 26800
Abs 0.1% (=1 g/1) 1.188 1.178 1.154 1.123 1.074
Estimated half-life:
The N-terminal of the sequence considered is M (Met).
The estimated half-life is: 30 hour (mammalian reticulocytes, in vitro). 
>20 hour (yeast, in vivo).
>10 hour (Escherichia coli, in vivo).
Instability index:
The instability index (II) is computed to be 39.13 
This classifies the protein as stable.
Aliphatic index: 69.86
Grand average of hydropathicity (GRAVY): -0.473
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Appendix C: Histone Deacetylase Data Base Entry
SWISS-PROT: Q91695
ID HD11„XENLA STANDARD; PRT; 480 AA.
AC Q91695;
DT Ol-FEB-1998 (REL. 36, CREATED)
DT Ol-FEB-1998 (REL. 36, LAST SEQUENCE UPDATE)
DT Ol-FEB-1998 (REL. 36, LAST ANNOTATION UPDATE)
DE PROBABLE HISTONE DEACETYLASE 1-1 (HD1) (MATERNALLY-EXPRESSED 
DE HISTONE DEACETYLASE) (HDM) (AB21).
OS XENOPUS LAEVIS (AFRICAN CLAWED FROG).
OC EUKARYOTA; METAZOA; CHORDATA; VERTEBRATA; TETRAPODA; AMPHIBIA; 
ANURA.
RN [1]
RP SEQUENCE FROM N.A.
RC TISSUE==OOCYTE;
RX MEDLINE; 98036059. [NCBI, Geneva, Japan]
RA LADOMERY M.R., LYONS S., SOMMERVILLE J.;
RL GENE 198:275-280(1997).
CC FUNCTION: RESPONSIBLE FOR THE DEACETYLATION OF LYSINE RESIDUES
ON
CC THE N-TER.MINAL PART OF THE CORE3 HISTONES (H2A, H2B , H3 AND H4).
CC HISTONE DEACETYLATION PL,AYS AJ3 IMPORTANT ROLE N
TRANSCRIPTIONAL
CC REGULATION, CELL CYCLE PROGRESSION AND DEVELOPMENTAL EVENTS 
(BY
CC SIMILARITY).
CC -!- SUBCELLULAR LOCATION: NUCLEAR (BY SIMILARITY).
CC -!- TISSUE SPECIFICITY: OOCYTE.
CC -!- DEVELOPMENTAL STAGE: ACCUMULATES IN PREVITELLOGENIC OOCYTES 
AND IS
CC MAINTAINED AT CONSTANT LEVEL THROUGHOUT OOGENESIS AND INTO 
EARLY
CC EMBRYOGENESIS. DECLINES TfROOUGH GASTRILEA TO JEEURULA .NOT
CC DETECTABLE BETWEEN NEURULA AND TAILBUD, NOR IN ADULT TISSUES 
OTHER
CC THAN OVARY.
CC -!- SIMILARITY: BELONGS TO THE HISTONE DEACETYLASE / ACUC / APHA 
CC FAMILY.
DR EMBL; X78454; G602098; -. [EMBL / GenBank / DDBJ] [CoDingSequence]
DR PRODOM [Domain structure / List of seq. sharing at least 1 domain]
DR PROTOMAP; Q91695.
DR SWISS-2DPAGE; GET REGION ON 2D PAGE.
KW HYDROLASE; NUCLEAR PROTEIN.
FT DOMAIN 299 302 POLY-GLY.
SQ SEQUENCE 480 AA; 54747 MW; 014FAEB5 CRC32;
MALTLGTKKK VCYYYDGDVG NYYYGQGHPM KPHRIRMTHN LLLNYGLYRK MEIFRPHKAS 
AEDMTKYHSD DYIKFLRSIR PDNMSEYSKQ MQRFNVGEDC PVFDGLFEFC QLSAGGSVAS
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AVKLNKQQTD ISVNWSGGLH HAKKSEASGF CYVNDIVLAI LELLKYHQRV VYIDIDIHHG 
DGVEEAFYTT DRVMTVSFHK YGEYFPGTGD LRDIGAGKGK YYAVNYALRD GIDDESYEAI 
FKPVMSKVME MFQPSAVVLQ CGADSLSGDR LGCFNLTIKG HAKCVEFIKT FNLPLLMLGG 
GGYTIRNVAR CWTYETAVAL DSEIPNELPY NDYFEYFGPD FKLHISPSNM TNQNTNEYLE 
KIKQRLFENL RMLPHAPGVQ MQAVVASDSIH DDSGEEDEDD PDKRISIRSS DKRIACDEEF 
SDSEDEGEGG RKNVANFKKV KRVKTEEEKE GEDKKDVKEE EKAKDEKTDS KRVKEETKSV
ProtParam tool
HD11_XENLA(Q91695)
DE PROBABLE HISTONE DEACETYLASE 1-1 (HD1) (MATERNALLY-EXPRESSED 
DE HISTONE DEACETYLASE) (HDM) (AB21).
OS XENOPUS LAEVIS (AFRICAN CLAWED FROG).
The computation has been carried out on the complete sequence.
Number of amino acids: 480
Molecular weight: 54747.5 
Theoretical pi: 5.50 
Amino acid composition:
Ala (A) 26 5.4%
Arg(R) 22 4.6%
Asn (N) 21 4.4%
Asp (D) 39 8.1%
Cys (C) 9 1.9%
Gln(Q) 13 2.7%
Glu (E) 41 8.5%
Gly (G) 37 7.7%
His (H) 15 3.1%
He (I) 2:3 4,8%
Leu (L) 32 6.7%
Lys(K) 42 8.8%
Met (M) 15 3.1%
Phe(F) 21 4.4%
Pro (P) 16 3.3%
Ser(S) ;30 6.2%
Thr(T) 19 4.0%
Trp (W) 2 0.4%
Tyr(Y) 27 5.6%
Val (V) 30 6.2%
Asx (B) 0 0.0%
Glx(Z) 0 0.0%
Xaa(X) 0 0.0%
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Total number of negatively charged residues (Asp + Glu): 80 
Total number of positively charged residues (Arg + Lys): 64
Extinction coefficients:
Conditions: 6.0 M guanidium hydrochloride
0.02 M phosphate buffer 
pH 6.5
-1 “1
Extinction coefficients are in units of M cm .
The first table lists values computed assuming ALL Cys 
residues appear as half cystines, whereas the second table 
assumes that NONE do.
276 278 277 220 282
nm nm inn nm nm
Ext. coefficient 51255 50143 48715 47020 44680
Abs 0.1% (=1 g/1) 0.936 0.916 0.890 0.859 0.816
276 278 228 282
nm nm nm nm nm
Ext. coefficient 49950 49000 47635 45940 43600
Abs 0.1% (=1 g/1) 0.912 0.895 0.870 0.839 0.796
Estimated half-life:
The N-terminal of the sequence considered is M (Met).
The estimated half-life is: 30 hour (mammalian reticulocytes, in vitro). 
>20 hour (yeast, in vivo).
>10 hour (Escherichia coli, in vivo).
Instability index:
The instability index (II) is computed to be 40.12
This classifies the protein as unstable.
Aliphatic index: 68.23
Grand average of hydropathicity (GRAVY): -0.660
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Appendix D: FGRY2 Data Base Entry
SWISS-PROT: P21574
ID YB56_XENLA STANDARD; PRT; 336 AA.
AC P21574;
DT Ol-MAY-1991 (REL. 18, CREATED)
DT Ol-NOV-1995 (REL. 32, LAST SEQUENCE UPDATE)
DT Ol-NOV-1995 (REL. 32, LAST ANNOTATION UPDATE)
DE CYTOPLASMIC RNA-BINDING PROTEIN P56 (Y BOX BINDING PROTEIN-2) (Y- 
BOX
DE TRANSCRIPTION FACTOR) (MRNP4).
GN FRGY2.
OS XENOPUS LAEVIS (AFRICAN CLAWED FROG).
OC EUKARYOTA; METAZOA; CHORDATA; VERTEBRATA; TETRAPODA; AMPHIBIA; 
ANURA.
RN [1]
RP SEQUENCE FROM N.A.
RX MEDLINE; 91062413. [NCBI, Geneva, Japan]
RA TAFURI S.R., WOLFFE A.P.;
RL PROC. NATL. ACAD. SCI. U.S.A. 87:9028-9032(1990).
RN [2]
RP SEQUENCE FROM N.A., AND PARTIAL SEQUENCE.
RX MEDLINE; 92107999. [NCBI, Geneva, Japan]
RA MURRAY M.T., SCHILLER D.L., FRANKE W.W.;
RL PROC. NATL. ACAD. SCI. U.S.A. 89:11-15(1992).
RN [3]
RP PARTIAL SEQUENCE.
RC TISSUE=OVARY;
RX MEDLINE; 92332467. [NCBI, Geneva, Japan]
RA DESCHAMPS S., VIEL A., GARRIGOS M., DENIS H., LE MAIRE M.;
RL J. BIOL. CHEM. 267:13799-13802(1992).
RN [4]
RP PARTIAL SEQUENCE.
RC TISSUE=OVARY;
RX MEDLINE; 91224309. [NCBI, Geneva, Japan]
RA DESCHAMPS S., VIEL A., DENIS H., LE MAIRE M.;
RL FEBS LETT, 282:110-114(1991).
CC -!- FUNCTION: BINDS TO CCAAT-CONTAINING Y BOX OF THE HSP70 GENES.
CC SEEMS TO BE A NEGATIVE REGULATORY FACTOR. ALSO BINDS TO MRNA. 
CC -!- SUBUNIT: POSSIBLY FORMS A HETERODIMER WITH P54 IN THE 6S AND 15S 
CC MRNA-BINDING PARTICLES.
CC -1- SUBCELLULAR LOCATION: CYTOPLASMIC, EITHER FREE OR ASSOCIATED 
WITH
CC RIBONUCLEOPROTEIN PARTICLES.
CC -!- TISSUE SPECIFICITY: TESTIS AND IMMATURE OOCYTES.
CC -!- PTM: PHOSPHORYLATION ACTIVATES IN VITRO RNA-BINDING.
CC -!- SIMILARITY: BELONGS TO THE COLD-SHOCK DOMAIN (CSD) FAMILY.
DR EMBL; M59454; G214157; [EMBL / GenBank / DDBJ] [CoDingSequence]
DR PIR; B38274; B38274.
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DR HSSP; P15277; 1MJC. [HSSP ENTRY ISWISS-3DIMAGE /
DR PDB-ENTRY / PDB-RASMOL / PDB-3DIMAGE]
DR PROSITE; PS00352; COLDJSHOCK; 1.
DR PRODOM [Domain structure / List of seq. sharing at least 1 domain]
DR PROTOMAP; P21574.
DR SWISS-2DPAGE; GET REGION ON 2D PAGE.
KW TRANSCRIPTION REGULATION; DNA-BINDING; NUCLEAR PROTEIN;
KW RNA-BINDING; PHOSPHORYLATION.
FT DOMAIN 44 108 CSD.
FT CONFLICT 254 254 A-> T (IN REF. 1).
SQ SEQUENCE 336 AA; 37202 MW; ECB4DC87 CRC32;
MSEAEAQEPE PVPQPESEPE IQKPGITAAKR NQANKKVLAT QVQGTVKWFN VRRGYGYFNR 
NDTKEDVFVH QTAIKKGGPR KFLRSVGDGY TVEF’DVVEGE KGAYAANVGG PGGVPVKGYR 
FAPGRRRFRR RLGRPRADTA GYESYYEYGS EQMSEGSRGE ETEPQQRPRR RRRPPFFYRR 
RLRRYPRPGG TTNQGAEVTE QTSEKFPVGV TSET^SLT^^C^I^IY PQRTPPRRFR QTFFRPFRPR 
PAPTTTPEYY PYEAKAESYE PPFPAPTFTF GFFGVTFFFF TYATTVAATA TYEYKAEPTT 
HPASEEYTPS PSPTDPYAPV TSSAPPPYIA PTPAPE
ProtParam tool
YB56_XENLA (P21574)
DE CYTOPLASMIC RNA-BINDING PROTEIN P56 (Y BOX BINDING PROTEIN-2) (Y- 
BOX
DE TRANSCRIPTION FACTOR) (MRNP4).
OS XENOPUS LAEVIS (AFRICAN CLAWED FROG).
The computation has been carried out on the complete sequence.
Number of amino acids: 336
Molecular weight: 37202.6
Theoretical pi: 9.60
Amino acid composition:
Ala (A) 31 9.2%
Arg (R) 42 12.5%
Asn(N) 15 4.5%
Asp (D) 15 4.5%
Cys(C) 0 0.0%
Gin (Q) 27 8.0%
Glu (E) 34 10.1%
Gly(G) 31 9.2%
His (H) 2 0.6%
He (I) 5 1.5%
Leu (L) 3 0.9%
Lys(K) 13 3.9%
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Met (M) 2 0.6%
Phe(F) 14 4.2%
Pro (P) 43 12.8%
Ser (S) 17 5.1%
Thr (T) 17 5.1%
Trp (W) 1 0.3%
Tyr (Y) 4 1.2%
Val (V) 20 6.0%
Asx (B) 0 0.0%
Glx (Z) 0 0.0%
Xaa (X) 0 0.0%
Total number of negatively charged residues (Asp + Glu): 49
Total number of positively charged residues (Arg + Lys): 55
Extinction coefficients:
Conditions: 6.0 M guanidium. hydrochloride
0.02 M phosphate buffer 
pH 6.5
-1 -1
Extinction coefficients are in units of M cm .
276 228 2'^^ 280 282 
nm mm nm nm nm
Ext. coefficient 11200 11200 11040 10810 10400 
Abs 0.1% (=1 g/1) 0.301 0.301 0.297 0.291 0.280
Estimated half-life:
The N-terminal of the sequence considered is M (Met).
The estimated half-life is: 30 hour (mammalian reticulocytes, in vitro). 
>20 hour (yeast, in vivo).
>10 hour (Escherichia coli, in vivo).
Instability index:
The instability index (II) is computed to be 81.71 
This classifies the protein as unstable.
Aliphatic index: 35.77
Grand average of hydropathicity (GRAVY): -1.371
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Appendix E: CSD Alignment
Domain 597
(Prodom Release 34.2)
Domain ID: 597/ <ProDom34.2)
Number of sequences in family: 50
Most frequent protein names: CSPB(8) CSPA(6) CSPD(4)
Commentary (automatic): PROTEIN COLD SHOCK SHOCK-LIKE FACTOR A TRANSCRIPTION
CSPB Y-BOX I
CAPA_PSEFR
CAPB_PSEFR
TAPB_PSEFR
CSPAJPSEAE
TAPA_PSEFR
CSPB_BACGL
CSPB_BACGO
CSPB_BACSU
CSPB_BACCE
CSPD_BACCE
CSPB_BACCL
CSPBJBACST
CSPD__BACSU
CSPB_LISMO
CSPA_BACCE
CSPA_LISMO
CSPC_BACSU
CSPC_BACCE
CSPE_BACCE
CSP1_LACPL
CSP2_LACPL
CSPA_STIAU
CSPD_ECOLI
CSP7_STRCL
CSPF_STRCO
CSPD_HAEIN
CSPI_ECOLI
CSPJ_ECOLI
CSPA_ECOLI
CSPA_SALTY
CSPB_ECOLI
CSPC_ECOLI
CSPEJECOLI
CSP_ARTGO
GRP2_NICSY
Y4CH_RHISN
CBFX_HUMAN
CBFX_MOUSE
CBFX_RAT
DBPA_HUMAN
YB1_CHICK
YB3_XENLA
YBl_XENLA
YB1_MOUSE
YB1_HUMAN
YB56_XENLA
YB54_XENLA
YBFH_APLCA
CSPF_ECOLI
CSPG_SALTY
consensus
wt
7 59 1.14
7 58 1.14
7 58 1.14
7 58 1.14
1 47 1.50
1 50 1.02
1 50 0.93
4 55 0.93
3 54 1.02
4 55 0.90
4 55 0.72
4 55 0.72
4 55 0.81
4 54 1.14
5 56 1.23
4 54 0.99
4 55 0.99
3 54 1.17
5 52 1.53
4 52 1.29
4 54 1.29
4 56 1.32
4 56 1.32
4 56 1.23
4 56 1.23
4 56 1.62
7 58 1.14
7 58 1.14
6 58 0.75
6 58 0.75
7 59 1.05
5 57 1.08
5 57 1.08
4 56 1.50
11 63 1.56
5 53 2.06
61 117 0.09
59 115 0.09
59 115 0.09
93 149 0.09
58 114 0.09
39 95 0.09
39 95 0.09
59 115 0.09
61 117 0.09
44 100 0.33
44 100 0.42
35 91 1.08
7 59 2.87
7 40 3.02
GTVKWFNDEKGFGFITPQGGGDDLFVHFKAIESDG------ FKSLKEGQTVSFVAEKGQ
GTVKWFNDEKGFGFITPQSG-DDLFVHFKAIQSDG------ FKSLKEGQQVSFIATRGQ
GTVKWFNDEKGFGFITPESG-PDLFVHFRAIQGNG------ FKSLKEGQKVTFIAVQGQ
GTVKWFNDAKGFGFITPESG-NDLFVHFRSIQGTG------FKSLQEGQKVSFVVVNGQ
......... FNDEKGFGFITPESG-PDLFVHFRAIQGNG-------FKSLKEGQKVTFIAVQGQ
..VKWFNSEKGFGLIEVEGQ-DDVFVHFSAIQGEG------ FKTLEESQAVSFEIVEGN
..IKWFNSEKGFGFIEVEGQ-DDVFVHFSAIQGEG------FKCLEEGQAVSFEIVEGN
GKVKWFNSEKGFGFIEVEGQ-DDVFVHFSAIQGEG------ FKTLEEGQAVSFEIVEGN
GKVKWFNNEKGFGFIEMEGS-EDVFVHFSAIQSDG------ YKALEEGQEVSFDITEGN
GKVKWFNGEKGFGFIEVEGG-EDVFVHFSAIQGDG------ FKTLEEGQEVSFEIVDGN
GKVKWFNNEKGYGFIEVEGG-SDVFVHFTAIQGEG------ FKTLEEGQEVSFEIVQGN
GKVKWFNNEKGYGFIEVEGG-SDVFVHFTAIQGEG------ FKSLEEGQEVSFEIVQGN
GKVKWFNNEKGFGFIEVEGG-DDVFVHFTAIEGDG------YKSLEEGQEVSFEIVEGN
GTVKWFNSEKGFGFIEVEGG-DDIFVHFSAIEGEG------FKTLDEGQSVEFEIVEG.
GQVKWFNNEKGFGFIEVPGE-NDVFVHFSAIETDG------ FKSLEEGQKVSFEIEDGN
GTVKWFNAEKGFGFIERENG-DDVFVHFSAIQGDG------FKSLDEGQAVTFDVEEG.
GTVKWFNAEKGFGFIERENG-DDVFVHFSAIQSDG------FKSLDEGQKVSFDVEQGA
GRVKWFNAEKGFGFIEREDG-DDVFVHFSAIQQDG------ YKSLEEGQQVEFDIVDGA
GKVKWFNSEKGFGFIEVADG-SDVFVHFSAITGDG——FKSLDEGQEVSFEV....
GTVKWFNADKGYGFITGEDG-NDVFVHFSAIQTDG------FKTLEEGQKVTFDEE...
GTVKWFNADKGFGFITGEDG-TDVFVHFSAIQTDG------ FKTLDEGQKVTYDEEQG.
GTVKWFNDAKGFGFITQDGGGEDVFCHHSAINMDG------FRTLQEGQKVEFEVTRGP
GTVKWFNNAKGFGFICPEGGGEDIFAHYSTIQMDG------ YRTLKAGQSVQFDVHQGP
GTVKWFNAEKGFGFIAQDGGGPDVFVHYSAINATG------ FRSLEENQVVNFDVTHGE
GTVKWFNSEKGFG FIAQDGGGPDVFAHYSNINAQG----- YRELQEGQAVT FDITQGQ
GIVKWFNNAKGFGFISAEGVDADIFAHYSVIEMDG------ YRSLKAGQKVQFEVLHSD
GLVKWFNADKGFGFITPDDGSKDVFVHFTAIQSNE------ FRTLNENQKVEFSIEQG.
GLVKWFNPEKGFGFITPKDGSKDVFVHFSAIQSND------FKTLTENQEVEFGIENG.
GIVKWFNADKGFGFITPDDGSKDVFVHFSAIQNDG------YKSLDEGQKVSFTIESGA
GIVKWFNADKGFGFITPDDGSKDVFVHFSAIQNDG------YKSLDEGQKVSFTIESGA
GLVKWFNADKGFGFISPVDGSKDVFVHFSAIQNDN------ YRTLFEGQKVTFSIESGA
GQVKWFNESKGFGFITPADGSKDVFVHFSAIQGNG------ FKTLAEGQNVEFEIQDGQ
GNVKWFNESKGFGFITPEDGSKDVFVHFSAIQTNG------ FKTLAEGQRVEFEITNGA
GTVKWFNAEKGFGFITPDDSDGDVFVHYSEIQTGG------ FKTLDENARVQFEIGQGA
GTVKWFSDQKGFGFITPDDGGEDLFVHQSGIRSEG------FRSLAEGETVEFEVESGG
GTVKWFNATKGFGFIQPDDGSADVFVHISAVERAG------LRELKDGQKISYEL....
GTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGE
GTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGE
GTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGE
GTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGE
GTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGE
GTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGE
GTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGE
GTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGE
GTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGE
GTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPRKFLRSVGDGETVEFDWEGE
GTVKWFNVRNGYGFINRNDSKEDVFVHQTAIKKNNPRKFLRSVGDGETVEFDWEGE
GTVKWFNVKSGYGFINRDDTKEDVFVHQTAIVKNNPRKYLRSVGDGEKVEFDVVEGE
GIVKTFDGKSGKGLITPSDGRIDVQLHVSALNLRD------AEEITTGLRVEFCRINGL
GLVKWFNPEKGFGFITPKDGSKDVFVHFSAIQSN..................................................
GTVKWFNSEKGFGFITPEDGSEDVFVHFSAIQSDG------FKSLEEGQKVSFEIVEGQ
60
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Appendix F: CK2a Shared Domains
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Appendix G: CK2p Shared Domains
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Much interest has focused recently on the regulatory role played by reversible 
acetylation of core histones during the transcription and replication of 
chromatin. The acetylation status of chromatin is determined by the 
equilibrium between the activities of histone acetyltransferases and histone 
deacetylases. The Xenopus protein HDm shows sequence homology to other 
putative histone deacetylases but is expressed only during early development, 
its proposed activity being to stabilize newly-replicated chromatin during 
blastula formation. Previous studies have shown that the 57 kDa HDm protein 
undergoes steady accumulation into the oocyte nucleus where it is organized in 
a multiprotein complex of approximately 360 kDa. This complex has histone 
deacetylase activity that is sensitive to trichostatin A and alkaline phosphatase 
treatment. Two regions of HDm are identified: the conserved N-terminal region 
which represent the enzyme core and a more variable, highly-charged C- 
terminal region, the regulatory features of which are examined here. The C- 
terminal region is required for nuclear uptake, regulation of which is promoted 
by phosphorylation at specific sites by the protein kinase CK2.
Key words: histones/chromatin; protein phosphorylation; nuclear import
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Introduction
Modification of core histones by acetylation has long been recognized as having 
important consequences for chromatin structure and how this relates to the processes 
of transcription and replication. The acetylation status of stored histones (Ahnouzni 
et ah, 1994), of histones being incorporated into newly-synthesized chromatin (Sobel 
et ah, 1995), of chromatin segments being activated for transcription 0 and of 
chromatin segments being silenced (), is determined by the relative activities of 
histone acetyltransferases (HATs) and histone deacetylases (HDs). Targets for these 
enzymes exist on all four core histones but histones H3 and H4 appear to be 
preferred substrates, the best characterized sites being the four residues, Lys5, Lys8, 
Lysl2 and Lysl6, located in the N-terminal region of H4 (Turner et al, 1992). 
Recent cloning of HAT (Brownell et ah, 1996) and HD genes (Taunton et ah, 1996) 
and identification of their proteins have given renewed impetus to exploring the 
diverse molecular mechanisms involving reversible acetylation.
Early embryogenesis in Xenopus proceeds from a fertilized egg to a blastula of 
-10,000 cells in a series of 13-14 rapid cell divisions. Throughout this period there is 
no transcriptional activity and the assembly of new chromatin from almost 
continuously replicating DNA is largely dependent on a maternal pool of histones 
and assembly factors. In general, chromatin assembly involves the association of pre- 
acetylated core histones with replicating DNA and subsequent stabilization of 
nucleosomes by histone deacetylation. Newly-synthesized histone H4 is acetylated at 
defined lysine residues by a cytoplasmic histone acetyltransferase (HAT B; Sobel et 
ah, 1994). Sequencing of the amino-terminus of newly-synthesized histone H4 from 
a range of different organisms has shown it to be diacetylated, at lysine residues 5 
and 12 (Sobel et ah, 1995), although yeast HAT B activity on histone H4 in vitro 
shows some variation from this pattern (Kleff et ah, 1995; Parthun et ah, 1996). 
Deacetylation would normally occur soon after histone deposition in new chromatin 
but information is only now becoming available as to how histones are accessed by 
histone deacetylase (HD) and to how the deacetylation reaction is regulated.
The aspect of histone deacetylation that has received most attention recently is its 
role in the regulation, most often repression, of the activity of specific sets of genes 
(reviewed by Wolffe, 1996, 1997). For instance, association of HDl with the adaptor 
protein RbAp48 (Taunton et ah, 1996), or with the corepressor of the mammalian 
Mad/Max complex, Sin3 (Alland et ah, 1997), or with N-CoR, the corepressor of the 
thyroid hormone receptor (Heinzel et ah, 1997), may serve to target the deacetylase 
complex to specific chromatin sites. Such interactions appear to be restricted to 
modulation of transcriptional activity of specific genes recognized though the 
presence of transcription factors, such as Mad-Max and the thyroid hormone 
receptor, localized to their promoters. The more extensive deacetylation reactions
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occurring after replication may involve alternative components. Two,
chromatographically-separable, multiprotein complexes containing histone 
deacetylases, designated HDA and HDB, have been described in yeast (Carmen et 
al, 1996; Rundlett et al., 1996) but, apart from the deacetylases themselves, other 
protein components have not been identified.
Xenopus AB21 (data bank accession number: X78454) was initially recognized as a 
homologue of the yeast gene regulator RPD3 (Vidal and Gabor, 1991) which was 
later shown also to be a homologue of human HDl (Taunton et al., 1996). There has 
now been cloned and identified an additional series of putative histone deacetylases - 
in yeast (Rundlett et al., 1996), Caenorhabditis (Waterston et al., 1992), Drosophila 
(De Rubertis et al., 1996), and mouse 0 “ all of which appear to have a conserved 
region stretching from near the amino terminus to more than half-way through the 
protein sequence. It is likely that this conserved region represents the enzyme core 
responsible for deacetylase activity (Ladomery et al., 1997).
The mRNA encoded hy Xenopus AB21 is expressed only in oocytes, remains stable 
in embryos up to neurula and has sequence characteristics of a maternal message. Its 
protein product HDm (maternal histone deacetylase; Ladomery et al., 1997) is 
synthesized during oogenesis, is stored through oocyte maturation,fertilization and 
early cleavage and decreases in amount after mid-blastula, when the cell-cycle time 
slows down to normal and cells start to differentiate. All of the HD activity detected 
in oocytes and early embryos can be accounted for by the presence of a 360 kDa 
protein complex that contains the HDm protein and this complex appears to fulfill 
the conditions required of a 'deposition' histone deacetylase (Sommerville et al., 
1998). Its primary function would be to deacetylate the core histones incorporated 
into newly-synthesized chromatin during the rapid cell cycles leading to blastula 
formation. A major event in the assembly and accumulation of the HD complex is 
the translocation of the HDm protein into the nucleus during oogenesis. Here we 
examine the features of HDm that are responsible for its nuclear uptake, identifying 
the charged carboxy-tail domain as a target for modification by phosphorylation.
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Results
Overexpression of HDm in growing oocytes leads to nuclear uptake and
chromatin binding
The Xenopus maternally-expressed protein HDm (Ladomery et ah, 1997) has been 
shown to be a marker for histone deacetylase (HD) activity during early 
development. This protein is a component of a 360 kDa complex that is accumulated 
in the nuclei of growing oocytes (Sommerville et al, 1998). One feature of HDm, 
also found in the homologues human HDl (Taunton et al, 1996) and Drosophila 
Rpd3 (De Rubertis et al, 1996), is the presence of the charged C-terminal domain 
which in the Xenopus protein contains 35% acidic (D + E) residues and 23% basic 
(K + R) residues (Figure 1). It is noted that, within this domain, HDm has a sequence 
441JKRVKTEEEKEGEDKKDVK458, similar to the bipartite nuclear localization 
signal (NLS, Dingwall and Laskey, 1991) 5344ORKTEEESPLKDKDAKK5551 which 
is contained in the Xenopus nuclear protein N1/N2. This sequence similarity may 
have some significance because the two proteins have related functions: whereas 
HDm is believed to deacetylate histones H3 and H4, N1/N2 acts as a chaperone for 
diacetylated H3 and H4 awaiting incorporation into chromatin (Kleinschmidt and 
Seiter, 1988).
Requirement ofthe tail domain for import of HDm into the nucleus can be tested 
in vivo by injecting radiolabelled fragments into the cytoplasm and recording 
subsequent levels in isolated nuclei. Injection of 35S-labelled HDm protein (Figure 
2A) into the cytoplasm of Xenopus oocytes results in a 10-fold concentration of the 
protein in the nucleus after 24 h (Figure 2B). In comparison, a truncated polypeptide 
(AH, Figure 1A) which lacks the charged tail domain, fails to be concentrated 
substantially in the nucleus (Figure IB). The kinetics of nuclear import of HDm are 
similar to those reported for nucleoplasmin (Vancurova et al. 1995), the efficient 
transport of which appears to be dependent on phosphorylation by an associated 
casein kinase II (CK2) activity. HDm has six potential CK2 phosphoiylation sites, 
five of which are located within the charged tail domain (Figure 1).
One advantage of the effectiveness of HDm uptake into oocyte nuclei is that the 
subsequent state of the chromatin can be examined directly. The lampbrush 
chromosomes of Xenopus oocytes are poorly immunostained with antibodies raised 
against the C-terminal domain (anti-AV). Previous studies showed only a low level 
of turnover of acetyl groups on histone H4 of lampbrush chromosomes (Sommerville 
et al., 1993) and also in the maternal pool of histones stored m Xenopus oocytes 
(Almouzni et al., 1994), indicating that endogenous histone deacetylase activity is 
maintained at a low level in oocytes. At 24h after injection of radiolabelled HDm 
into the cytoplasm of actively transcribing (stage III) oocytes, nuclear
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immunostaining with anti-AV is greatly increased. In addition to de novo 
immunostaining of the chromosomes, the chromosomes are seen to be condensed 
(foreshortened, Figure 3A,B) compared with injection of unrelated protein (the 
mRNA-associated DEAD-box helicase p54, Figure 3C). Furthermore a high 
background immunostaining of nucleoplasm indicates high-level loading of the 
nucleus with HDm (Figure 3B). From measurement of relative radiolabelling, it can 
be calculated that approximately 10 pg of HDm is imported into the nucleus under 
the conditions described, a value approaching the total mass of histone in the 
chromatin. Incubation of injected oocytes in the presence of 10 mM sodium butyrate 
or 5 ng/ml trichostatin A (TSA, both potent inhibitors of deacetylase activity) does 
not inhibit uptake of HDm into the nucleus and chromatin binding, but does prevent 
chromosome condensation (Figure 3D). Thus, injection of complete molecules of 
HDm into living oocytes results in their import into the nucleus, binding to the 
chromatin and gross changes in the structure of the chromatin. We cannot tell, from 
these experiments alone, how specific are the effects: particularly to what extent 
HDm might be targeted to particular sites on the chromatin and to whether HDm is 
actually deacetylating histones in this in vivo situation. However, it is noted that 
immunostaining tends to be punctate rather than evenly spread along the 
chromosome axis (Figure 3B) and that not all lateral loops on the condensed 
lampbrush chromosomes are retracted, indicating that transcription at some loci is 
continuing after exposure to HDm. Also, isolation of chromosomes at 8h after 
injection of HDm reveals chromosomes with less evidence of length contraction and 
loop retraction but which, nevertheless, immunostain clearly with anti-AV (not 
shown).
The charged tail domain is phosphorylated at selected sites by the nuclear protein 
kinase CK2
HDm contains six possible sites for phosphorylation by CK2 but no obvious sites for 
phosphorylation by cell cycle-dependent kinases. Five of the six CK2 sites are 
located in the charged tail domain and are represented in GST fusion proteins as 
shown in Figure 4A. CK2 activity is readily available from oocyte nuclei (germinal 
vesicles) isolated under oil and this activity can be separated from most of the 
nuclear protein by affinity binding to heparin-Sepharose (A.J.L. and J.S., 
unpublished). Nevertheless, the presence of nuclear proteins provides internal 
markers for the phosphorylation reactions, the histone H3/H4 chaperone N1/N2 
(running at 110/105 kDa on SDS-PAGE) and the histone H2A/H2B chaperone 
nucleoplasmin (running at 30 kDa on SDS-PAGE) being particularly appropriate. 
Incubation of the different fusion proteins with nuclear extract and 32PyATP shows 
that only proteins containing the charged tail domain (AR and AY) are
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phospholabelled: proteins containing only the amino-terminal CK2 site are never 
phospholabelled (Figure 4B). The GST-AV protein undergoes limited proteolysis if 
expressed in E. coli K strains, resulting in products running on SDS-PAGE with 
apparent masses of 43 kDa and 39 kDa due to polypeptide cleaved from the carboxyl 
end. Since the 43 kD product phosphorylates almost as efficiently as complete GST- 
AV, it can be concluded that accessible sites are located beyond 5 kDa from the 
carboxyl terminus. However, the 39 kDa product is much less efficiently 
phospholabelled, indicating rare availability of sites located beyond 9 kDa from the 
carboxyl terminus. Little difference is seen in phospholabelling patterns of the GST 
fusion propteins using either whole nuclei or CK2 activity isolated from the nuclei 
(Figure 4B), indicating that the activity of CK2 is sufficient to account for the 
phosphorylation of HDm observed in nuclear extracts. As predicted, the CK2 activity 
is efficiently inhibited by low concentrations of heparin and is also specific for the 
mRNA-bmding proteins FRGY2a/b (Figure 4B).
A more accurate fix on the phospholabelled sites is obtained from analysing 
peptides, produced by trypsin digestion of full-length phospholabelled GST-AV, on 
an amino acid sequencer. Two peaks of radioactivity were obtained by separation of 
the digest on fme-bore HPLC (Figure 5A). Peptides from the peak fractions were 
then sequenced and material from each cycle was collected on filters and assayed for 
radioactivity. In peptide 1 (Figure 5B), radioactivity was recovered only in cycle 22, 
indicating that the serine residue at position 22, but not the serine residue at position 
17 (which is another of the potential CK2 sites), is phosphorylated. In peptide 2 
(Figure 5C), peaks of radioactivity were recovered from cycles 8 and 10, 
corresponding to the two serine residues present at these positions. These same peaks 
of radioactivity were found in two separate sequencing runs. No evidence was found 
of a peptide containing the sequence TEEE in a labelled form, which tends to 
discount the CK2 site that is located within the putative NLS. From these results, it 
appears that phosphorylation of HDm, in vitro, is restricted to three out of six 
possible sites.
Phosphorylated isoforms of HDm are present in the nuclei offull-grown oocytes 
On closer examination of immunobots of proteins extracted from the nuclei of stage 
VI oocytes and separated by SDS-PAGE, it is seen that the immunoreactive band is 
composed of several closely-arrayed sub-bands. That these sub-bands represent 
diffently charged isoforms is indicated by isoelectrofocussing (not shown) and that 
the isoforms result from differential phosphoiylation is confirmed by treatment with 
alkaline phosphatase, which results in the resolution of the immunostaining material 
as a single, sharp band (Figure 8). At least four distinct isoforms can be 
discriminated, and it is reasonable to assume that they correspond to non-
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phosphorylated HDm plus phosphorylation at one, two and three of the sites 
described in the last section. The only other stage of development which exhibits 
such multiple isoforms is blastula (not shown), during which stage of development 
most of the histone deacetylation is believed to occur.
Nuclear uptake offusion protein is dependend on the C-terminal region of HDm 
containing the putative NLS
On injecting phospholabelled GST-AV into the cytoplasm of full-grown (stage VI) 
oocytes, the kinetics of nuclear uptake can be recorded by SDS- 
PAGE/autoradiography of the contents of nuclei isolated after various time intervals. 
Of the various forms of GST-AV injected, only the protein with a complete carboxyl 
terminus is accumulated in the nucleus (Figure 6A): the 42 kDa (-5) and 37 kDa 
truncated forms are not detected in the nucleus and are eventually (over 50 h) 
dephosphorylated and/or degraded in the cytoplasm. The kinetics of nuclear uptake 
of GST-AV (Figure 6B) show a rapid and efficient translocation: over 80% of the 
protein is isolated with the nucleus 10 h after injection. Total protein uptake in these 
experiments amounts to more than 1 ng/oocyte, which compares with a synthetic rate 
of core histones in full-grown oocytes of 0.5 ng/h (Adamson and Woodland, 1974) 
(check histone/NP values)
Inhibition of CK2 activity blocks nuclear uptake of the tail domain
Injection of phosphorylated and dephosphorylated GST-AV into oocytes treated with 
the inhibitor of CK2, quercetin and its inactive analogue quercetin 3p-D-rutinoside 
(rutin).
Phosphorylation of the tail domain enhances interaction with importin a
Nuclear HDm is dephosphorylated during progesterone-induced maturation of 
stage VI oocytes
The multiple bands revealed on immunstaining blots of stage VI nuclear protein 
undergo change within the first few hours of treating the oocytes with progesterone. 
Progesterone induces oocyte maturation, which is characterized by many changes 
including chromatin condensation, hyperphosphoiylation ofthe nuclear lamins and 
nuclear breakdown (GVB). However, in the few hours preceding GVB, nuclei can 
still be isolated and immunoblotting of their proteins shows a time-dependent 
resolution of multiple HDm bands into the single, fastest migrating, band. It is likely 
that this change is due to the activation of a nuclear phosphatase.
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Discussion
Role of phosphorylation in HD nuclear uptake
Import of a protein into the nucleus is generally dependent upon the presence of a 
nuclear localization signal (NLS). The NLS can take the form of either a block of 
mainly basic residues, the model being the sequence 126PKK.KRVK132 that occurs in 
SV40 T-ag, or a bipartite motif in which two short basic regions are separated by ten 
unspecified residues (Dingwall and Laskey, 1991). The function of the NLS can be 
regulated, however, by phosphorylation of proximal sites, resulting in either 
acceleration or inhibition of nuclear uptake of the protein. For instance, the rate of 
NLS-dependent nuclear import of T-ag is increased 40-fold by phosphorylation of 
Seri 12 by CK2, whereas phosphorylation of Thrl24 by cdc2 inhibits nuclear import 
(Rhis et a/., 1991; Jans and Jans, 1994). Phosphorylation of such residues in the 
vicinity of the NLS acts to regulate import through modulation of protein-protein 
interactions.
From the microinjection experiments in this report, we show the carboxy-terminal 
region of ~40 amino acid residues to be essential for efficient nuclear uptake of 
HDm. Within this region, we tentatively identify the sequence
438KKVKRVKTEEEKEGEDKKDVK458 as being important for nuclear uptake. 
Either the first seven residues, or a bipartite grouping of residues 441-442 and 454­
458 could act as an NLS. It is interesting to note that a very similar sequence 
533EVRKKRKTEEESPLKDKDAK.K551 has been been identified as the NLS in the 
Xenopus nuclear protein N1/N2, originally as the first seven residues (Kleinschmidt 
and Seiter, 1986) and latterly as a bipartite grouping of residues 534-535 and 545­
549 (Dingwall and Laskey, 1991). HDm and N1/N2 have related functions in the 
utilization of histones during the early development ofXenopus. During oogenesis, 
there is accumulation of a large pool of histones ( ng/cell; Adamson and Woodland, 
1974), sufficient for assembly of much of the new chromatin through the 13-14 rapid 
cell divisions of early embryogenesis. The stored histones exist in oocytes in 
association with specific protein chaperones which together form soluble complexes: 
histone H3/H4 coupled with NI/N2 to form a complex sedimenting at 5S and a 
histone H2A/H2B coupled with nucleoplasmin to form a complex sedimenting at 7S 
(Kleinschmidt et al, 1985). However, these stored core histones are accumulated as 
acetylated forms: non-nucleosomal histone H4, for example, has been shown to be 
diacetylated, not only mXenopus oocytes and early embryos (Almouzni et al, 1994), 
but also during the early development of sea urchins (Chambers and Shaw, 1987) 
and starfish (Ikegami et al, 1993). Once the acetylated histones are incorporated into 
chromatin, the new nucleosomal structures are stabilized by histone deacetylation. 
HDm is believed to be the catalytic agent involved in developmentally-regulated
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deacetylation m Xenopus (Ladomery et al., 1997). Histone deacetylase activity is the 
property of a 360 kDa protein complex containing HDm, which has been shown to 
deacetylate peptides representing the amino-terminal region of histone H4, in 
addition to mixtures of acetylated core histones (Sommerville et al, 1998). The 
HDm complex and N1/N2 similarly interact with core histones in the nucleus and so 
might be expected to share regulatory features.
Nuclear import of the other histone chaperone, nucleoplasmin, has been shown to 
be regulated by phosphorylation, particularly phosphorylation of sites in the vicinity 
of the NLS by CK2 (Vacurova et al, 1995). Of the six potential sites in HDm for 
phosphorylation by CK2, we have shown in this report that three are phosphorylated 
in vitro by a form of CK2 isolated from Xenopus oocyte nuclei (germinal vesicles). 
These three sites are occupied by serine residues which all lie within the charged tail 
domain, at positions -15, -17 and -45 from the start of the putative NLS. The most 
proximal two sites are more efficiently phosphorylated than the distal site and have a 
location relative to the putative NLS similar to the CK2 sites (at positions -14 and - 
15) whose phosphorylation enhances the rate of nuclear import of T-ag (Rhis et al, 
1991; Jans and Jans, 1994). In comparison, the CK2 sites in nucleoplasmin, most 
likely to be used in NLS-dependent regulation, are located at positions +7 and +8 
beyond the end of the NLS.
One potential CK2 site in HDm that we did not detect as a phospholabelled 
peptide is 145TEEE148, which lies within the putative bipartite NLS. This same 
sequeence occupies an identical position within the bipartite NLS ofN1/N2. 
However, it is still possible that this site plays a regulatory role in HDm: it may be 
phosphorylated under special conditions not met in the in vitro labelling procedure 
used here.
. That phosphorylation of HDm is actually occuring during import into oocyte 
nuclei in vivo, is indicated by the separation, on SDS-PAGE, of multiple 
immunostaining bands. The multiple banding is seen in protein samples taken from 
isolated nuclei, but not from isolated cytoplasms (Sommerville et al, 1998) and we 
show here that at least four components can be resolved to a single band after 
treatment with alkaline phosphatase. Although the number of slower migrating bands 
corresponds to the number of phospholabelled residues detected after in vitro 
phosphorylation, we do not know if the same sites are being used in vivo. The 
presence of multiple HDm bands in the nuclei of full-grown (stage VI) oocytes and 
their rapid resolution to a single band after treatment of the oocytes with 
progesterone, indicates that activity of phosphatases is low prior to induction of 
maturation, but that, within a few hours, activity becomes high enough to completely 
dephosphorylate the stored HDm before GVBD. It should be noted that the pool of 
HDm stored in the nucleus is not distributed throughout the nucleoplasm but rather is
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associated with the nuclear envelope: immunostaining of sectioned oocytes and 
cleavage stage embryos shows a concentration of signal around the inside of the 
nuclear membrane. There have been previous reports that HD activity is associated 
with nuclear matrix material in immature chicken erythrocytes (Li et al, 1997).
That the stored HDm in non-injected oocytes is not associated with the 
endogenous chromatin is shown by examination of isolated lampbrush 
chromosomes, which are not immunostained by the same antibodies that 
immunostain chromosomes from oocytes injected with an excess of in vitro- 
synthesized HDm. Over-supply of synthetic HDm apparently brings about a release 
from the constrains which anchor the endogenous HDm on the nuclear envelope. A 
secondary effect of the binding of injected HDm to the chromosomes is that it causes 
premature condensation of the chromosomes. However, we do not know if this effect 
is due to targeting of histone deacetylase activity to the chromatin or to some other, 
less-specific, cause. Nevertheless, we do note that such condensation is blocked by 
low concentrations of trichostatin A (TSA), which is a specific inhibitor of HDm- 
associated histone deacetylase activity (Sommerville et al, 1998).
Phosphorylation of HDm may be important in respects other than regulation of 
nuclear import. We have shown previously that treatment of extracts containing the 
360 kDa histone deacetylase complex with alkaline phosphatase leads to a loss of 
enzyme activity (Sommerville et al, 1998). In addition to the apparently 
phosphoiylated forms of HDm seen in nuclear extracts from stage VI oocytes, 
similar slower migrating forms are seen in extracts from embryos at midblastula. 
Changes in the level of phosphorylation ofXenopus nucleoplasmin have been 
reported to occur at oocyte maturation, when slower migrating forms appear, and just 
after the midblastula transition, when they appears to be a dephosphorylated (Burglin 
et al, 1987). The reason for maintaining nucleoplasmin in a phosphorylated state 
through early embryogenesis is not altogether clear, although this covers the period 
of maximum release of histones to be assembled into new chromatin.
No observations have been made on the mechanism of nuclear uptake of other 
histone deacetylases, therefore we do not know to what extent our results will apply 
to other cell types. It is most likely that HDm is primarily a chromatin deposition 
deacetylase since it is expressed only during oogenesis and early embryogenesis 
(Ladomery et al., 1997), whereas the histone deacetylases in yeast (Vidal and Gaber, 
1991; Rundlett et al, 1996), Drosophila (De Rubertis et al, 1996) and mammalian 
somatic cells (reviewed, Wollfe, 1997) have been ascribed functions in the regulation 
of gene transcription. Nevertheless, there does appear to be some conservation of 
features in the tail domain that we have identified as having regulatory functions in 
HDm (Figure 9).
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Materials and Methods
Proteins and antibodies
HDm and polypeptide fragments were synthesized either as glutathione S-transferase 
(GST) fusions, or from run-o'ff transcripts translated in rabbit reticulocyte lysates 
(RL). GST fusion proteins were expressed from pGEM (Pharmacia) vectors and 
isolated on glutathione-Sepharose 4B according to the manufacturer’s instructions. 
Antibodies to DR/DH and DV fusion proteins were raised in rabbits as were 
antibodies directed against a synthetic peptide representing the carboxy-terminal 
seventeen amino acid residues of HDm (anti-Cpep). Reticulocyte lysate translation 
products were synthesized in the TnT (Promega) system for 2 h at 30OC in the 
presence of 10 mCi/ml of 35S-methionine (1,000 Ci/mmol, Amersham).
Transcription was from either the complete cDNA sequence in pBlueScript 
(Promega) or from 3’ truncations extending into the coding region. Labelled protein 
was obtained from Sephadex-G50 spin column fractions .
Oocyte extracts
Ovary fragments were gently mixed for 1-2 h (until the tissue had disaggregated) in 
calcium-free OR-2 medium () containing 2 mg/ml of collagenase (Sigma, Type I). 
Defolliculated oocytes were washed through several changes of calcium-containing 
medium and allowed to recover for 16-24 h before being used. Pools of 50 oocytes 
(stages I-IV) or 25 oocytes (stages V and VI) were collected and homogenized by 
cycling twenty times through a pipette tip in three volumes of homogenization 
buffer: 0.1 M KCl; 2 mM MgCh; 2 mM dithiothreitol; 0.2% Nonidet P-40; 20mM 
Tris-HCl, pH 7.5. Ater centrifugation at 10,000 rpm for 15 min in a swing-out rotor 
(Sorvall SW24), the clarified supernatant (SN1O) was carefully removed. Nuclei and 
cytoplasms were isolated under paraffin oil as described previously (Paine et al, 
1992) and were resuspended in either homogenization buffer or protein kinase buffer 
(see below).
Immunostaining
Total protein minus pigment and yolk equivalent to three oocytes or embryos was 
separated by SDS-PAGE and transferred to nitrocellulose membranes (Schleicher & 
Schuell). Blots were incubated for 2 h at 20OC with either anti-DV, anti-DR/DH or 
anti-Cpep (1:2000) then with peroxidase-conjugated anti-rabbit IgG (1:3000, 
Chemicon) and developed with 3,3'diaminobenzidine/H20)2.
Protein transfers were also developed using the ECL (Amersham International) 
procedure, after reaction with anti-Cpep (1:5000) and peroxidase-conjugated anti­
rabbit IgG (1:10,000)
Fragments of ovary dissected from immature Xenopus were fixed for 1 h in 3% 
paraformaldehyde/0.25% glutaraldehyde/0.1 M phosphate buffer, pH 7.2, and wax-
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embedded and sectioned as described (Kelly et al., 1991). Dewaxed sections were 
immunostained with anti-DR/DH (1:200) followed by FITC-conjugated anti-rabbit 
IgG (1:500, Chemicon) as described previously Q.
Protein phosphorylation
About Img of the GST-DR, GST-DR/DH and GST-DV fusion proteins were added 
to extracts equivalent to a single nucleus (GV) from stage VI oocytes or from an 
equivalent amount of CK2 isolated from nuclear extracts by chromatography on 
heparin-Sepharose (Pharmacia) . After incubation in the presence of 32PgATP at 
20OC for 30 min, samples were run on SDS-PAGE gels and analysed by 
autoradiography.
Identification of phosphorylated residues
Phospholabelled GST-DV fusion protein was digested with tiypsin (20mg/ml) in 0.1 
M ammonium bicarbonate at 37OC for 4 h. After lyophilization, the sample was 
raised in 50ml of 0.1% trifluoroacetic acid and 20ml of this was applied to a C-18 
microbore column. The elution gradient used was a 5 min isocrat step of 5% 
acetonitrile, followed by a gradient to 50% acetonitrile over 30 min and a 10 min rise 
to 95%. Fractions were collected every min (80ml) and 2ml aliquots were spotted on 
to filter paper and assayed overnight for radioactivity using a phosphorimager. Peak 
radioactive fractions were lyophilized and resuspended in 10ml of 30% acetonitrile. 
These samples were spotted on to a half disk of Sequelon-AA (Millipore) membrane 
(PVDF derivitised with aryl amine groups) and dried at 55°C on a heating block. The 
dried peptide was then attached to the membrane by addition of 5ml of a lOmg/ml 
solution of carbodiimide (EDC). After leaving at room temperature for 20 min, the 
membrane was washed three times in 0.5ml of 50% methanol and then placed in the 
sequencer. The extracted ATZ derivative from each sequencing cycle was collected, 
dried and resuspended in 10 ml of 90% methanol. Aliquots of 2ml were spotted on to 
filter paper and assayed overnight for radioactivity using the phosphorimager.
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Figure legends
Fig. 1. Sequence motifs present in the charged carboxy-termmal domain of HDm.
Fig. 2. HDm uptake into oocyte nuclei and binding to chromatin. (A) Autoradiograph 
showing that HDm and the DH fragment are substantially the only labelled proteins 
synthesized in the reticulocyte lysate system. (B) Injection of labelled proteins into 
the cytoplasm of stage V oocytes results in higher levels of nuclear accumulation of 
HDm (filled circles) than DH (open squares). (C-F) Immunostaining with anti-DV of 
lampbrush chromosomes from stage III oocytes : phase (C) and fluorescent (D) 
images of a condensed bivalent chromosome produced 24h after injection with HDm 
(the limits of the bivalent are indicated by arrows); (E) fluorescent image of (non­
condensed) bivalent after injection with a non-HDm sample (bivalent runs across the 
field, beyond the arrows); (F) fluorescent image of telomeric region (T) 24 h after 
injection with HDm and incubation in 5 ng/ml trichostatin (TSA). Bar represents 
10mm.
Fig. 3. Phosphorylation of fusion proteins containing different regions of HDm by 
CK2 activity from oocyte nuclei.
Fig. 4. Mapping of phosphorylation sites in HDm.
Fig. 5. Dependence on the carboxy-terminal region of HDm for nuclear uptake. 
Fig. 6. Requirement of tail-domain phosphorylation for nuclear import and binding 
to importin a.
Fig. 7. Dephosphorylation of nuclear HDm during oocyte maturation.
Fig. 8. Sequence comparison of tail domains of histone deacetylases from higher 
eukaryotes.
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FIG. 3 Uptake of HDm into the nucleus and chromatin binding.
METHODS: Oocytes were microinjected with 10-20 nl samples of HDm extract and 
incubated at 20°C for the time indicated. Germinal vesicles were isolated under oil as
described2l and iampbrush chromosomes were prepared as described previously12.
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Summary
Reversible acetylation of core histones plays an important regulatory role in 
transcription and replication of chromatin. The acetylation status of chromatin 
is determined by the equilibrium between activities of histone acetyltransferases
and histone deacetylases (HDs). The Xenopus protein HDm shows sequence 
homology to other putative histone deacetylases, but its mRNA is expressed 
only during early development. Both HDm protein and acetylated non­
chromosomal histones are accumulated in developing oocytes, indicating that 
the key components for histone deposition into new chromatin during blastula 
formation are in place by the end of oogenesis. Here we show that the main, 57 
kDa, form of HDm undergoes steady accumulation in the nucleus where it is 
organized in a multiprotein complex of ~360 kDa. This complex has HD activity 
that is sensitive to trichostatin A, zinc ions and phosphatase treatment. The 57 
kDa HDm protein is a marker for HD activity throughout oogenesis and early 
embryogenesis. An earlier-expressed 63 kDa protein, which is exclusively 
cytoplasmic and associated with membrane fractions, may be a precursor of 
the 57 kDa form that it is modified for membrane attachment. Reasons for 
redistribution of ‘HDm during early development are discussed.
Abbreviations: AP, alkaline phosphatase; GST, giurathioue-S~trausferase; HAT, 
histone acetyltransferase; HD, histone deacetylase; TSA, trichostatin A.
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Introduction
Early embryogenesis m Xenopus proceeds from a fertilized egg to a blastula of 
-10,000 cells in a series of 13-14 rapid cell divisions. Throughout this period there is 
no transcriptional activity and the assembly of new chromatin from almost 
continuously replicating DNA is largely dependent on a maternal pool of histones 
and assembly factors. In general, chromatin assembly involves the association of pre- 
acetylated core histones with replicating DNA and subsequent stabilization of 
nucleosomes by histone deacetylation. Newly-synthesized histone H4 is acetylated at 
defined lysine residues by a cytoplasmic histone acetyltransferase (HAT B; Sobel et 
al., 1994). Sequencing of the amino-terminus of newly-synthesized histone H4 from 
a range of different organisms has shown it to be diacetylated, at lysine residues 5 
and 12 (Sobel et al., 1995), although yeast HAT B activity on histone H4 in vitro 
shows some variation from this pattern (Kleff et al., 1995; Parthun et al., 1996). 
Deacetylation would normally occur soon after histone deposition in new chromatin 
but information is only now becoming available as to how histones are accessed by 
histone deacetylase (HD) and to how the deacetylation reaction is regulated.
The aspect of histone deacetylation that has received most attention recently is its 
role in the regulation, most often repression, of the activity of specific sets of genes 
(reviewed by Wolffe, 1996, 1997). For instance, association of HDl with the adaptor 
protein RbAp48 (Taunton et al., 1996), or with the corepressor of the mammalian 
Mad/Max complex, Sin3 (Alland et al., 1997), or with N-CoR, the corepressor of the 
thyroid hormone receptor (Heinzel et al., 1997), may serve to target the deacetylase 
complex to specific chromatin sites. Such interactions appear to be restricted to 
modulation of transcriptional activity of specific genes recognized though the 
presence of transcription factors, such as Mad-Max and the thyroid hormone 
receptor, localized to their promoters. The more extensive deacetylation reactions 
occurring after replication may involve alternative components. Two, 
chromatographically-separable, multiprotein complexes containing histone 
deacetylases, designated HDA and HDB, have been described in yeast (Carmen et 
al., 1996; Rundlett et ai., 1996) but, apart from the deacetylases themselves, other 
protein components have not been identified.
Xenopus AB21 (data bank accession number: X78454) was initially recognized as 
a homologue of the yeast gene regulator &PD3 (Vidal and Gabor, 1991) which was 
later shown also to be a homologue of human HDl (Taunton et al., 1996). There has 
now been cloned and identified an additional series of putative histone deacetylases - 
in yeast (Rundlett et al., 1996), Caenorhabditis (Waterston et al., 1992), Drosophila 
(De Rubertis et al., 1996), and mouse (Bartl et al., 1997) - all of which appear to 
have a conserved region stretching from near the amino terminus to more than half­
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way through the protein sequence. It is likely that this conserved region represents 
the enzyme core responsible for deacetylase activity (Ladomery et al., 1997).
The mRNA encoded by Xenopus AB21 is expressed only in oocytes, remains 
stable in embryos up to neurula and has sequence characteristics of a maternal 
message. Its protein product, HDm (maternal histone deacetylase; Ladomery et al., 
1997), is synthesized during oogenesis and decreases in amount after mid-blastula, 
when the cell-cycle slows down to a normal rate and cells start to differentiate. Here 
we show that HDm is a marker for HD activity during early development and 
describe its presence in protein complexes and the timing of its transportation into 
the nucleus.
Materials and methods
Proteins and Antibodies
Glutathione S-transferase (GST) fusion proteins were expressed from pGEM 
(Pharmacia) vectors and isolated on glutathione-Sepharose 4B according to the 
manufacturer’s instructions. The fragments of HDm cDNA used in the constructs 
have been described (Ladomery et al., 1997). Antibodies to AR/AH and AV fusion 
proteins were raised in rabbits as were antibodies directed against a synthetic peptide 
representing the carboxy-terminal sixteen amino acid residues of HDm plus an 
additional N-terminal cysteine (anti-Cpep).
Oocyte Extracts
Ovary fragments were gently mixed for 1-2 hours (until the tissue had disaggregated) 
in calcium-free OR-2 medium (Evans and Kay, 1991) containing 2 mg/ml of 
collagenase (Sigma, Type I). Defolliculated oocytes were washed through several 
changes of calcium-containing medium and allowed to recover for 16-24 hours 
before being used. Oocytes were sorted into individual stages according to Dumont 
(1977). Pools of 50 oocytes (stages I-IV) or 25 oocytes (stages V and VI) were 
collected and homogenized by cycling twenty times through a pipette tip in three 
volumes of homogenization buffer: 0.1 M KCl; 2 mM MgC%; 2 mM dithiothreitol; 
20mM Tris-HCl, pH 7.5. In some early experiments, the homogenization buffer was 
adjusted to 0.2% Nonidet-P40. After centrifugation at 10,000 rpm for 15 minutes in a 
swing-out rotor (Sorvall SW24), the clarified supernatant (SNIO) was carefully 
removed. Alternatively, extraction was performed using the organic solvent 1,1,2- 
trichlorotrifluoroethane (Freon, Sigma) as described (Evans and Kay, 1991). 
Partitioning using Triton X-114 was carried out as described previously (Hancock et 
al., 1989). Nuclei and cytoplasms were isolated under paraffin oil as described
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previously (Paine et at, 1992) and were resuspended in homogenization buffer for
further extraction.
Immunostaining
Total protein, minus pigment and yolk, equivalent to two oocytes, embryos or 
cytoplasms or to ten nuclei, was separated by SDS-PAGE and transferred to 
nitrocellulose membranes (Schleicher & Schuell). Blots were incubated for 2 hours 
at 20°C with IgG (0.2-1.0 pg/ml) isolated from either anti-AV, anti-AR/AH or anti- 
Cpep antiserum, then with peroxidase-conjugated anti-rabbit IgG (1:10,000, 
Chemicon) and developed using the ECL (Amersham International) procedure.
Fragments of ovary dissected from immaXre Xenopus were fixed for 1 h in either 
3% trichloroacetic acid or 3% paraformaldehyde/0.25% glutaraldehyde/0.1 M 
phosphate buffer, pH 7.2, and wax-embedded and sectioned as described (Kelly et 
al., 1991). Dewaxed sections were immunostained with anti-AR/AH (1:200) 
followed by FITC-conjugated anti-rabbit IgG (1:500, Chemicon).
Enzyme Assay
Deacetylase substrates were prepared essentially as described by Sendra et al.(1988). 
Purified rat liver histones (2 mg) or a peptide corresponding to the eighteen amino­
terminal residues of histone H4 (1 mg) were dissolved in 0.5 ml of 50 mM Na borate 
pH 9.0 and mixed with 6 mCi of ^H-acetic anhydride (Amersham, 8.9 Ci/mmole, 12 
mCi/ml in dioxane). After 3 hours at 0°C the mixture was adjusted to 0.25 M HCl 
and the peptides precipitated with 12 vol. acetone, washed three times in cold 
acetone and dried under vacuum. Histone deacetylase activity was assayed according 
to Li et al. (1996). Up to 100 pi of nuclear extract was mixed with 150 pi of assay 
buffer (25 mM Na phosphate/citric acid pH 7.0), 20 pi of ^H-acetylated peptide or 
histone mix (about 1.2 x 106 dpm, dissolved in assay buffer) and dH2O up to a total 
volume of 300 pi. After 1 hour at 37°C the reaction was stopped by adding acetic 
acid and HCl to 0.12 M and 0.72 M respectively followed by 2 ml of ethyl acetate 
(Sigma). Samples were then vortexed and centrifuged at 9000 x g for 1 minute. Half 
the volume of ethyl acetate was removed and the dissolved 2H-acetate was measured 
by scintillation counting. Samples were dephosphorylated by adding 2 U of alkaline 
phosphatase (Sigma, type III) to 2.5 pi of embryo extract, or 20 pi of oocyte extract, 
adjusting to pH 8.3, and incubating for Ihour at 22°C prior to assay.
Gradient Analysis
Clarified supernatants (SNIO fractions) were layered on 10-25% glycerol gradients 
made up in: 0.1 M KCl; 2 mM MgCb; 2 mM dithiothreitol; 0.2% Nonidet P-40; 
20mM Tris-HCl, pH 7.5. After centrifugation at 30,000 or 36,000 rpm in a 6 x 5 ml
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swing-out rotor (Beckman SW5OTi) at 0°C for 16 hours, the tube contents were 
fractionated. Fractions were analysed for HDm (by immunoblotting) and HD activity
(by the in vitro assay). Size was calculated using protein standards in parallel 
gradients: haemoglobin (67 kDa); IgG (160 kDa); apoferritin (443 kDa); IgM (960
kDa).
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Results
HDm and Potential Histone Deacetylase Activity are Accumulated tbrougb
Oogenesis
The maternal histone deacetylase, HDm, consists of a region highly conserved 
between various putative deacetylases (Ladomery et al., 1997) plus a more variable 
region terminating with a sequence of 100 residues rich in charged side chains (Fig. 
1). It is hypothesized that the conserved region represents the enzyme core and the 
variable region contains regulatory sequences which may be specific to the particular 
deacetylase. Antibodies were raised against GST-HDm fusion proteins containing 
the conserved region (anti-AR/AH), the charged tail domain (anti-AV) and against a 
synthetic peptide representing the carboxy-terminal sixteen amino acid residues of 
HDm (anti-Cpep). All three antibodies recognize a protein of 57 kD present in 
extracts from Xenopus oocytes and embryos separated by SDS-PAGE.
The immunoblotting profiles were compared with an in vitro assay (Li et al.,
1996) to monitor levels of histone deacetylase (HD) activity in the same oocyte and 
embryo extracts. As can be seen (Fig. 2A), the amount of soluble HDm per oocyte 
increases steadily through the course of oogenesis, • to reach a peak in full-grown 
(stage VI) oocytes. It was shown previously that this amount of immunoreactive 
protein remains fairly constant through oocyte maturation (M), fertilization and the 
rapid cell cleavage stages of early embryogenesis, but decreases after blastula 
(Ladomery et al., 1997). Measurement of HD activity in the same samples (Fig. 2C) 
shows that the profile of activity through oogenesis and early embryogenesis is very 
similar to that of the HDm antigen itself. However, these values represent -10,000­
fold higher levels in oocytes compared to mid-blastula embryos on a per cell basis, 
emphasizing the degree of control over HD activity that must be exerted during 
oogenesis when the transcriptionally-active lambrush chromosomes maintain 
acetylated forms of histone H4 (Sommerville et al., 1993) and stored histone H4 is 
accumulated in a diacetylated state (Almounzi et al., 1994).
HDm is Accumulatedfirst in tbe Cytoplasm, tben in tbe Nucleus, of Growing 
Oocytes
Immunoblots, comparing the relative contents of soluble HDm in the cytoplasm and 
nucleus of oocytes at different stages of development (stage III - stage VI), show that 
HDm is present at much higher concentrations in the nucleus, indicating that the 57 
kDa HDm protein undergoes immediate translocation into the nucleus after synthesis 
(Fig. 2B). In apparent contradiction to this picture of immediate nuclear 
accumulation, immunostaining of immature (stage I-II) oocytes in ovarian sections
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shows that the highest concentrations of the HDm antigen are to be found in 
cytoplasmic structures at, or close to, the periphery of the oocyte (Fig. 3A). Similar 
distributions, in the form of vesicle-like structures, are detected using either anti-AV 
or anti-Cpep. Sections of larger (stage IV-V) oocytes show less immunostaining at 
the cell peripheiy and detectable amounts in the nucleus. However, nuclear staining 
is not distributed throughout the nucleoplasm, but rather is located at, or close to, the 
nuclear envelope. So even the nuclear form, which is readily extractable, appears to 
be restricted in its distribution and probably sequestered from the chromatin, which 
lies internally in oocyte nuclei.
The in situ staining of early oocytes highlights material which would be expected 
to sediment on low-speed centrifugation, and therefore to be lost from the oocyte 
extracts (SNIO). Because of this, it was decided to extract the homogenates more 
thoroughly using the organic solvent Freon (Evans and Kay, 1991). In such extracts 
substantial amounts of an additional antigen of -63 kDa were detected on 
immunoblots (Fig. 4A). Freon extraction of isolated nuclei and cytoplasms 
confirmed that most of the cytoplasmic signal in the earlier oocyte stages comes from 
the ~63kDa material (Fig. 4B). From further quantitation, it is estimated that in 
previtellogenic (stage I) oocytes more than 95% of the immunoreactive protein is 
cytoplasmic, whereas in full-grown (stage VI) oocytes more than 95% of the 
immunoreactive protein is nuclear.
On measuring HD activity in nuclear and cytoplasmic isolates after Freon 
extraction, it is seen that the nuclear material is much more active than the 
cytoplasmic material (Fig. 4C). Because cytoplasms not extracted with Freon 
('soluble-fractions') contain up to 50% as much activity as do cytoplasms extracted 
with Freon (Fig. 4C), yet contain no detectable 63 kDa antigen (Fig. 2B), it can be 
concluded HD activity in cytoplasmic fractions derives from the small amounts of 57 
kDa protein that they contain.
Cytoplasmic HDm may be Modified by Acylation
The finding that the cytoplasmic antigen pellets rapidly, is lost from cell extracts 
treated with non-ionic detergents such as Nonidet-P40 (not shown) and can be 
solubilized in Freon, is consistant with its modification by acylation. Acylated 
proteins, such as members of the ras family, can be separated from non-modified 
soluble forms by phase separation using the detergent Triton-Xl 14 (Hancock et al., 
1989). On applying this technique to oocyte extracts, it is seen on immunoblotting 
that almost all of the more slowly migrating, immunoreactive protein partitions into 
the detergent phase (Fig. 5A).The amino acid sequence of HDm shows no consensus 
at the amino terminus for modification by myristoylation, nor for prenylation at, or 
close to, the carboxy terminus: however, palmitoylation at internal cysteine residues
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is a distinct possibility (Milligan et al., 1995). Since palmitoylation involves thioester 
linkage of the fatty acid to the protein, this modification can be distinguished on the 
basis of its susceptibility to cleavage by base such as hydroxylamine. Treatment of 
oocyte extracts with 0.5-2.0 M hydroxylamine results in reduction in amount of the 
-63 kDa form, but not of 57 kDa form, as estimated by immunoblotting (Fig. 5B), 
indicating that the slower migrating immunoreactive components result from a 
modification of HDm compatible with palmitoylation. The conversion of the -63 
kDa immunoreactivily to protein at 57 kDa is clearly seen on comparing the effect of 
hydroxylamine with that of alkaline phosphatase, which does not change the original 
pattern of immunostained bands (Fig. 5C). That the 63 kDa protein is indeed closely 
related to the 57 kDa HDm protein, and not some fortuitously crossreacting 
component, is confirmed by positive immunoblotting with all three antibodies to the 
different regions of HDm (Fig. 5 C,D). Antibodies raised against non-related 
proteins, such as the a-subunits of protein kinase CK2, do not crossreact with the 63 
kDa band (Fig. 5D).
Characterization of HD Activity Present in Oocyte and Embryo Extracts 
Two types of HD activity found in yeast cells (Carmen et al., 1996) can be 
differentiated on the basis of sensitivity to the specific inhibitor trichostatin A (TSA, 
Ikegami et al., 1993). Whereas HDA is inhibited by 80% in the presence of 10 uM 
TSA, HDB is inhibited by less than 20% under the same assay conditions (Carmen et 
al., 1996). On titrating HD activity with increasing concentration of TSA, extracts 
from either oocytes or embryos show a single transition of sensitivity, developing 
-80% inhibition at 0.5 ng/ml (-2 nM) TSA (Fig. 6A). Therefore the HD activity 
present in Xenopus oocytes and early embryos appears to be mainly, if not 
exclusively, of the HDA type.
It has been noted previously that yeast deacetylase is sensitive to the divalent 
cation Zn2+ (Carmen et al., 1996). HDm activity in extracts from both oocytes and 
embryos is about 80% inhibited by ImM ZnCh (Fig. 6B). No similar effect is 
obtained with Mg2+, indicating that excess zinc may be specifically disrupting the 
structure of HDm. A possible role of Zn2+ in the structure of deacetylases has been 
suggested previously (Ladomery et al., 1997).
It has been reported previously (Brosch et al., 1992) that the substrate specificity 
of Zea mays deacetylase is influenced by treatment with alkaline phosphatase (AP). 
Treatment of oocyte and embryo extracts with 50 units/ml AP at 222C for 60 min 
results in a loss of 60-90% of the HD activity in the in vitro assay (Fig. 6C). 
Endogenous HD activity in nuclear extracts was not increased by preincubation with 
ATP to a final concentration of 5 mM (not shown).
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We have been unable to demonstrate significant HD activity in preparations of 
recombinant HDm expressed in bacteria as GST fusion proteins. This suggests that 
HDm must be modified in vivo to gain catalytic activity, possibly through association 
with other proteins or, in view of our results with AP, by phosphorylation. Attempts 
to increase the in vitro deacetylase activity of oocyte extracts, by adding various 
forms of recombinant HDm, were also unsuccessful. In fact, high concentrations of 
the GST-AR/AH protein (>1 mg/ml) actually reduced HD activity by up to 86% 
(results not shown). A possible explanation for this is that rHDm can sequester 
acetylated histones without cleaving them. If this proves to be the case, then the 
apparent presence of histone deacetylase-inhibiting activity in crude cell extracts 
(Carmen et al., 1996; D. A. W., unpublished results) could be due to the presence of 
free HD subunits.
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HDm is a Component of Multimolecular Complexes with Histone Deacetylase 
Activity
Yeast HDA and HDB activities are associated with protein complexes of -350 kDa 
and -600 kDa, respectively (Carmen et al., 1996). The relationship between 
molecular size and deacetylase activity m Xenopus oocyte extracts was measured by 
rate-centrifugation analysis. Clarified supernatants were layered on linear 10-25% 
glycerol gradients, which were centrifuged until a 19S marker (IgM) approached, or 
reached, the bottom of the gradient and then ffacttonated. The fractions were 
analysed for HDm content (by immunoblotting) and histone deacetylase activity 
(using the in vitro assay).
Supernatants from previtellogenic (PV) ovary (containing only stage I oocytes) 
give a heterodisperse distribution of HDm activity, which extends from fractions 
corresponding to single proteins to complexes of -360 kDa (Fig. 7A). Although 
stage I oocytes contain mainly the vesicle-associated 63 kDa form, the HD activity 
detected probably derives from the released 57 kDa form which shows up in the 
immunoblot (Fig. 7B). As described earlier, extraction with Freon gives a more 
efficient extraction of HDm proteins from early-stage oocytes. Sedimentation 
analysis of Freon-extracted PV ovary reveals not only a better recovery of the 63 kDa 
protein but also its sharper resolution into a single peak that sediments at a rate 
corresponding to a total mass of -200 kDa (Fig. 7C). It is not known whether this 
inactive form of HDm is present as a multimeric protein in the membrane fraction or 
forms such a complex on its release from the membranes.
In comparison with non-extracted PV ovary samples, supernatants from non- 
extracted vitellogenic (stage V) oocyte homogenates give a more distinct peak of HD 
activity (Fig. 7A), which corresponds to those fractions showing peak
immunoreactivity of the 57 kD protein (Fig. 7D). This peak would correspond to a 
protein complex with a total mass of -360 kDa. Again, the 63 kDa cytoplasmic 
antigen is spread through much of the gradient but appears to contribute little to 
enzyme activity.
Supernatants from full-grown (stage VI) oocytes lack the 63 kDa protein and 
show HD activity sedimenting sharply at -360 kDa (Fig 8A). A similar peak of 
activity is obtained from isolated nuclei (Fig. 8B). Immunoblot analysis of fractions 
from both nuclei (Fig. 8C) and cytoplasms (Fig. 8D) confirms that the 57 kDa 
protein in the -360 kDa complex is mostly nuclear in origin. Pretreatment of stage 
VI oocytes with progesterone for 16 hours, which leads to the completion of oocyte 
maturation (including nuclear breakdown), has no significant effect on the 
sedimentation properties of the HD complex (Fig. 8A). Supernatants from Freon- 
extracted homogenates of early embryos (at mid-blastula) show that, in addition to 
the mature 57 kDa protein, there is a reappearance of the 63 kDa form (Fig. 8E). The
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most likely explanation is that this reappearance is due to de novo protein synthesis 
and membrane-association of the putative precursor form. A second phase of 
translation would also explain the previously-noted observation that the mRNA 
encoding HDm persists as a stable maternal message through early development until 
neurula (Ladomery et al, 1997). Thus the pool of oocyte-synthesized HDm appears 
to be supplemented during blastula formation by further translation of its mRNA.
All of the results presented here indicate that the active form of histone 
deacetylase present in oocytes and early embryos consists of a protein complex of 
~360 kDa which contains the 57 kDa HDm protein. To confirm that HDm- 
containing complex is associated with the HD activity detected in oocytes, 
immunoprecipitation experiments were carried out using anti-Cpep. Of the total 
amount of enzyme activity incubated with affinity selected IgG, 50% was recovered 
bound to protein A-Sepharose after thorough washing of the resin (Fig. 9). This 
compares with 0.6% of the activity bound to the resin in the absence of specific IgG. 
The affinity-bound fraction retained its activity while still coupled to the resin and, 
overall, about 95% of the input activity was recovered in the various fractions (Fig. 
9), indicating the robust nature of the enzyme.
Discussion
Relationship between HDm proteins and HD Activity
In all of the samples tested from Xenopus oocytes and early embryos, there is a direct 
correspondence between the amount of the 57 kDa HDm protein detected and the 
level of HD activity assayed. This relationship is apparent in a range of different 
situations, particularly in the developmental expression pattern and in sedimentation 
characteristics. The observation that over 50% of recovered HD activity is 
immunoprecipitated by antibodies directed against the carboxy-terminal peptide of 
HDm indicates that HDm represents the major HD activity present in oocytes. No 
other crossreacting bands are detected on immunoblotting soluble extracts from 
oocytes with antibodies directed against regions of HDm conserved in all other 
histone deacetylases described (Ladomery et al., 1997). However, extraction of 
oocyte homogenates or membrane fractions with detergents or organic solvent 
releases substantial amounts of additional immunoreactive protein with an apparent 
mass on SDS-PAGE of 63 kDa. The observations that the 63 kDa band partners the 
57 kDa band in almost every situation of isolation, extraction and separation and that 
both bands crossreact with the three specific antibodies used in this study, point to a 
close relationship between the two proteins. The ability of hydroxylamine to covert 
the 63 kDa form to a 57 kDa form strongly indicates that the relationship is between 
a form modified by acylation (most likely palmitoylation) and its unmodified form.
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The interpretation that the acylated form represents a cytoplasmic, membrane- 
associated precursor of the largely nuclear, unmodified form, gains support from the 
changes seen in their relative abundance with development. Immunoblotting shows 
progressive loss of the 63 kDa protein from the cytoplasm and progressive 
accumulation of the 57 kDa protein in the nucleus. The immunocytological studies 
can also be interpreted as showing translocation of HDm antigen from cytoplasm to 
nucleus.
HD Complexes in Oocytes
In several respects the HD complexes described here are similar to the HDA 
complexes described for S. cerevisiae (Carmen et al., 1996; Rundlett et al., 1996). In 
yeast, two distinct types of complex are found: HDA, which has an estimated mass 
of ~350 kDa, deacetylates all four core histones, and is strongly inhibited by TSA; 
and HDB, which has a mass of ~600 kDa and is relatively insensitive to TSA. All of 
the 57 kDa HDm antigen and nearly all of the HD activity recovered from both 
whole oocytes and oocyte nuclei, is found in a peak of material sedimenting with an 
average mass of 360 kDa. Although the membrane-released 63 kDa protein is also 
recovered as a protein complex (of -200 kDa) we are unable to detect much HD 
activity in this material. No complexes were detected with masses approaching 600 
kDa. Analysis of HD activity from oocyte extracts by gel-filtration (not shown) also 
gives an estimated mass between 350 and 400 kDa. The composition of the oocyte 
complex is not yet known, although crosslinking experiments indicate that they 
contain more than one molecule of HDm. Yet multimers of HDm alone may not be 
sufficient for HD activity, for none of the recombinant HDm proteins that have been 
expressed in bacteria have shown any activity. Work is in progress to identify other 
proteins in the -360 kDa complex which might be required as cofactors for HD 
activity and to determine the role of phosphorylation in its control.
All of the samples extracted from oocytes and embryos show sensitivity to TSA 
comparable to that of yeast HDA, with 80% inhibition of HD activity at a 
concentration of 0.5 ng/ml (-2nM) TSA. Although substrate specificity has not yet 
been examined in detail, the conditions of in vitro deacetylation used in this present 
study show that a mixture of rat liver histones or a peptide corresponding to the 
amino-terminal eighteen amino acid residues of histone H4, act equally well as 
substrates for the oocyte enzyme.
Sequestering of HD Activity during Oogenesis
Accumulation of HDm-contaming complexes, along with their associated HD 
activity, presents a problem for the oocyte in handling such enormous amounts of 
potential activity. A single full-grown oocyte contains as much HD activity as 10,000
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embryonic cells at blastula. Yet oocytes contain chromatin, in the form of lampbrush 
chromosomes, that is highly active in transcription, a condition reflected by the 
widespread occurrence of hyperacetylated forms of histone H4. On immunostaining 
lampbrush chromosomes using antibodies which recognize specifically the four 
different acetylation sites in the amino-terminal region of histone H4 (Turner et al, 
1992), three of the sites, Lys8, Lysl2 and Lysl6, were found to be acetylated at 
multiple foci within the chromatin (Sommerville et al., 1993). Furthermore, such 
extensive acetylation appeared to be stable, because incubation of the oocytes in the 
potent inhibitor of histone deacetylases, sodium butyrate, did not increase the signal 
given by the antibodies to acetylated lysines. Thus it appears that the HD activity 
accumulated in oocytes has little natural access to the endogenous chromatin. Indeed, 
lampbrush chromosomes isolated from stage III/IV oocytes are not immunostamed 
using the anti-HDm antibodies (J. S., unpublished).
In addition to the acetylated histones contained in the chromatin, oocytes are 
accumulating large pools of acetylated histones to be used in the formation of new 
chromatin during the 13-14 cell divisions leading to blastula. It is estimated that each 
full-grown oocyte contains 21 ng of maternal histone H4 (Adamson and Woodland, 
1974) which remains in a diacetylated form until after incorporation into the newly- 
replicated chromatin (Dimitrov et al., 1993; Almouzni et al., 1994). The storage of 
acetylated maternal histones and their rapid incorporation into new embryonic 
chromatin is a phenomenon that has been described in different developmental 
systems. For instance, in both sea urchins (Chambers and Shaw, 1984) and starfish 
(Ikegami et al., 1993) maternal histone H4 is stored in a diacetylated form which is 
followed, during blastula formation, by a wave of deacetylation. All of these 
observations serve to emphasize the need to keep apart stored HD activity and stored 
acetylated histones until after deposition in embryonic chromatin.
The observation that extracts taken from all stages of early Xenopus development 
have an immediately available histone deacetylase activity would argue that 
sequestration of HD activity from, stored histones involves compartmentalization 
within the intact cells rather than the regulated expression of inhibitoiy factors. The 
difficulty in extracting all of the HDm from early-stage oocytes gives a pointer to 
possible mechanisms. Most of the HDm antigen is recovered from stage I-III oocytes 
only after extraction with the organic solvent Freon, which efficiently solubilizes the 
membranous material present in oocyte homogenates. Use of a nonionic detergent 
such as NP40 does not aid recovery, presumably due to loss of the membrane- 
associated protein into detergent micelles (extraction into the detergent phase was , in 
fact, achieved using Triton -XI14). If not solvent extracted, the non-soluble 
component of HDm is lost into pellet fractions after low speed centrifugation. The 
presence of HDm in a non-soluble, fast-sedimenting fraction is compatible with the
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immunostaining results which show the highest concentrations of reactive material at 
the oocyte membrane and in vesicular structures close to the cell perimeter. It is 
possible that these sites represent structures responsible for the anchorage of HDm in 
the cytoplasm. The insoluble HDm antigen has an apparent mass on SDS-PAGE of 
63 kDa, which is significantly greater than that of the soluble 57 kDa form. It is 
likely that the higher molecular weight forms arise through modification of the HDm 
protein, and it is suggested here that this modification is in the form of acylation.
Although sequestration of HDm in the cytoplasm might be achieved by membrane 
attachment alone and would explain one way of keeping HD activity away from 
accumulating acetylated histones, as discussed earlier, the recovered cytoplasmic 
material shows little HD activity. However, HDm with associated HD activity does 
accumulate in the nucleus in what appears to be a fairly soluble form. Studies using 
chicken immature erythrocytes claim an association of nuclear HD activity with 
nuclear matrix material (Li et al., 1996). While we have no evidence for such an 
association, it is interesting to note that immunoreactivity in later stage oocytes 
occurs around the periphery of the nucleus and not throughout the nucleoplasm. As 
mentioned earlier, oocyte chromatin, organized as lampbrush chromosomes, is 
located internally in the nucleus and remains unstained with anti-HDm. Therefore, 
even in the nucleus, restraints may be placed on the ability of HDm to make contact 
with the chromatin and possibly also with the stored maternal histones. However, an 
alternative explanation is that the stored histones are protected from deacetylation by 
their close association with chaperones such as N1/N2 and nucleoplasmin.
The reason for accumulation of HDm in the oocyte nucleus is not altogether clear, 
but the nuclear envelope may serve as a final point of assembly of the active HD 
complex. This complex could then be distributed among the early embryonic cells, 
through cell divisions, along with components of the envelope. It is also possible that 
HDm has an additional role in deacetylating proteins other than histones in the 
oocyte nucleus: as yet no information is available on other types of acetylated protein 
in oocytes.
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Figure legends
Fig. 1. Representation of the HDm protein showing the location of the conserved 
region and the variable region, with the the highly-charged tail domain boxed black. 
Parts of the protein sequence used to raise the antibodies anti-AR/AH, anti-AV and 
anti-Cpep are shown below.
Fig. 2. Levels of soluble HDm protein and HD activity in oocytes at different stages 
of development. (A) Immunoblot, using anti-Cpep, of extracts from different stage 
oocytes. Each track contains the protein equivalent of two oocytes. Stages are from I 
to VI plus stage VI oocytes matured (VIM) by treatment with progesterone for 16 
hours. The fusion protein GST-AV (0.1 pg) is used as a positive control at 48 kDa. 
(B) Immunoblot, using anti-Cpep, of nuclear (N) and cytoplasmic (C) proteins from 
stage III to stage VI oocytes. Each track contains the protein equivalent of ten nuclei 
or two cytoplasms. (C) Histone deacetylase activity assayed in extracts from oocytes 
(stages as in A) or embryos (C, 8-cell; B, mid-blastula; G, gastrula). Activity is 
expressed as dpm of 3H-acetate released from histone by extracts equivalent to a 
single oocyte or embryo (total column height). Also indicated is the relative 
amount/cell (%, black column height), which becomes disappearingly small as cell 
divisions increase in number.
Fig, 3, Immunostaming of sectioned ovary and embryo. (A) Fluorescence image of 
stage II oocytes stained with anti-Cpep, showing imunostaining restricted to vesicle­
like structures (V) at the periphery of the cytoplasm. (B) Section shown in (A) 
viewed for DAPI staining. The oocytes are contained within a layer of follicle cells, 
the nuclei of which are stained (F). (C) Fluorescence image of a stage IV oocyte 
stained with anti-AV, showing immunostaining deposits (arrows) at the periphery of 
the nucleus (N). (D) as (C), but of a stage V oocyte showing more complete covering 
of immunostainmg material (arrows) at the nuclear envelope. (E) Fluorescence image 
of a blastula-stage embryo stained with anti-AV, showing nuclear immunostaming 
(arrowheads). The cytoplasmic fluorescence is on the yolk platelets which may bind 
cytoplasmic antigen. (F) Corresponding DAPI staining, showing positions of nuclei 
and chromosomes. The bar represents 50 pm.
Fig. 4. Levels of HDm protein and HD activity extracted from oocyte preparations 
after treatment with the organic solvent Freon. (A) Immunoblot, using anti-Cpep, of 
extracts from different stage oocytes homogenized in Freon. Each track contains the 
protein equivalent of two oocytes. Stages as described in Fig. 2. (B) Immunoblot, 
using anti-Cpep, of nuclear (N) and cytoplasmic (C) proteins after Freon extraction.
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Solubilized material from stage III to stage VI oocytes was analysed. Each track 
contains the protein equivalent of ten nuclei or two cytoplasms. (C) Histone 
deacetylase activity assayed in extracts from nuclei (N, black columns) and 
cytoplasms (C, cross-hatched columns). Activity is expressed as dpm of 3H-acetate 
released from histone by extracts equivalent to a single oocyte. Of the two columns 
in each set, the left-hand one is for homogenates treated with Freon and the right­
hand one is for soluble extracts.
Fig. 5. Characterization of the membrane-bound 63 kDa protein. (A) Immunoblot, 
using anti-Cpep, showing partitioning of the 63 kDa antigen from the membrane 
vesicle fraction into the Triton-Xl 14 phase (TX) rather than the supernatant (S). (B) 
Immunoblot, using anti-Cpep, showing proteins from the membrane vesicle fraction 
treated with increasing concentrations of hydroxylamine. The fusion protein GST- 
AV (0.1 pg) is used as a positive control at 48 kDa. (C) As (B), but showing a 
comparison of treatment with IM hydroxylamine (HA) with treatment with 2 U/pl of 
alkaline phosphatase (AP). (D) Immunoblots of membrane vesicle (V) and soluble 
(S) fractions using anti-AV, anti-AR/AH and anti-CK2a.
Fig. 6. Characteristics of oocyte and embryo HD activity. (A) Sensitivity to 
trichostatin A (TSA). (B) Sensitivity to zinc ions. (C) Sensitivity to treatment with 
alkaline phosphatase. Soluble extracts from stage VI oocytes (black columns) were 
incbated in the absence (-) or presence (+) of alkaline phosphatase (2U/pl of extract).
Fig. 7. Sedimentation analysis of protein complexes that contain HDm protein and 
HD activity in developing oocytes. (A) Activity profiles of soluble extracts from 
previtellogenic (PV, white squares) ovary (including -4,000 stage I oocytes) and 
from 25 stage V oocytes (black circles). Peak sedimentation positions of molecular 
mass markers (Mr) are shown (crosses). (B) Immunoblot, using anti-Cpep, of PV 
material recovered from alternative fractions in (A) reacted with anti-Cpep. The 
fusion protein GST-AV (0.1 pg) is used as a positive control at 48 kDa. (C) As (B), 
but from a gradient used to separate a Freon-treated sample. (D) Immunoblot of stage 
V material recovered from alternate fractions in (A) reacted with anti-AV.
Fig. 8, Sedimentation analysis of protein complexes that contain HDm protein and 
HD activity in full-grown oocytes, mature oocytes and early embiyos. (A) Activity 
profiles of soluble extracts from 50 stage VI oocytes (black circles) and from 50 
stage VI oocytes that had been matured for 16 hours by treatment with progesterone 
(white squares). Peak sedimentation positions of molecular mass markers (Mr) are 
shown (crosses). (B) Activity profile of soluble extract from 100 nuclei (black
239
circles) isolated from stage VI oocytes. (C) Immunoblot, using anti-Cpep, of stage VI 
nuclear material recovered from alternative fractions in (B). The material pelleted in 
the gradient (P) and the fusion protein GST-AV are included in the blot. (D) As (C), 
but from a gradient used to separate the Freon-treated extract of 100 stage VI 
cytoplasms. This blot is overexposed to show that the veiy small amount of the 57 
kDa protein isolated from the cytoplasm is contained in particles sedimenting at the 
same rate as those containing the nuclear protein. (E) As (C), but from a gradient 
used to separate the Freon-treated extract of 50 blastula stage VI embryos.
Fig. 9. Specific immunoprecipitation of HD activity from a soluble stage VI oocyte 
extract. Samples eluted from anti-Cpep resin (a-P, black colunms) are compared with 
samples eluted from control resin (C, cross-hatched columns). Unbound (UB), first 
wash (Wl), second wash (W2), third wash (W3) and resin-bound (bound) fractions 
were assayed for HD activity and expressed as a percentage of the total activity 
applied to the resin.
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